Press releases, news & announcements 27 April 2026 DSM B.V. publishes 2025 Annual Report DSM B.V. publishes 2025 Annual Report 15 April 2025 DSM B.V. publishes 2024 Annual Report DSM B.V. publishes 2024 Annual Report 29 February 2024 dsm-firmenich publishes 2023 Integrated Annual Report dsm-firmenich, innovators in nutrition, health, and beauty, today announces the publication of its first Integrated Annual Report (IAR). 29 February 2024 dsm-firmenich publishes 2023 Integrated Annual Report dsm-firmenich, innovators in nutrition, health, and beauty, today announces the publication of its first Integrated Annual Report (IAR). 2 May 2023 DSM provides Q1 2023 trading update | DSM Prioritising profitability over sales volumes has supported our margins, which improved sequentially into the first quarter.” DSM provides Q1 2023 trading update | DSM Prioritising profitability over sales volumes has supported our margins, which improved sequentially into the first quarter.” 28 April 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, DSM and DSM-Firmenich are required to announce transactions in relation to the ordinary shares in their respective share capital in accordance with the Dutch public offer rules. DSM - delivery of shares Following the Offering Circular published on 22 November 2022, DSM and DSM-Firmenich are required to announce transactions in relation to the ordinary shares in their respective share capital in accordance with the Dutch public offer rules. 26 April 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, DSM and DSM-Firmenich are required to announce transactions in relation to the ordinary shares in their respective share capital in accordance with the Dutch public offer rules. DSM - delivery of shares Following the Offering Circular published on 22 November 2022, DSM and DSM-Firmenich are required to announce transactions in relation to the ordinary shares in their respective share capital in accordance with the Dutch public offer rules. 25 April 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, DSM and DSM-Firmenich are required to announce transactions in relation to the ordinary shares in their respective share capital in accordance with the Dutch public offer rules. DSM - delivery of shares Following the Offering Circular published on 22 November 2022, DSM and DSM-Firmenich are required to announce transactions in relation to the ordinary shares in their respective share capital in accordance with the Dutch public offer rules. 24 April 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, DSM and DSM-Firmenich are required to announce transactions in relation to the ordinary shares in their respective share capital in accordance with the Dutch public offer rules. DSM - delivery of shares Following the Offering Circular published on 22 November 2022, DSM and DSM-Firmenich are required to announce transactions in relation to the ordinary shares in their respective share capital in accordance with the Dutch public offer rules. 21 April 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, DSM and DSM-Firmenich are required to announce transactions in relation to the ordinary shares in their respective share capital in accordance with the Dutch public offer rules. DSM - delivery of shares Following the Offering Circular published on 22 November 2022, DSM and DSM-Firmenich are required to announce transactions in relation to the ordinary shares in their respective share capital in accordance with the Dutch public offer rules. 20 April 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, DSM and DSM-Firmenich are required to announce transactions in relation to the ordinary shares in their respective share capital in accordance with the Dutch public offer rules. DSM - delivery of shares Following the Offering Circular published on 22 November 2022, DSM and DSM-Firmenich are required to announce transactions in relation to the ordinary shares in their respective share capital in accordance with the Dutch public offer rules. 19 April 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, DSM and DSM-Firmenich are required to announce transactions in relation to the ordinary shares in their respective share capital in accordance with the Dutch public offer rules. DSM - delivery of shares Following the Offering Circular published on 22 November 2022, DSM and DSM-Firmenich are required to announce transactions in relation to the ordinary shares in their respective share capital in accordance with the Dutch public offer rules. 19 April 2023 DSM agrees terms to acquire postbiotics pioneer Adare Biome DSM announces that it has entered into exclusive negotiations with Adare Pharma Solutions in order to acquire Adare Biome, a pioneer in the development and manufacturing of postbiotics, for an enterprise value of €275 million. This transaction represents an estimated 2023 EV/EBITDA multiple of 18x. DSM agrees terms to acquire postbiotics pioneer Adare Biome DSM announces that it has entered into exclusive negotiations with Adare Pharma Solutions in order to acquire Adare Biome, a pioneer in the development and manufacturing of postbiotics, for an enterprise value of €275 million. This transaction represents an estimated 2023 EV/EBITDA multiple of 18x. 6 April 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 5 April 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 4 April 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 3 April 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 3 April 2023 DSM completes sale of Engineering Materials business Royal DSM announces the completion of the sale of its Engineering Materials business to Advent International and LANXESS for an Enterprise Value of €3.85 billion. DSM completes sale of Engineering Materials business Royal DSM announces the completion of the sale of its Engineering Materials business to Advent International and LANXESS for an Enterprise Value of €3.85 billion. 31 March 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 30 March 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 30 March 2023 Large scale pilot proves methane-reducing feed additive Bovaer® is ready for roll-out in the Netherlands Dutch dairy company Royal FrieslandCampina, DSM, and feed supplier Agrifirm have successfully incorporated Bovaer® into the regular farming activities of 158 dairy farms in the Netherlands in the world’s first large-scale on-farm use of the methane-reducing feed additive for cattle. Large scale pilot proves methane-reducing feed additive Bovaer® is ready for roll-out in the Netherlands Dutch dairy company Royal FrieslandCampina, DSM, and feed supplier Agrifirm have successfully incorporated Bovaer® into the regular farming activities of 158 dairy farms in the Netherlands in the world’s first large-scale on-farm use of the methane-reducing feed additive for cattle. 29 March 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 29 March 2023 DSM quantifies food system impact DSM reveals the first audited results of its progress in helping to address urgent societal and environmental challenges linked to how the world produces and consumes food. DSM quantifies food system impact DSM reveals the first audited results of its progress in helping to address urgent societal and environmental challenges linked to how the world produces and consumes food. 28 March 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 27 March 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 24 March 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 23 March 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 22 March 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 21 March 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 20 March 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 17 March 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 16 March 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 15 March 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 14 March 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 13 March 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 8 March 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 7 March 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 6 March 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 3 March 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 2 March 2023 DSM publishes Integrated Annual Report 2022 | DSM Royal DSM, a global purpose-led, performance-driven leader in Health, Nutrition & Bioscience, today announces the publication of its 2022 Integrated Annual Report (IAR). DSM publishes Integrated Annual Report 2022 | DSM Royal DSM, a global purpose-led, performance-driven leader in Health, Nutrition & Bioscience, today announces the publication of its 2022 Integrated Annual Report (IAR). 27 February 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 27 February 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 24 February 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 24 February 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 20 February 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 20 February 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 17 February 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 17 February 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 16 February 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 16 February 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 16 February 2023 DSM reports 2022 results DSM delivered a solid performance in 2022 against a background of continued global supply chain challenges and significantly higher energy and raw materials costs, consolidating the strong growth of 2021. Pricing actions to counter higher costs, supported top-line growth, however with a price-cost gap impacting near-term margins, especially in Animal, Nutrition & Health. 16 February 2023 DSM reports 2022 results DSM delivered a solid performance in 2022 against a background of continued global supply chain challenges and significantly higher energy and raw materials costs, consolidating the strong growth of 2021. Pricing actions to counter higher costs, supported top-line growth, however with a price-cost gap impacting near-term margins, especially in Animal, Nutrition & Health. 13 February 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 13 February 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 10 February 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 10 February 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 8 February 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 8 February 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 3 February 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 3 February 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 2 February 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 2 February 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 1 February 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 1 February 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 30 January 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 30 January 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 24 January 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 24 January 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 23 January 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 23 January 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 23 January 2023 DSM shareholders approve DSM-Firmenich merger at EGM | DSM DSM today held an Extraordinary General Meeting of Shareholders (EGM). The DSM Shareholders approved the proposed merger between DSM and Firmenich International SA (Firmenich) and voted in favour of all related resolutions as set out in the notice of the EGM. 23 January 2023 DSM shareholders approve DSM-Firmenich merger at EGM | DSM DSM today held an Extraordinary General Meeting of Shareholders (EGM). The DSM Shareholders approved the proposed merger between DSM and Firmenich International SA (Firmenich) and voted in favour of all related resolutions as set out in the notice of the EGM. 20 January 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 20 January 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 19 January 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 19 January 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 18 January 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 18 January 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 17 January 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 17 January 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 16 January 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 16 January 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 13 January 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 13 January 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 12 January 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 12 January 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 11 January 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 11 January 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 10 January 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 10 January 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 9 January 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 6 January 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 5 January 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 4 January 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 3 January 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 2 January 2023 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 30 December 2022 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 30 December 2022 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 29 December 2022 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 29 December 2022 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 27 December 2022 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 27 December 2022 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 23 December 2022 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 23 December 2022 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 20 December 2022 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 20 December 2022 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 19 December 2022 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 19 December 2022 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 15 December 2022 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 15 December 2022 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options. 13 December 2022 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. 13 December 2022 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. 6 December 2022 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. 6 December 2022 DSM - delivery of shares Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. 30 November 2022 DSM starts construction of production facility for its novel Bovaer® methane-reducing feed in Dalry The plant will significantly increase global production of Bovaer®, DSM’s unique methane-reducing feed additive for cattle. In an official groundbreaking ceremony attended by the First Minister of Scotland, Nicola Sturgeon, and Dimitri de Vreeze, Co-CEO of DSM, the company marked the next step in its plan to use Bovaer® to reduce global methane emissions and contribute to worldwide methane reduction targets. 30 November 2022 DSM starts construction of production facility for its novel Bovaer® methane-reducing feed in Dalry The plant will significantly increase global production of Bovaer®, DSM’s unique methane-reducing feed additive for cattle. In an official groundbreaking ceremony attended by the First Minister of Scotland, Nicola Sturgeon, and Dimitri de Vreeze, Co-CEO of DSM, the company marked the next step in its plan to use Bovaer® to reduce global methane emissions and contribute to worldwide methane reduction targets. 17 November 2022 Science Based Targets initiative validates DSM’s ambition to reduce direct greenhouse gas emissions as 1.5°C aligned DSM confirms that its target to cut scope 1 and 2 greenhouse gas (GHG) emissions has been determined to be in line with the latest climate science and in keeping global warming to no more than 1.5°C by the Science Based Targets initiative (SBTi). 17 November 2022 Science Based Targets initiative validates DSM’s ambition to reduce direct greenhouse gas emissions as 1.5°C aligned DSM confirms that its target to cut scope 1 and 2 greenhouse gas (GHG) emissions has been determined to be in line with the latest climate science and in keeping global warming to no more than 1.5°C by the Science Based Targets initiative (SBTi). 1 November 2022 DSM provides Q3 2022 trading update DSM’s trading update for the first nine months of 2022 is out now and our Health, Nutrition & Bioscience businesses all delivered good sales growth. Market demand remained resilient in what is a challenging macro-economic environment with the rising cost inflation. 1 November 2022 DSM provides Q3 2022 trading update DSM’s trading update for the first nine months of 2022 is out now and our Health, Nutrition & Bioscience businesses all delivered good sales growth. Market demand remained resilient in what is a challenging macro-economic environment with the rising cost inflation. 1 September 2022 DSM completes acquisition of Prodap DSM today announces the completion of its acquisition of Prodap, a leading animal nutrition and technology company in Brazil. 1 September 2022 DSM completes acquisition of Prodap DSM today announces the completion of its acquisition of Prodap, a leading animal nutrition and technology company in Brazil. 1 September 2022 DSM completes sale of Protective Materials business DSM, a global purpose-led science-based company, today announces the completion of the sale of its Protective Materials business to Avient Corporation 1 September 2022 DSM completes sale of Protective Materials business DSM, a global purpose-led science-based company, today announces the completion of the sale of its Protective Materials business to Avient Corporation 2 August 2022 DSM reports H1 2022 results A good half year performance underpinned by resilient market demand. DSM reports H1 2022 results A good half year performance underpinned by resilient market demand. 2 August 2022 DSM sets new climate targets to accelerate route to net-zero DSM announces that it pledges to purchase all of its electricity worldwide from renewable sources DSM sets new climate targets to accelerate route to net-zero DSM announces that it pledges to purchase all of its electricity worldwide from renewable sources 28 June 2022 DSM provides 2021 and 2022 Q1 comparative figures Royal DSM, a global purpose-led science-based company, today provides the investment community with comparative quarterly figures for 2021 and 2022 Q1. DSM provides 2021 and 2022 Q1 comparative figures Royal DSM, a global purpose-led science-based company, today provides the investment community with comparative quarterly figures for 2021 and 2022 Q1. 7 June 2022 DSM acquires Brazil’s leading animal nutrition technology company to boost precision services offering Royal DSM, a global purpose-led science-based company, announces it has reached an agreement to acquire Prodap, a Brazilian animal nutrition and technology company that combines technology offerings, consulting services, and customized nutritional solutions to drive efficiency and sustainability in animal farming. DSM acquires Brazil’s leading animal nutrition technology company to boost precision services offering Royal DSM, a global purpose-led science-based company, announces it has reached an agreement to acquire Prodap, a Brazilian animal nutrition and technology company that combines technology offerings, consulting services, and customized nutritional solutions to drive efficiency and sustainability in animal farming. 31 May 2022 DSM announces sale of Engineering Materials business Royal DSM, a global purpose-led science-based company, today announces that it has reached an agreement to sell its Engineering Materials business to Advent International and LANXESS for an Enterprise Value of €3.85 billion. DSM announces sale of Engineering Materials business Royal DSM, a global purpose-led science-based company, today announces that it has reached an agreement to sell its Engineering Materials business to Advent International and LANXESS for an Enterprise Value of €3.85 billion. 24 May 2022 DSM and the World Food Programme partner to improve nutrition around the world Royal DSM and the World Food Programme (WFP) have agreed to extend their partnership and scale up rice fortification worldwide for a further three years. The partnership will seek to improve the availability and accessibility of nutritious foods in order to reach vulnerable people where key dietary decisions are made. DSM and the World Food Programme partner to improve nutrition around the world Royal DSM and the World Food Programme (WFP) have agreed to extend their partnership and scale up rice fortification worldwide for a further three years. The partnership will seek to improve the availability and accessibility of nutritious foods in order to reach vulnerable people where key dietary decisions are made. 10 May 2022 Final dividend 2021 Royal DSM Royal DSM, a global purpose-led science-based company, confirmed its resolution to declare a dividend for the financial year 2021 of €2.50 per ordinary share was passed today, 10 May 2022, at its Annual General Meeting of Shareholders. Final dividend 2021 Royal DSM Royal DSM, a global purpose-led science-based company, confirmed its resolution to declare a dividend for the financial year 2021 of €2.50 per ordinary share was passed today, 10 May 2022, at its Annual General Meeting of Shareholders. 10 May 2022 DSM announces results of 2022 Annual General Meeting of Shareholders Royal DSM, a global purpose-led science-based company, today held its Annual General Meeting of Shareholders. All the resolutions on the agenda were approved by the shareholders. DSM announces results of 2022 Annual General Meeting of Shareholders Royal DSM, a global purpose-led science-based company, today held its Annual General Meeting of Shareholders. All the resolutions on the agenda were approved by the shareholders. 10 May 2022 DSM, UNICEF and Sight and Life extend global partnership to address malnutrition at scale Royal DSM, a global purpose-led science-based company, the United Nations’ children’s agency UNICEF, and Swiss-based nutrition think tank and incubator Sight and Life have renewed their long-term partnership to deliver better nutrition for at-risk groups in countries in Sub-Saharan Africa and Asia. DSM, UNICEF and Sight and Life extend global partnership to address malnutrition at scale Royal DSM, a global purpose-led science-based company, the United Nations’ children’s agency UNICEF, and Swiss-based nutrition think tank and incubator Sight and Life have renewed their long-term partnership to deliver better nutrition for at-risk groups in countries in Sub-Saharan Africa and Asia. 10 May 2022 DSM - repurchase of shares (2-6 May 2022) Royal DSM, a global purpose-led science-based company, has repurchased 40,085 of its own shares in the period from 2 May 2022 up to and including 6 May 2022 at an average price of €156.08. DSM - repurchase of shares (2-6 May 2022) Royal DSM, a global purpose-led science-based company, has repurchased 40,085 of its own shares in the period from 2 May 2022 up to and including 6 May 2022 at an average price of €156.08. 3 May 2022 DSM - repurchase of shares (25-29 April 2022) Royal DSM, a global purpose-led science-based company, has repurchased 157,671 of its own shares in the period from 25 April 2022 up to and including 29 April 2022 at an average price of €156.34. DSM - repurchase of shares (25-29 April 2022) Royal DSM, a global purpose-led science-based company, has repurchased 157,671 of its own shares in the period from 25 April 2022 up to and including 29 April 2022 at an average price of €156.34. 3 May 2022 DSM provides Q1 2022 trading update DSM delivered a good first quarter. DSM provides Q1 2022 trading update DSM delivered a good first quarter. 27 April 2022 Elanco and Royal DSM Announce Strategic Alliance in U.S. for Bovaer® – A Revolutionary, Methane-Reducing Feed Additive for Cattle Elanco Animal Health Incorporated (ELAN: NYSE) and Royal DSM have created a strategic alliance connecting two leading, sustainability-focused companies to address one of society’s most significant opportunities of the decade, mitigating climate change by reducing greenhouse gas emissions from farming. Elanco has secured the exclusive U.S. licensing rights to develop, manufacture and commercialize Bovaer® for beef and dairy cattle. Elanco and Royal DSM Announce Strategic Alliance in U.S. for Bovaer® – A Revolutionary, Methane-Reducing Feed Additive for Cattle Elanco Animal Health Incorporated (ELAN: NYSE) and Royal DSM have created a strategic alliance connecting two leading, sustainability-focused companies to address one of society’s most significant opportunities of the decade, mitigating climate change by reducing greenhouse gas emissions from farming. Elanco has secured the exclusive U.S. licensing rights to develop, manufacture and commercialize Bovaer® for beef and dairy cattle. 26 April 2022 DSM - repurchase of shares (18-22 April 2022) Royal DSM, a global purpose-led science-based company, has repurchased 142,403 of its own shares in the period from 18 April 2022 up to and including 22 April 2022 at an average price of €155.73. DSM - repurchase of shares (18-22 April 2022) Royal DSM, a global purpose-led science-based company, has repurchased 142,403 of its own shares in the period from 18 April 2022 up to and including 22 April 2022 at an average price of €155.73. 20 April 2022 Arla Foods and DSM start large-scale on-farm pilot to reduce greenhouse gas emissions from dairy cows by 30% European dairy cooperative Arla Foods and global purpose-led science-based company, Royal DSM, are set to start a large-scale on-farm pilot with the methane reducing feed additive Bovaer® on 10,000 dairy cows across three European countries. Arla Foods and DSM start large-scale on-farm pilot to reduce greenhouse gas emissions from dairy cows by 30% European dairy cooperative Arla Foods and global purpose-led science-based company, Royal DSM, are set to start a large-scale on-farm pilot with the methane reducing feed additive Bovaer® on 10,000 dairy cows across three European countries. 20 April 2022 DSM - repurchase of shares (11- 15 April 2022) Royal DSM, a global purpose-led science-based company, has repurchased 101,258 of its own shares in the period from 11 April 2022 up to and including 15 April 2022 at an average price of €158.07. DSM - repurchase of shares (11- 15 April 2022) Royal DSM, a global purpose-led science-based company, has repurchased 101,258 of its own shares in the period from 11 April 2022 up to and including 15 April 2022 at an average price of €158.07. 20 April 2022 DSM announces sale of Protective Materials business Royal DSM, a global purpose-led science-based company, today announces that it has reached an agreement to sell its Protective Materials business to Avient Corporation for an Enterprise Value of €1.44 billion. DSM announces sale of Protective Materials business Royal DSM, a global purpose-led science-based company, today announces that it has reached an agreement to sell its Protective Materials business to Avient Corporation for an Enterprise Value of €1.44 billion. 12 April 2022 DSM - repurchase of shares (4- 8 April 2022) Royal DSM, a global purpose-led science-based company, has repurchased 173,491 of its own shares in the period from 4 April 2022 up to and including 8 April 2022 at an average price of €162.36. DSM - repurchase of shares (4- 8 April 2022) Royal DSM, a global purpose-led science-based company, has repurchased 173,491 of its own shares in the period from 4 April 2022 up to and including 8 April 2022 at an average price of €162.36. 5 April 2022 DSM - repurchase of shares (28 March-1 April 2022) Royal DSM, a global purpose-led science-based company, has repurchased 171,521 of its own shares in the period from 28 March 2022 up to and including 1 April 2022 at an average price of €162.39. DSM - repurchase of shares (28 March-1 April 2022) Royal DSM, a global purpose-led science-based company, has repurchased 171,521 of its own shares in the period from 28 March 2022 up to and including 1 April 2022 at an average price of €162.39. 4 April 2022 DSM provides preliminary 2021 comparative figures Royal DSM, a global purpose-led science-based company, today provides preliminary comparative financial figures for 2021 following the establishment of DSM’s Health, Nutrition & Bioscience (“HNB”) structure, which became effective as of 1 January 2022. DSM provides preliminary 2021 comparative figures Royal DSM, a global purpose-led science-based company, today provides preliminary comparative financial figures for 2021 following the establishment of DSM’s Health, Nutrition & Bioscience (“HNB”) structure, which became effective as of 1 January 2022. 29 March 2022 DSM - repurchase of shares (21-25 March 2022) Royal DSM, a global purpose-led science-based company, has repurchased 205,518 of its own shares in the period from 21 March 2022 up to and including 25 March 2022 at an average price of €160.28. DSM - repurchase of shares (21-25 March 2022) Royal DSM, a global purpose-led science-based company, has repurchased 205,518 of its own shares in the period from 21 March 2022 up to and including 25 March 2022 at an average price of €160.28. 24 March 2022 FrieslandCampina and DSM take major step to reduce greenhouse gas emissions from dairy cattle The Bovaer® pilot collaboration between the Dutch companies FrieslandCampina, DSM, and Agrifirm marks an important step forward in increasing the sustainability of the dairy sector. Some 200 FrieslandCampina dairy farms in the Netherlands will take part in the pilot in the second half of 2022. Providing the results are positive, the use of Bovaer® will be further upscaled from 2023. FrieslandCampina and DSM take major step to reduce greenhouse gas emissions from dairy cattle The Bovaer® pilot collaboration between the Dutch companies FrieslandCampina, DSM, and Agrifirm marks an important step forward in increasing the sustainability of the dairy sector. Some 200 FrieslandCampina dairy farms in the Netherlands will take part in the pilot in the second half of 2022. Providing the results are positive, the use of Bovaer® will be further upscaled from 2023. 22 March 2022 DSM - repurchase of shares (14- 18 March 2022) Update March 22nd: DSM has repurchased 176,083 of its own shares in the period from 10 March 2022 up to and including 11 March 2022 at an average price of €150.87. DSM - repurchase of shares (14- 18 March 2022) Update March 22nd: DSM has repurchased 176,083 of its own shares in the period from 10 March 2022 up to and including 11 March 2022 at an average price of €150.87. 15 March 2022 DSM - repurchase of shares (10-11 March 2022) DSM has repurchased 176,083 of its own shares in the period from 10 March 2022 up to and including 11 March 2022 at an average price of €150.87. DSM - repurchase of shares (10-11 March 2022) DSM has repurchased 176,083 of its own shares in the period from 10 March 2022 up to and including 11 March 2022 at an average price of €150.87. 10 March 2022 DSM announces repurchase of shares to cover share plans and stock dividend Royal DSM, a global purpose-led science-based company, today announces the repurchase, starting 10 March 2022, of 1,330,000 ordinary shares. DSM announces repurchase of shares to cover share plans and stock dividend Royal DSM, a global purpose-led science-based company, today announces the repurchase, starting 10 March 2022, of 1,330,000 ordinary shares. 2 March 2022 DSM publishes 2021 Integrated Annual Report DSM publishes 2021 annual report on the company's social, environmental and financial performance for the year. DSM publishes 2021 Integrated Annual Report DSM publishes 2021 annual report on the company's social, environmental and financial performance for the year. 24 February 2022 DSM receives landmark EU market approval for its methane-reducing feed additive Bovaer® Royal DSM, a global purpose-led science-based company, announces that European Union (EU) member states approved the marketing of the methane-reducing feed additive for dairy cows, Bovaer®, in the EU. After inclusion in the EU registry, expected in the coming weeks, it is the first time a feed additive authorised in the EU for environmental benefits can be marketed. This marks a significant milestone for DSM, paving the way for Bovaer® to revolutionize the dairy market. 24 February 2022 DSM receives landmark EU market approval for its methane-reducing feed additive Bovaer® Royal DSM, a global purpose-led science-based company, announces that European Union (EU) member states approved the marketing of the methane-reducing feed additive for dairy cows, Bovaer®, in the EU. After inclusion in the EU registry, expected in the coming weeks, it is the first time a feed additive authorised in the EU for environmental benefits can be marketed. This marks a significant milestone for DSM, paving the way for Bovaer® to revolutionize the dairy market. 15 February 2022 DSM reports 2021 results Strong financial growth alongside significant progress toward our sustainability and strategy ambitions made 2021 a year to be proud of. 15 February 2022 DSM reports 2021 results Strong financial growth alongside significant progress toward our sustainability and strategy ambitions made 2021 a year to be proud of. 17 December 2021 DSM completes the acquisition of Vestkorn Milling Royal DSM, a global purpose-led science-based company, today announces the completion of its acquisition of Vestkorn Milling for an enterprise value of €65m. This acquisition of one of Europe’s leading producers of pea- and bean-derived ingredients for plant-based protein products was first announced on 29 November 2021. 17 December 2021 DSM completes the acquisition of Vestkorn Milling Royal DSM, a global purpose-led science-based company, today announces the completion of its acquisition of Vestkorn Milling for an enterprise value of €65m. This acquisition of one of Europe’s leading producers of pea- and bean-derived ingredients for plant-based protein products was first announced on 29 November 2021. 29 November 2021 DSM to acquire Vestkorn Milling to accelerate growth in plant-based proteins Royal DSM, a global purpose-led science-based company, announces today that it has signed an agreement to acquire Norwegian company Vestkorn Milling, one of Europe’s leading producers of pea- and bean-derived ingredients for plant-based protein products, for an enterprise value of €65m. 29 November 2021 DSM to acquire Vestkorn Milling to accelerate growth in plant-based proteins Royal DSM, a global purpose-led science-based company, announces today that it has signed an agreement to acquire Norwegian company Vestkorn Milling, one of Europe’s leading producers of pea- and bean-derived ingredients for plant-based protein products, for an enterprise value of €65m. 19 November 2021 DSM receives positive EFSA opinion for methane-reducing feed additive Bovaer® DSM has received a positive European Food Safety Authority (EFSA) opinion for the use of its novel methane-reducing feed additive for ruminants, Bovaer®, in the European Union. The EFSA opinion confirms that the feed additive reduces enteric methane emissions from dairy cows and is safe for the animal and the consumer. 19 November 2021 DSM receives positive EFSA opinion for methane-reducing feed additive Bovaer® DSM has received a positive European Food Safety Authority (EFSA) opinion for the use of its novel methane-reducing feed additive for ruminants, Bovaer®, in the European Union. The EFSA opinion confirms that the feed additive reduces enteric methane emissions from dairy cows and is safe for the animal and the consumer. 9 November 2021 DSM plans new production site for Bovaer® in Dalry, Scotland DSM is planning to realize large scale production capacity for its novel methane-reducing feed additive for ruminants, Bovaer® with a new plant at its existing site in Dalry, Scotland, supported by Scottish Enterprise. 9 November 2021 DSM plans new production site for Bovaer® in Dalry, Scotland DSM is planning to realize large scale production capacity for its novel methane-reducing feed additive for ruminants, Bovaer® with a new plant at its existing site in Dalry, Scotland, supported by Scottish Enterprise. 2 November 2021 DSM provides first nine months 2021 trading update DSM delivers a very good nine months of the year. 2 November 2021 DSM provides first nine months 2021 trading update DSM delivers a very good nine months of the year. 19 October 2021 DSM completes the acquisition of First Choice Ingredients DSM acquires First Choice Ingredients, a leading supplier of dairy-based savory flavorings. 19 October 2021 DSM completes the acquisition of First Choice Ingredients DSM acquires First Choice Ingredients, a leading supplier of dairy-based savory flavorings. 14 September 2021 DSM announces food system commitments to set a healthier future for people, planet and livelihoods Quantifiable commitments aim to address how the world produces and consumes food by 2030. 14 September 2021 DSM announces food system commitments to set a healthier future for people, planet and livelihoods Quantifiable commitments aim to address how the world produces and consumes food by 2030. 14 September 2021 DSM accelerates its strategic journey to a fully focused Health, Nutrition & Bioscience company DSM is simplifying its operating structure and reorganizing its Health, Nutrition & Bioscience activities into three Business Groups. 14 September 2021 DSM accelerates its strategic journey to a fully focused Health, Nutrition & Bioscience company DSM is simplifying its operating structure and reorganizing its Health, Nutrition & Bioscience activities into three Business Groups. 8 September 2021 DSM sites in Jiangsu Province, China in first group to sign Renewable Energy Power Purchase Agreements The four plants will become among the first in the province to run on renewable energy. 8 September 2021 DSM sites in Jiangsu Province, China in first group to sign Renewable Energy Power Purchase Agreements The four plants will become among the first in the province to run on renewable energy. 3 September 2021 DSM to acquire First Choice Ingredients to accelerate growth in food and beverage DSM to acquire developer of clean label, fermented dairy and dairy-based savory flavorings for taste and functional solutions. 3 September 2021 DSM to acquire First Choice Ingredients to accelerate growth in food and beverage DSM to acquire developer of clean label, fermented dairy and dairy-based savory flavorings for taste and functional solutions. 31 August 2021 DSM - repurchase of shares (23-27 Aug 2021) DSM has completed the repurchase 250,000 shares announced on 9 August 2021 for a total consideration of €44.6 million. DSM - repurchase of shares (23-27 Aug 2021) DSM has completed the repurchase 250,000 shares announced on 9 August 2021 for a total consideration of €44.6 million. 24 August 2021 DSM - repurchase of shares (16-20 Aug 2021) DSM repurchased 109,792 shares from 16 to 20 August 2021 at an average price of €178.66. DSM - repurchase of shares (16-20 Aug 2021) DSM repurchased 109,792 shares from 16 to 20 August 2021 at an average price of €178.66. 17 August 2021 DSM - repurchase of shares (9-13 Aug 2021) DSM repurchased 80,268 shares from 9 to 13 August 2021 at an average price of €175.75. DSM - repurchase of shares (9-13 Aug 2021) DSM repurchased 80,268 shares from 9 to 13 August 2021 at an average price of €175.75. 12 August 2021 DSM to be powered by 100% renewable electricity in North America by the end of 2021 New Power Purchase Agreement (PPA) will dramatically reduce DSM's CO2 emissions by approximately 50,000 tons/year. DSM to be powered by 100% renewable electricity in North America by the end of 2021 New Power Purchase Agreement (PPA) will dramatically reduce DSM's CO2 emissions by approximately 50,000 tons/year. 9 August 2021 DSM announces repurchase of shares to cover stock dividend DSM will repurchase 250,000 ordinary shares to cover commitments for the interim stock dividend 2021. DSM announces repurchase of shares to cover stock dividend DSM will repurchase 250,000 ordinary shares to cover commitments for the interim stock dividend 2021. 3 August 2021 DSM accelerates science based GHG emissions reduction target to 50% by 2030 DSM accelerates its 30% greenhouse gas (GHG) emissions reduction target to 50% by 2030. DSM accelerates science based GHG emissions reduction target to 50% by 2030 DSM accelerates its 30% greenhouse gas (GHG) emissions reduction target to 50% by 2030. 3 August 2021 DSM reports H1 2021 results DSM delivers very good first half year results, with full year outlook updated to reflect stronger Materials performance. DSM reports H1 2021 results DSM delivers very good first half year results, with full year outlook updated to reflect stronger Materials performance. 27 July 2021 DSM acquires next-generation eubiotics platform start-up DSM acquires biotech start-up Midori, developers of breakthrough eubiotics for more sustainable animal farming. DSM acquires next-generation eubiotics platform start-up DSM acquires biotech start-up Midori, developers of breakthrough eubiotics for more sustainable animal farming. 15 July 2021 DSM’s global head office to move to Maastricht, the Netherlands New office to exemplify DSM’s culture and philosophy of hybrid working and be an inspiring environment for people to connect and collaborate. DSM’s global head office to move to Maastricht, the Netherlands New office to exemplify DSM’s culture and philosophy of hybrid working and be an inspiring environment for people to connect and collaborate. 13 July 2021 DSM informs market on the announced sale of AOC to Lone Star Funds affiliate DSM informs its stakeholders that CVC Capital Partners today announced the proposed sale of AOC. DSM informs market on the announced sale of AOC to Lone Star Funds affiliate DSM informs its stakeholders that CVC Capital Partners today announced the proposed sale of AOC. 17 June 2021 DSM - repurchase of shares (14-15 June 2021) DSM has completed the repurchase of 800,000 of its own shares at an average price of €150.36. DSM - repurchase of shares (14-15 June 2021) DSM has completed the repurchase of 800,000 of its own shares at an average price of €150.36. 16 June 2021 DSM concludes early redemption of €500 million bond €500 million 1.375% bond originally due to mature in September 2022 redeemed early. DSM concludes early redemption of €500 million bond €500 million 1.375% bond originally due to mature in September 2022 redeemed early. 15 June 2021 DSM - repurchase of shares (7-11 June 2021) DSM repurchased 66,456 shares from 7 to 11 June 2021 at an average price of €152.02. DSM - repurchase of shares (7-11 June 2021) DSM repurchased 66,456 shares from 7 to 11 June 2021 at an average price of €152.02. 8 June 2021 DSM - repurchase of shares (31 May - 4 June 2021) DSM repurchased 117,895 shares from 31 May to 4 June 2021 at an average price of €151.73. DSM - repurchase of shares (31 May - 4 June 2021) DSM repurchased 117,895 shares from 31 May to 4 June 2021 at an average price of €151.73. 3 June 2021 DSM completes sale of DSM Advanced Solar backsheets business to Worthen Industries, Inc. Sale completes divestment of all DSM’s solar activities. DSM completes sale of DSM Advanced Solar backsheets business to Worthen Industries, Inc. Sale completes divestment of all DSM’s solar activities. 1 June 2021 DSM - repurchase of shares (24-28 May 2021) DSM repurchased 102,721 shares from 24 to 28 May 2021 at an average price of €151.13. DSM - repurchase of shares (24-28 May 2021) DSM repurchased 102,721 shares from 24 to 28 May 2021 at an average price of €151.13. 25 May 2021 DSM - repurchase of shares (17-21 May 2021) DSM repurchased 126,930 shares from 17 to 21 May 2021 at an average price of €148.27. DSM - repurchase of shares (17-21 May 2021) DSM repurchased 126,930 shares from 17 to 21 May 2021 at an average price of €148.27. 19 May 2021 DSM announces early redemption of €500 million bond €500 million 1.375% bond issued 24 September 2015 to be redeemed earlier than scheduled. DSM announces early redemption of €500 million bond €500 million 1.375% bond issued 24 September 2015 to be redeemed earlier than scheduled. 18 May 2021 DSM - repurchase of shares (10-14 May 2021) DSM repurchased 145,703 shares from 10 to 14 May 2021 at an average price of €147.94. DSM - repurchase of shares (10-14 May 2021) DSM repurchased 145,703 shares from 10 to 14 May 2021 at an average price of €147.94. 18 May 2021 DSM launches cycling challenge series to encourage people to improve their health through exercise and nutrition Get on your bike for the DSM Keep Challenging Series. Sign-up now! DSM launches cycling challenge series to encourage people to improve their health through exercise and nutrition Get on your bike for the DSM Keep Challenging Series. Sign-up now! 11 May 2021 DSM - repurchase of shares (3-7 May 2021) DSM repurchased 192,978 shares from 3 to 7 May 2021 at an average price of €151.32. DSM - repurchase of shares (3-7 May 2021) DSM repurchased 192,978 shares from 3 to 7 May 2021 at an average price of €151.32. 7 May 2021 Dutch PPE Solutions starts large-scale production of filter material for medical facemasks Joint venture is first to deliver professional facemasks with filter material made entirely on Dutch soil. Dutch PPE Solutions starts large-scale production of filter material for medical facemasks Joint venture is first to deliver professional facemasks with filter material made entirely on Dutch soil. 6 May 2021 Final dividend 2020 Royal DSM DSM declares a dividend for the 2020 financial year of €2.40 per ordinary share. Final dividend 2020 Royal DSM DSM declares a dividend for the 2020 financial year of €2.40 per ordinary share. 6 May 2021 DSM announces results of 2021 Annual General Meeting of Shareholders DSM held a virtual Annual General Meeting of Shareholders on 6 May 2021 when shareholders approved all resolutions on the agenda. DSM announces results of 2021 Annual General Meeting of Shareholders DSM held a virtual Annual General Meeting of Shareholders on 6 May 2021 when shareholders approved all resolutions on the agenda. 6 May 2021 Annual General Meeting of Shareholders 2021 Summary of the resolutions and voting at DSM's most recent Annual General Meeting of Shareholders held virtually on 6 May 2021. Annual General Meeting of Shareholders 2021 Summary of the resolutions and voting at DSM's most recent Annual General Meeting of Shareholders held virtually on 6 May 2021. 5 May 2021 DSM provides Q1 2021 trading update DSM delivers very good Q1 with sales +7% and adjusted EBITDA +13%, updates Outlook 2021 reflecting strong Materials recovery. DSM provides Q1 2021 trading update DSM delivers very good Q1 with sales +7% and adjusted EBITDA +13%, updates Outlook 2021 reflecting strong Materials recovery. 29 April 2021 DSM announces cancellation of 6.6m treasury shares to conclude reduction in share capital Cancellation concludes reduction in share capital following share buyback program executed from 1 April 2019 to February 2020. DSM announces cancellation of 6.6m treasury shares to conclude reduction in share capital Cancellation concludes reduction in share capital following share buyback program executed from 1 April 2019 to February 2020. 1 April 2021 DSM completes sale of Resins & Functional Materials businesses Sale to Covestro agreed in September 2020 for an equity value of €1.6 billion has finalized today. DSM completes sale of Resins & Functional Materials businesses Sale to Covestro agreed in September 2020 for an equity value of €1.6 billion has finalized today. 31 March 2021 DSM acquires Flavor & Fragrance bio-based intermediates business from Amyris DSM acquires business consisting of 7 bio-based intermediate products to add to existing Aroma Ingredients portfolio. DSM acquires Flavor & Fragrance bio-based intermediates business from Amyris DSM acquires business consisting of 7 bio-based intermediate products to add to existing Aroma Ingredients portfolio. 16 March 2021 DSM announces repurchase of shares to cover stock dividend DSM will repurchase 800,000 ordinary shares to cover commitments for the final stock dividend 2020. DSM announces repurchase of shares to cover stock dividend DSM will repurchase 800,000 ordinary shares to cover commitments for the final stock dividend 2020. 11 March 2021 DSM announces DSM Advanced Solar backsheets business to be acquired by Worthen Industries, Inc. DSM to sell residual solar backsheet business to Worthen Industries, Inc. following the sale of its solar coatings business to Covestro. DSM announces DSM Advanced Solar backsheets business to be acquired by Worthen Industries, Inc. DSM to sell residual solar backsheet business to Worthen Industries, Inc. following the sale of its solar coatings business to Covestro. 4 March 2021 DSM announces new Supervisory Board Chairman and proposes new Supervisory Board member Supervisory Board appoints Thomas Leysen to succeed Rob Routs as Chair and proposes Corien M. Wortmann-Kool as a new member. DSM announces new Supervisory Board Chairman and proposes new Supervisory Board member Supervisory Board appoints Thomas Leysen to succeed Rob Routs as Chair and proposes Corien M. Wortmann-Kool as a new member. 2 March 2021 DSM continues to make strong progress on its People, Planet and Profit ambitions DSM publishes 2020 annual report on the company's social, environmental and financial performance for the year. DSM continues to make strong progress on its People, Planet and Profit ambitions DSM publishes 2020 annual report on the company's social, environmental and financial performance for the year. 16 February 2021 DSM reports 2020 results DSM posts solid results in a challenging COVID-19 environment, continues to make good progress on execution of long-term strategic plan. 16 February 2021 DSM reports 2020 results DSM posts solid results in a challenging COVID-19 environment, continues to make good progress on execution of long-term strategic plan. 20 January 2021 DSM Nutritional Products’ President & CEO Chris Goppelsroeder to retire Chris Goppelsroeder to retire on 1 April 2021 with DSM's Co-CEO Dimitri de Vreeze stepping into the role. 20 January 2021 DSM Nutritional Products’ President & CEO Chris Goppelsroeder to retire Chris Goppelsroeder to retire on 1 April 2021 with DSM's Co-CEO Dimitri de Vreeze stepping into the role. 11 January 2021 DSM and TU Delft establish artificial intelligence laboratory to drive bioscience innovation The Artificial Intelligence Lab for Biosciences first of its kind in Europe to apply artificial intelligence to full-scale biomanufacturing, 11 January 2021 DSM and TU Delft establish artificial intelligence laboratory to drive bioscience innovation The Artificial Intelligence Lab for Biosciences first of its kind in Europe to apply artificial intelligence to full-scale biomanufacturing, 6 January 2021 In memoriam Hans van Liemt It is with sadness that we share with you the news of the passing away of our former Managing Board Chairman, Hans van Liemt. In memoriam Hans van Liemt It is with sadness that we share with you the news of the passing away of our former Managing Board Chairman, Hans van Liemt. 4 December 2020 Pro cycling’s newest elite team unveiled - Team DSM Strategic partnership with Team Sunweb sees professional cycling team transform into Team DSM for 2021 season onwards. 4 December 2020 Pro cycling’s newest elite team unveiled - Team DSM Strategic partnership with Team Sunweb sees professional cycling team transform into Team DSM for 2021 season onwards. 3 November 2020 DSM reports results first nine months 2020 DSM reports a solid first nine months in a challenging COVID-19 environment, with a continuing robust performance in Q3. 3 November 2020 DSM reports results first nine months 2020 DSM reports a solid first nine months in a challenging COVID-19 environment, with a continuing robust performance in Q3. 8 October 2020 DSM provides preliminary 2019 and 2020 H1 comparative figures DSM’s Resins & Functional Materials businesses moved to discontinued operations with their agreed sale to Covestro AG. DSM provides preliminary 2019 and 2020 H1 comparative figures DSM’s Resins & Functional Materials businesses moved to discontinued operations with their agreed sale to Covestro AG. 2 October 2020 DSM completes acquisition of Erber Group DSM acquires Erber's Biomin specialty animal nutrition and health & Romer Labs food/feed safety diagnostics businesses. DSM completes acquisition of Erber Group DSM acquires Erber's Biomin specialty animal nutrition and health & Romer Labs food/feed safety diagnostics businesses. 30 September 2020 DSM announces sale of Resins & Functional Materials businesses DSM to sell its Resins & Functional Materials and associated businesses to Covestro AG for an Equity Value of €1.6 billion. 30 September 2020 DSM announces sale of Resins & Functional Materials businesses DSM to sell its Resins & Functional Materials and associated businesses to Covestro AG for an Equity Value of €1.6 billion. 24 September 2020 DSM proposes new Supervisory Board member DSM's Supervisory Board nominates Mrs. Carla Mahieu for appointment as a new Supervisory Board member at next AGM. 24 September 2020 DSM proposes new Supervisory Board member DSM's Supervisory Board nominates Mrs. Carla Mahieu for appointment as a new Supervisory Board member at next AGM. 4 September 2020 Dutch JV to produce facemasks & PPE filter material locally Partners investing several million €'s on manufacturing equipment and construction of new manufacturing facilities in Netherlands. 4 September 2020 Dutch JV to produce facemasks & PPE filter material locally Partners investing several million €'s on manufacturing equipment and construction of new manufacturing facilities in Netherlands. 1 September 2020 DSM - repurchase of shares (24-28 August 2020) DSM repurchased 27,328 shares from 24 to 28 August 2020 at an average price of €134.92. 1 September 2020 DSM - repurchase of shares (24-28 August 2020) DSM repurchased 27,328 shares from 24 to 28 August 2020 at an average price of €134.92. 25 August 2020 DSM - repurchase of shares (17-21 August 2020) DSM repurchased 70,444 shares from 17 to 21 August 2020 at an average price of €131.13. DSM - repurchase of shares (17-21 August 2020) DSM repurchased 70,444 shares from 17 to 21 August 2020 at an average price of €131.13. 18 August 2020 DSM - repurchase of shares (7-14 August 2020) DSM repurchased 102,228 shares from 7 to 14 August 2020 at an average price of €129.61. DSM - repurchase of shares (7-14 August 2020) DSM repurchased 102,228 shares from 7 to 14 August 2020 at an average price of €129.61. 7 August 2020 DSM announces repurchase of shares to cover stock dividend Repurchase of 200,000 ordinary shares equivalent to approximately €25 million on 6 August 2020. DSM announces repurchase of shares to cover stock dividend Repurchase of 200,000 ordinary shares equivalent to approximately €25 million on 6 August 2020. 4 August 2020 DSM reports H1 2020 results DSM reports a solid H1 2020 in a challenging COVID-19 environment, overall earnings outlook remains suspended. DSM reports H1 2020 results DSM reports a solid H1 2020 in a challenging COVID-19 environment, overall earnings outlook remains suspended. 13 July 2020 DSM appoints Cristina Monteiro new EVP People & Organization and member of the Executive Committee Cristina Monteiro appointed Executive Vice President People & Organization and member of the Executive Committee as of 1 September 2020. DSM appoints Cristina Monteiro new EVP People & Organization and member of the Executive Committee Cristina Monteiro appointed Executive Vice President People & Organization and member of the Executive Committee as of 1 September 2020. 1 July 2020 DSM appoints Zhou Tao (Joe) as President DSM China Zhou Tao (Joe) succeeds Dr. Weiming Jiang as President DSM China as of 1 July 2020. DSM appoints Zhou Tao (Joe) as President DSM China Zhou Tao (Joe) succeeds Dr. Weiming Jiang as President DSM China as of 1 July 2020. 17 June 2020 DSM issues €1 billion long-term bonds to finance acquisition of Erber Group New bonds in two tranches of €500m allow DSM to lock-in low interest rates to finance the acquisition of the Erber Group. DSM issues €1 billion long-term bonds to finance acquisition of Erber Group New bonds in two tranches of €500m allow DSM to lock-in low interest rates to finance the acquisition of the Erber Group. 12 June 2020 DSM finalizes share repurchase to cover share plans and stock dividend and cancels remainder of its €1 billion share buy-back As prudent measure given Covid-19 environment and acquisition of Erber Group, DSM cancels remainder of €1 billion share buy-back program. DSM finalizes share repurchase to cover share plans and stock dividend and cancels remainder of its €1 billion share buy-back As prudent measure given Covid-19 environment and acquisition of Erber Group, DSM cancels remainder of €1 billion share buy-back program. 12 June 2020 DSM to add world-leading animal nutrition and health specialty businesses with acquisition of Erber Group DSM adds Erber Group’s mycotoxin risk and gut health performance management and food and feed safety diagnostic solutions to portfolio. DSM to add world-leading animal nutrition and health specialty businesses with acquisition of Erber Group DSM adds Erber Group’s mycotoxin risk and gut health performance management and food and feed safety diagnostic solutions to portfolio. 8 May 2020 Final dividend 2019 Royal DSM DSM declares a dividend for the financial year 2019 of €2.40 per ordinary share. Final dividend 2019 Royal DSM DSM declares a dividend for the financial year 2019 of €2.40 per ordinary share. 8 May 2020 DSM announces results of 2020 Annual General Meeting of Shareholders DSM held a virtual Annual General Meeting of Shareholders on 8 May 2020 when shareholders approved all resolutions on the agenda. DSM announces results of 2020 Annual General Meeting of Shareholders DSM held a virtual Annual General Meeting of Shareholders on 8 May 2020 when shareholders approved all resolutions on the agenda. 8 May 2020 Annual General Meeting of Shareholders 2020 Summary of the resolutions and voting at DSM's Annual General Meeting of Shareholders 2020. Annual General Meeting of Shareholders 2020 Summary of the resolutions and voting at DSM's Annual General Meeting of Shareholders 2020. 7 May 2020 DSM to help accelerate Dutch Covid-19 testing by making 2.8 million nose swabs DSM will produce sufficient swabs to meet the entire country’s testing needs for the next three months. DSM to help accelerate Dutch Covid-19 testing by making 2.8 million nose swabs DSM will produce sufficient swabs to meet the entire country’s testing needs for the next three months. 7 May 2020 DSM reports Q1 2020 results DSM reports a solid Q1 2020, suspends overall earnings outlook given current limited visibility in Materials. DSM reports Q1 2020 results DSM reports a solid Q1 2020, suspends overall earnings outlook given current limited visibility in Materials. 28 April 2020 Production of FFP2 masks begins Consortium of AFPRO Filters, Auping and DSM has begun large-scale production of FFP2 facemasks for healthcare workers. Production of FFP2 masks begins Consortium of AFPRO Filters, Auping and DSM has begun large-scale production of FFP2 facemasks for healthcare workers. 21 April 2020 DSM firmly on course to achieve 75% renewable electricity with largest PPA partnerships to date DSM signs largest renewable energy Power Purchase Agreement (PPA) to date. DSM firmly on course to achieve 75% renewable electricity with largest PPA partnerships to date DSM signs largest renewable energy Power Purchase Agreement (PPA) to date. 1 April 2020 DSM completes acquisition of Glycom DSM acquires world's leading supplier of Human Milk Oligosaccharides (HMO) for early life nutrition applications. DSM completes acquisition of Glycom DSM acquires world's leading supplier of Human Milk Oligosaccharides (HMO) for early life nutrition applications. 26 March 2020 DSM Co-CEOs statement on the COVID-19 outbreak We are humbled by our people’s efforts and want to provide a broader update on how DSM is responding to the constantly evolving situation. DSM Co-CEOs statement on the COVID-19 outbreak We are humbled by our people’s efforts and want to provide a broader update on how DSM is responding to the constantly evolving situation. 24 March 2020 DSM - repurchase of shares (16-20 March 2020) DSM repurchased 239,127 shares from 16 to 20 March 2020 at an average price of €89.77. DSM - repurchase of shares (16-20 March 2020) DSM repurchased 239,127 shares from 16 to 20 March 2020 at an average price of €89.77. 17 March 2020 DSM - repurchase of shares (9-13 March 2020) DSM repurchased 705,494 shares from 9 to 13 March 2020 at an average price of €96.33. DSM - repurchase of shares (9-13 March 2020) DSM repurchased 705,494 shares from 9 to 13 March 2020 at an average price of €96.33. 10 March 2020 DSM - repurchase of shares (2-6 March 2020) DSM repurchased 455,379 shares from 2 to 6 March 2020 at an average price of €106.13. DSM - repurchase of shares (2-6 March 2020) DSM repurchased 455,379 shares from 2 to 6 March 2020 at an average price of €106.13. 2 March 2020 DSM announces regular repurchase to cover share plans and stock dividend, in addition to ongoing repurchase to complete €1 billion share buy-back DSM will repurchase 1,400,000 ordinary shares to cover share plans and stock dividend. DSM announces regular repurchase to cover share plans and stock dividend, in addition to ongoing repurchase to complete €1 billion share buy-back DSM will repurchase 1,400,000 ordinary shares to cover share plans and stock dividend. 27 February 2020 DSM publishes 2019 Integrated Annual Report 2019 Integrated Annual Report on DSM's performance and progress during 2019 in terms of People, Planet and Profit published. 27 February 2020 DSM publishes 2019 Integrated Annual Report 2019 Integrated Annual Report on DSM's performance and progress during 2019 in terms of People, Planet and Profit published. 25 February 2020 DSM appoints new EVP Materials and member of the Executive Committee Helen Mets appointed Executive Vice President Materials and member of the Executive Committee as of 1 March 2020. 25 February 2020 DSM appoints new EVP Materials and member of the Executive Committee Helen Mets appointed Executive Vice President Materials and member of the Executive Committee as of 1 March 2020. 25 February 2020 DSM - repurchase of shares (17-21 February 2020) DSM repurchased 183,602 shares from 17 to 21 February 2020 at an average price of €115.01. 25 February 2020 DSM - repurchase of shares (17-21 February 2020) DSM repurchased 183,602 shares from 17 to 21 February 2020 at an average price of €115.01. 21 February 2020 DSM to acquire Glycom to accelerate growth in Early Life Nutrition DSM to acquire world's leading supplier of Human Milk Oligosaccharides (HMO) for early life nutrition applications. 21 February 2020 DSM to acquire Glycom to accelerate growth in Early Life Nutrition DSM to acquire world's leading supplier of Human Milk Oligosaccharides (HMO) for early life nutrition applications. 18 February 2020 DSM - repurchase of shares (10-14 February 2020) DSM repurchased 80,423 shares from 10 to 14 February 2020 at an average price of €116.31. 18 February 2020 DSM - repurchase of shares (10-14 February 2020) DSM repurchased 80,423 shares from 10 to 14 February 2020 at an average price of €116.31. 13 February 2020 DSM reports 2019 results DSM delivered a good financial performance for the year and achieved the key milestones in the first year of its Strategy 2021. 13 February 2020 DSM reports 2019 results DSM delivered a good financial performance for the year and achieved the key milestones in the first year of its Strategy 2021. 11 February 2020 DSM - repurchase of shares (3-7 February 2020) DSM repurchased 80,423 shares from 3 to 7 February 2020 at an average price of €113.07. 11 February 2020 DSM - repurchase of shares (3-7 February 2020) DSM repurchased 80,423 shares from 3 to 7 February 2020 at an average price of €113.07. 4 February 2020 DSM - repurchase of shares (27-31 January 2020) DSM repurchased 195,502 shares from 27 to 31 January 2020 at an average price of €110.38. 4 February 2020 DSM - repurchase of shares (27-31 January 2020) DSM repurchased 195,502 shares from 27 to 31 January 2020 at an average price of €110.38. 28 January 2020 DSM - repurchase of shares (20-24 January 2020) DSM repurchased 110,420 shares from 20 to 24 January 2020 at an average price of €111.85. 28 January 2020 DSM - repurchase of shares (20-24 January 2020) DSM repurchased 110,420 shares from 20 to 24 January 2020 at an average price of €111.85. 23 January 2020 DSM partners with Generation Unlimited to create employment opportunities for young people in agri-food businesses Partnership aims to create a longer-term vision for sustainable food systems in Africa. 23 January 2020 DSM partners with Generation Unlimited to create employment opportunities for young people in agri-food businesses Partnership aims to create a longer-term vision for sustainable food systems in Africa. 21 January 2020 DSM - repurchase of shares (13-17 January 2020) DSM repurchased 213,886 shares from 13 to 17 January 2020 at an average price of €109.84. 21 January 2020 DSM - repurchase of shares (13-17 January 2020) DSM repurchased 213,886 shares from 13 to 17 January 2020 at an average price of €109.84. 20 January 2020 DSM names Feike Sijbesma Honorary Chairman As Honorary Chairman Feike Sijbesma will continue to act as DSM's ambassador. 20 January 2020 DSM names Feike Sijbesma Honorary Chairman As Honorary Chairman Feike Sijbesma will continue to act as DSM's ambassador. 14 January 2020 DSM - repurchase of shares (6-10 January 2020) DSM repurchased 225,888 shares from 6 to 10 January 2020 at an average price of €114.73. 14 January 2020 DSM - repurchase of shares (6-10 January 2020) DSM repurchased 225,888 shares from 6 to 10 January 2020 at an average price of €114.73. 7 January 2020 DSM - repurchase of shares (2-3 January 2020) DSM repurchased 28,011 shares from 2 to 3 January 2020 at an average price of €116.83. DSM - repurchase of shares (2-3 January 2020) DSM repurchased 28,011 shares from 2 to 3 January 2020 at an average price of €116.83. 30 December 2019 Royal DSM completes acquisition of Royal CSK DSM acquires specialty dairy solutions provider CSK (Koninklijke CSK Food Enrichment C.V.) for about €150 million. 30 December 2019 Royal DSM completes acquisition of Royal CSK DSM acquires specialty dairy solutions provider CSK (Koninklijke CSK Food Enrichment C.V.) for about €150 million. 24 December 2019 DSM - repurchase of shares (16-20 December 2019) DSM repurchased 308,286 shares from 16 to 20 December 2019 at an average price of €115.95. 24 December 2019 DSM - repurchase of shares (16-20 December 2019) DSM repurchased 308,286 shares from 16 to 20 December 2019 at an average price of €115.95. 17 December 2019 DSM - repurchase of shares (9-13 December 2019) DSM repurchased 347,955 shares from 9 to 13 December 2019 at an average price of €114.42. 17 December 2019 DSM - repurchase of shares (9-13 December 2019) DSM repurchased 347,955 shares from 9 to 13 December 2019 at an average price of €114.42. 10 December 2019 DSM - repurchase of shares (2-6 December 2019) DSM repurchased 438,649 shares from 2 to 6 December 2019 at an average price of €114.60. 10 December 2019 DSM - repurchase of shares (2-6 December 2019) DSM repurchased 438,649 shares from 2 to 6 December 2019 at an average price of €114.60. 9 December 2019 Update on DSM Supervisory Board composition Thomas Leysen nominated as new Supervisory Board member while Rob Routs, Eileen Kennedy & Pradeep Pant nominated for reappointment. 9 December 2019 Update on DSM Supervisory Board composition Thomas Leysen nominated as new Supervisory Board member while Rob Routs, Eileen Kennedy & Pradeep Pant nominated for reappointment. 3 December 2019 DSM - repurchase of shares (25-29 November 2019) DSM repurchased 284,636 shares from 25 to 29 November 2019 at an average price of €117.00. 3 December 2019 DSM - repurchase of shares (25-29 November 2019) DSM repurchased 284,636 shares from 25 to 29 November 2019 at an average price of €117.00. 2 December 2019 Royal DSM announces CEO succession CEO Feike Sijbesma will hand over his responsibilities to Managing Board colleagues Geraldine Matchett and Dimitri de Vreeze as Co-CEO’s in February 2020. 2 December 2019 Royal DSM announces CEO succession CEO Feike Sijbesma will hand over his responsibilities to Managing Board colleagues Geraldine Matchett and Dimitri de Vreeze as Co-CEO’s in February 2020. 26 November 2019 DSM - repurchase of shares (18-22 November 2019) DSM repurchased 445,046 shares from 18 to 22 November 2019 at an average price of €116.60. 26 November 2019 DSM - repurchase of shares (18-22 November 2019) DSM repurchased 445,046 shares from 18 to 22 November 2019 at an average price of €116.60. 19 November 2019 DSM - repurchase of shares (11-15 November 2019) DSM repurchased 428,180 shares from 11 to 15 November 2019 at an average price of €116.15. 19 November 2019 DSM - repurchase of shares (11-15 November 2019) DSM repurchased 428,180 shares from 11 to 15 November 2019 at an average price of €116.15. 18 November 2019 Royal DSM to acquire Royal CSK, combining complementary strengths to better serve global dairy industries Acquisition strengthens dairy portfolio and application know-how and expertise, particularly in the areas of cheese taste, texture and bio-preservation. 18 November 2019 Royal DSM to acquire Royal CSK, combining complementary strengths to better serve global dairy industries Acquisition strengthens dairy portfolio and application know-how and expertise, particularly in the areas of cheese taste, texture and bio-preservation. 12 November 2019 DSM - repurchase of shares (4-8 November 2019) DSM repurchased 358,500 shares from 4 to 8 November 2019 at an average price of €114.17. 12 November 2019 DSM - repurchase of shares (4-8 November 2019) DSM repurchased 358,500 shares from 4 to 8 November 2019 at an average price of €114.17. 5 November 2019 DSM - repurchase of shares (28 October - 1 November 2019) DSM repurchased 196,255 shares from 28 October to 1 November 2019 at an average price of €107.26. 5 November 2019 DSM - repurchase of shares (28 October - 1 November 2019) DSM repurchased 196,255 shares from 28 October to 1 November 2019 at an average price of €107.26. 5 November 2019 DSM reports results first nine months 2019 DSM reports a good first nine months in 2019 with a solid performance in Q3. 5 November 2019 DSM reports results first nine months 2019 DSM reports a good first nine months in 2019 with a solid performance in Q3. 29 October 2019 DSM - repurchase of shares (21-25 October 2019) DSM repurchased 153,111 shares from 21 to 25 October 2019 at an average price of €106.73. 29 October 2019 DSM - repurchase of shares (21-25 October 2019) DSM repurchased 153,111 shares from 21 to 25 October 2019 at an average price of €106.73. 22 October 2019 DSM - repurchase of shares (14-18 October 2019) DSM repurchased 190,019 shares from 14 to 18 October 2019 at an average price of €108.44. 22 October 2019 DSM - repurchase of shares (14-18 October 2019) DSM repurchased 190,019 shares from 14 to 18 October 2019 at an average price of €108.44. 15 October 2019 DSM - repurchase of shares (7-11 October 2019) DSM repurchased 183,500 shares from 7 to 11 October 2019 at an average price of €107.03. 15 October 2019 DSM - repurchase of shares (7-11 October 2019) DSM repurchased 183,500 shares from 7 to 11 October 2019 at an average price of €107.03. 8 October 2019 DSM - repurchase of shares (30 September - 4 October 2019) DSM repurchased 212,170 shares from 30 September to 4 October 2019 at an average price of €107.78. DSM - repurchase of shares (30 September - 4 October 2019) DSM repurchased 212,170 shares from 30 September to 4 October 2019 at an average price of €107.78. 1 October 2019 DSM - repurchase of shares (23-27 September 2019) DSM repurchased 162,212 shares from 23 to 27 September 2019 at an average price of €106.77. DSM - repurchase of shares (23-27 September 2019) DSM repurchased 162,212 shares from 23 to 27 September 2019 at an average price of €106.77. 24 September 2019 DSM - repurchase of shares (16-20 September 2019) DSM repurchased 274,642 shares from 16 to 20 September 2019 at an average price of €108.43 24 September 2019 DSM - repurchase of shares (16-20 September 2019) DSM repurchased 274,642 shares from 16 to 20 September 2019 at an average price of €108.43 17 September 2019 DSM - repurchase of shares (9-13 September 2019) DSM repurchased 245,676 shares from 9 to 13 September 2019 at an average price of €113.21. 17 September 2019 DSM - repurchase of shares (9-13 September 2019) DSM repurchased 245,676 shares from 9 to 13 September 2019 at an average price of €113.21. 10 September 2019 DSM - repurchase of shares (2-6 September 2019) DSM repurchased 131,289 shares from 2 to 6 September 2019 at an average price of €115.38. 10 September 2019 DSM - repurchase of shares (2-6 September 2019) DSM repurchased 131,289 shares from 2 to 6 September 2019 at an average price of €115.38. 5 September 2019 DSM celebrates 150 years of biotechnology innovation DSM celebrates 150 years of rich history in social entrepreneurship and biotechnology innovations in the Dutch city of Delft 5 September 2019 DSM celebrates 150 years of biotechnology innovation DSM celebrates 150 years of rich history in social entrepreneurship and biotechnology innovations in the Dutch city of Delft 3 September 2019 DSM - repurchase of shares (26-30 August 2019) DSM repurchased 95,745 shares from 26 to 30 August 2019 at an average price of €110.88. 3 September 2019 DSM - repurchase of shares (26-30 August 2019) DSM repurchased 95,745 shares from 26 to 30 August 2019 at an average price of €110.88. 27 August 2019 DSM - repurchase of shares (19-23 August 2019) DSM repurchased 168,100 shares from 19 to 23 August 2019 at an average price of €110.62. DSM - repurchase of shares (19-23 August 2019) DSM repurchased 168,100 shares from 19 to 23 August 2019 at an average price of €110.62. 27 August 2019 DSM completes creation of vitamin E Joint Venture with Nenter and begins upgrade of plant JV consists of vitamin E production facilities in Jingzhou and a minority shareholding in Nenter’s intermediates facility in Shishou, China. DSM completes creation of vitamin E Joint Venture with Nenter and begins upgrade of plant JV consists of vitamin E production facilities in Jingzhou and a minority shareholding in Nenter’s intermediates facility in Shishou, China. 20 August 2019 DSM - repurchase of shares (12-16 August 2019) DSM repurchased 276,022 shares from 12 to 16 August 2019 at an average price of €108.76. DSM - repurchase of shares (12-16 August 2019) DSM repurchased 276,022 shares from 12 to 16 August 2019 at an average price of €108.76. 13 August 2019 DSM - repurchase of shares (5-9 August 2019) DSM repurchased 263,977 shares from 5 to 9 August 2019 at an average price of €108.13. DSM - repurchase of shares (5-9 August 2019) DSM repurchased 263,977 shares from 5 to 9 August 2019 at an average price of €108.13. 6 August 2019 DSM - repurchase of shares (29 July - 2 August 2019) DSM repurchased 131,000 shares from 29 July to 2 August 2019 at an average price of €112.52. DSM - repurchase of shares (29 July - 2 August 2019) DSM repurchased 131,000 shares from 29 July to 2 August 2019 at an average price of €112.52. 1 August 2019 DSM reports H1 2019 results DSM reports a good H1 2019 and maintains the previously increased full year outlook. DSM reports H1 2019 results DSM reports a good H1 2019 and maintains the previously increased full year outlook. 16 July 2019 DSM - repurchase of shares (8-12 July 2019) DSM repurchased 19,871 shares from 8 to 12 July 2019 at an average price of €109.81. DSM - repurchase of shares (8-12 July 2019) DSM repurchased 19,871 shares from 8 to 12 July 2019 at an average price of €109.81. 10 July 2019 DSM and Evonik take next step in sustainable aquaculture: Veramaris facility starts commercial production Veramaris' commercial-scale $200 million facility for production of omega-3 EPA & DHA from natural marine algae opens in Nebraska (US). DSM and Evonik take next step in sustainable aquaculture: Veramaris facility starts commercial production Veramaris' commercial-scale $200 million facility for production of omega-3 EPA & DHA from natural marine algae opens in Nebraska (US). 9 July 2019 DSM - repurchase of shares (1-5 July 2019) DSM repurchased 41,213 shares from 1 to 5 July 2019 at an average price of €109.50. DSM - repurchase of shares (1-5 July 2019) DSM repurchased 41,213 shares from 1 to 5 July 2019 at an average price of €109.50. 2 July 2019 DSM - repurchase of shares (24-28 June 2019) DSM repurchased 150,213 shares from 24 to 28 June 2019 at an average price of €108.69. DSM - repurchase of shares (24-28 June 2019) DSM repurchased 150,213 shares from 24 to 28 June 2019 at an average price of €108.69. 1 July 2019 DSM announces Kazunori Maruyama as President of DSM Japan Kazunori Maruyama brings a wealth of experience and will continue to strengthen DSM's second largest business in Asia. DSM announces Kazunori Maruyama as President of DSM Japan Kazunori Maruyama brings a wealth of experience and will continue to strengthen DSM's second largest business in Asia. 1 July 2019 In Memoriam Simon de Bree It is with great sadness that we share the news that our former Managing Board Chairman Simon de Bree has passed away. In Memoriam Simon de Bree It is with great sadness that we share the news that our former Managing Board Chairman Simon de Bree has passed away. 28 June 2019 DSM announces early redemption of the €300 million 1.75% bond maturing 13 November 2019 DSM exercises right to redeem all the €300,000,000 1.75% Notes due on 13 November on first optional redemption date of 13 August 2019. DSM announces early redemption of the €300 million 1.75% bond maturing 13 November 2019 DSM exercises right to redeem all the €300,000,000 1.75% Notes due on 13 November on first optional redemption date of 13 August 2019. 25 June 2019 DSM - repurchase of shares (17-21 June 2019) DSM repurchased 94,194 shares from 17 to 21 June 2019 at an average price of €108.56. DSM - repurchase of shares (17-21 June 2019) DSM repurchased 94,194 shares from 17 to 21 June 2019 at an average price of €108.56. 18 June 2019 DSM - repurchase of shares (10-14 June 2019) DSM repurchased 147,395 shares from 10 to 14 June 2019 at an average price of €106.02. DSM - repurchase of shares (10-14 June 2019) DSM repurchased 147,395 shares from 10 to 14 June 2019 at an average price of €106.02. 11 June 2019 DSM - repurchase of shares (3-7 June 2019) DSM repurchased 206,267 shares from 3 to 7 June 2019 at an average price of €102.96. DSM - repurchase of shares (3-7 June 2019) DSM repurchased 206,267 shares from 3 to 7 June 2019 at an average price of €102.96. 4 June 2019 DSM - repurchase of shares (27-31 May 2019) DSM repurchased 163,903 shares from 27 to 31 May 2019 at an average price of €100.64. DSM - repurchase of shares (27-31 May 2019) DSM repurchased 163,903 shares from 27 to 31 May 2019 at an average price of €100.64. 28 May 2019 DSM - repurchase of shares (20-24 May 2019) DSM repurchased 284,500 shares from 20 to 24 May 2019 at an average price of €101.52. DSM - repurchase of shares (20-24 May 2019) DSM repurchased 284,500 shares from 20 to 24 May 2019 at an average price of €101.52. 21 May 2019 DSM - repurchase of shares (13-17 May 2019) DSM repurchased 222,500 shares from 13 to 17 May 2019 at an average price of €99.97. DSM - repurchase of shares (13-17 May 2019) DSM repurchased 222,500 shares from 13 to 17 May 2019 at an average price of €99.97. 14 May 2019 DSM - repurchase of shares (6-10 May 2019) DSM repurchased 494,782 shares from 6 to 10 May 2019 at an average price of €101.18. DSM - repurchase of shares (6-10 May 2019) DSM repurchased 494,782 shares from 6 to 10 May 2019 at an average price of €101.18. 13 May 2019 DSM expands in India with acquisition of SRF Ltd.’s Specialty Materials business DSM to acquire leading player in the development, production and sale of specialty materials in India. DSM expands in India with acquisition of SRF Ltd.’s Specialty Materials business DSM to acquire leading player in the development, production and sale of specialty materials in India. 8 May 2019 Annual General Meeting of Shareholders 2019 Summary of the resolutions and voting at DSM's Annual General Meeting of Shareholders 2019. Annual General Meeting of Shareholders 2019 Summary of the resolutions and voting at DSM's Annual General Meeting of Shareholders 2019. 8 May 2019 Final dividend 2018 Royal DSM DSM declares a dividend for the financial year 2018 of €2.30 per ordinary share. Final dividend 2018 Royal DSM DSM declares a dividend for the financial year 2018 of €2.30 per ordinary share. 8 May 2019 DSM announces results of 2019 Annual General Meeting of Shareholders DSM held its Annual General Meeting of Shareholders on 8 May 2019. Shareholders approved all resolutions on the agenda. DSM announces results of 2019 Annual General Meeting of Shareholders DSM held its Annual General Meeting of Shareholders on 8 May 2019. Shareholders approved all resolutions on the agenda. 7 May 2019 DSM - repurchase of shares (29 April - 3 May 2019) DSM repurchased 172,159 shares from 29 April to 3 May 2019 at an average price of €100.61. DSM - repurchase of shares (29 April - 3 May 2019) DSM repurchased 172,159 shares from 29 April to 3 May 2019 at an average price of €100.61. 7 May 2019 DSM reports Q1 2019 results DSM reports a good start to the year and increases full year outlook. DSM reports Q1 2019 results DSM reports a good start to the year and increases full year outlook. 30 April 2019 DSM - repurchase of shares (23-26 April 2019) DSM repurchased 165,141 shares from 23 to 26 April 2019 at an average price of €101.54. DSM - repurchase of shares (23-26 April 2019) DSM repurchased 165,141 shares from 23 to 26 April 2019 at an average price of €101.54. 23 April 2019 DSM - repurchase of shares (15-18 April 2019) DSM repurchased 123,006 shares from 15 to 18 April 2019 at an average price of €102.40. DSM - repurchase of shares (15-18 April 2019) DSM repurchased 123,006 shares from 15 to 18 April 2019 at an average price of €102.40. 16 April 2019 DSM - repurchase of shares (8-12 April 2019) DSM repurchased 229,636 shares from 8 to 12 April 2019 at an average price of €101.48. DSM - repurchase of shares (8-12 April 2019) DSM repurchased 229,636 shares from 8 to 12 April 2019 at an average price of €101.48. 9 April 2019 DSM - repurchase of shares (1-5 April 2019) DSM repurchased 144,066 shares from 1 to 5 April 2019 at an average price of €99.84. DSM - repurchase of shares (1-5 April 2019) DSM repurchased 144,066 shares from 1 to 5 April 2019 at an average price of €99.84. 3 April 2019 DSM Executive Committee members purchase DSM shares All seven members of the Executive Committee to purchase shares in Royal DSM by converting 50% of their gross STI's into ordinary shares. DSM Executive Committee members purchase DSM shares All seven members of the Executive Committee to purchase shares in Royal DSM by converting 50% of their gross STI's into ordinary shares. 26 March 2019 DSM proposes new supervisory board member Shareholders to vote on Erica Mann's appointment, and Pauline van der Meer Mohr's re-appointment, as members of DSM's Supervisory Board. DSM proposes new supervisory board member Shareholders to vote on Erica Mann's appointment, and Pauline van der Meer Mohr's re-appointment, as members of DSM's Supervisory Board. 18 March 2019 DSM completes increase shareholding in Andre Pectin to 75% DSM increases shareholding in Andre Pectin, a leading specialty food ingredient producer of hydrocolloids to 75%. DSM completes increase shareholding in Andre Pectin to 75% DSM increases shareholding in Andre Pectin, a leading specialty food ingredient producer of hydrocolloids to 75%. 14 March 2019 DSM commences €1 billion share buy-back and announces regular repurchase to cover share plans and stock dividend €1 billion buy back intended to reduce issued capital, plus a further repurchase of 2,600,000 shares to cover share plans and stock dividend. DSM commences €1 billion share buy-back and announces regular repurchase to cover share plans and stock dividend €1 billion buy back intended to reduce issued capital, plus a further repurchase of 2,600,000 shares to cover share plans and stock dividend. 13 March 2019 DSM sets science-based reduction targets for emissions DSM’s targets assessed by Science Based Targets initiative to be in line with the level of decarbonization required to keep global temperature increase below 2° C. DSM sets science-based reduction targets for emissions DSM’s targets assessed by Science Based Targets initiative to be in line with the level of decarbonization required to keep global temperature increase below 2° C. 8 March 2019 DSM’s 2018 Integrated Annual Report: strong progress on People, Planet and Profit, creating value for all stakeholders Report demonstrates DSM’s consistent progress as a growth company with ambitious business and sustainability efforts that creates People, Planet and Profit value. DSM’s 2018 Integrated Annual Report: strong progress on People, Planet and Profit, creating value for all stakeholders Report demonstrates DSM’s consistent progress as a growth company with ambitious business and sustainability efforts that creates People, Planet and Profit value. 1 March 2019 DSM announces start of Avansya 50/50 Joint Venture with Cargill will produce zero-calorie, great-tasting sweeteners through fermentation. DSM announces start of Avansya 50/50 Joint Venture with Cargill will produce zero-calorie, great-tasting sweeteners through fermentation. 14 February 2019 DSM reports 2018 results DSM reports a very strong year, including a robust Q4 and increases dividend by 25% from €1.85 to €2.30 per ordinary share. 14 February 2019 DSM reports 2018 results DSM reports a very strong year, including a robust Q4 and increases dividend by 25% from €1.85 to €2.30 per ordinary share. 6 February 2019 DSM celebrates 30 years as a listed company At the time DSM's IPO was the biggest introduction in the history of the Amsterdam Stock Exchange. 6 February 2019 DSM celebrates 30 years as a listed company At the time DSM's IPO was the biggest introduction in the history of the Amsterdam Stock Exchange. 4 February 2019 DSM announces agreement to increase its shareholding in Andre Pectin from 29% to 75% DSM will increase its shareholding in Yantai Andre Pectin Co. Ltd. (Andre Pectin), a leading specialty food ingredient producer of hydrocolloids. 4 February 2019 DSM announces agreement to increase its shareholding in Andre Pectin from 29% to 75% DSM will increase its shareholding in Yantai Andre Pectin Co. Ltd. (Andre Pectin), a leading specialty food ingredient producer of hydrocolloids. 31 January 2019 DSM announces management change DSM Netherlands Edith Schippers, who was most recently Minister of Health, Welfare and Sports in the Netherlands who will join DSM on 1st February, replacing Atzo Nicolaï. 31 January 2019 DSM announces management change DSM Netherlands Edith Schippers, who was most recently Minister of Health, Welfare and Sports in the Netherlands who will join DSM on 1st February, replacing Atzo Nicolaï. 31 January 2019 DSM announces new Chief Innovation Officer Patricia Malarkey, most recently Head of Research & Development and member of the Executive Committee at Syngenta, will join DSM as Chief Innovation Officer and member of the Executive Committee. 31 January 2019 DSM announces new Chief Innovation Officer Patricia Malarkey, most recently Head of Research & Development and member of the Executive Committee at Syngenta, will join DSM as Chief Innovation Officer and member of the Executive Committee. 29 January 2019 DSM announces JV with Nenter to produce vitamin E DSM will create a 75/25 joint venture with Nenter & Co., Inc., which will include all Nenter’s production and related assets for Vitamin E. 29 January 2019 DSM announces JV with Nenter to produce vitamin E DSM will create a 75/25 joint venture with Nenter & Co., Inc., which will include all Nenter’s production and related assets for Vitamin E. 17 January 2019 DSM pioneers a biogum future DSM Hydrocolloids strengthens foothold in the industry and unveils new brand identities for its gellan gum and xanthan gum portfolios. 17 January 2019 DSM pioneers a biogum future DSM Hydrocolloids strengthens foothold in the industry and unveils new brand identities for its gellan gum and xanthan gum portfolios. 10 January 2019 DSM North America opens newly expanded 66 acre solar field in Belvidere, New Jersey 20.2 MW solar project now largest net-metered solar installation in New Jersey and the second largest on the US East Coast. 10 January 2019 DSM North America opens newly expanded 66 acre solar field in Belvidere, New Jersey 20.2 MW solar project now largest net-metered solar installation in New Jersey and the second largest on the US East Coast. 14 February 2018 DSM reports 2017 results DSM again reports an excellent year, as it significantly exceeded its Strategy 2018 targets for EBITDA, ROCE and organic sales growth. 14 February 2018 DSM reports 2017 results DSM again reports an excellent year, as it significantly exceeded its Strategy 2018 targets for EBITDA, ROCE and organic sales growth. 1 March 2018 DSM publishes 2017 Integrated Annual Report The 2017 Integrated Annual Report details the company's progress and performance over the year in terms of People, Planet and Profit. DSM publishes 2017 Integrated Annual Report The 2017 Integrated Annual Report details the company's progress and performance over the year in terms of People, Planet and Profit. 19 March 2018 DSM announces repurchase of shares to cover share based compensation plans and stock dividend DSM intends to repurchase 1,600,000 ordinary shares to cover commitments under share based compensation plans and and part of the final dividend 2017. DSM announces repurchase of shares to cover share based compensation plans and stock dividend DSM intends to repurchase 1,600,000 ordinary shares to cover commitments under share based compensation plans and and part of the final dividend 2017. 23 March 2018 DSM - repurchase of shares (19-22 March 2018) DSM repurchased 136,650 shares from 19 to 22 March 2018 at an average price of €80.59. DSM - repurchase of shares (19-22 March 2018) DSM repurchased 136,650 shares from 19 to 22 March 2018 at an average price of €80.59. 30 March 2018 DSM - repurchase of shares (23-29 March 2018) DSM repurchased 188,000 shares from 23 to 29 March 2018 at an average price of €79.38. DSM - repurchase of shares (23-29 March 2018) DSM repurchased 188,000 shares from 23 to 29 March 2018 at an average price of €79.38. 6 April 2018 DSM - repurchase of shares (3-5 April 2018) DSM repurchased 87,000 shares from 3 to 5 April 2018 at an average price of €80.10. DSM - repurchase of shares (3-5 April 2018) DSM repurchased 87,000 shares from 3 to 5 April 2018 at an average price of €80.10. 12 April 2018 DSM announces preliminary Q1 2018 results and increases outlook Continued strong organic sales growth in underlying business estimated at 11%. Adjusted EBITDA growth of underlying business estimated at 7% despite significant FX headwind. Additional temporary vitamin price benefit estimated at €165m on Adjusted EBITDA. Overall very strong quarter with total Adjusted EBITDA up 55%. DSM announces preliminary Q1 2018 results and increases outlook Continued strong organic sales growth in underlying business estimated at 11%. Adjusted EBITDA growth of underlying business estimated at 7% despite significant FX headwind. Additional temporary vitamin price benefit estimated at €165m on Adjusted EBITDA. Overall very strong quarter with total Adjusted EBITDA up 55%. 13 April 2018 DSM - repurchase of shares (6-12 April 2018) DSM repurchased 88,350 shares from 6 to 12 April 2018 at an average price of €81.74. DSM - repurchase of shares (6-12 April 2018) DSM repurchased 88,350 shares from 6 to 12 April 2018 at an average price of €81.74. 8 May 2018 DSM reports Q1 2018 results Royal DSM issues its full Q1 2018 results, which are in line with the preliminary figures for Q1 2018 previously announced on 12 April 2018. DSM reports Q1 2018 results Royal DSM issues its full Q1 2018 results, which are in line with the preliminary figures for Q1 2018 previously announced on 12 April 2018. 9 May 2018 DSM announces results of 2018 Annual General Meeting of Shareholders DSM held its Annual General Meeting of Shareholders on 9 May 2018. Shareholders approved all resolutions on the agenda. DSM announces results of 2018 Annual General Meeting of Shareholders DSM held its Annual General Meeting of Shareholders on 9 May 2018. Shareholders approved all resolutions on the agenda. 9 May 2018 Final dividend 2017 Royal DSM DSM declares a dividend for the financial year 2017 of €1.85 per ordinary share. Final dividend 2017 Royal DSM DSM declares a dividend for the financial year 2017 of €1.85 per ordinary share. 18 May 2018 DSM informs market on the announced sale of Fibrant’s Caprolactam business to Highsun DSM and CVC Capital Partners indirectly own 35% and 65% respectively of the shares of Fibrant BV through Chemicalnvest joint venture. DSM informs market on the announced sale of Fibrant’s Caprolactam business to Highsun DSM and CVC Capital Partners indirectly own 35% and 65% respectively of the shares of Fibrant BV through Chemicalnvest joint venture. 18 May 2018 DSM - repurchase of shares (14-17 May 2018) DSM repurchased 91,500 shares from 14 to 17 May 2018 at an average price of €87.39. DSM - repurchase of shares (14-17 May 2018) DSM repurchased 91,500 shares from 14 to 17 May 2018 at an average price of €87.39. 30 May 2018 DSM - repurchase of shares (18-24 May 2018) DSM repurchased 176,500 shares from 18 to 24 May 2018 at an average price of €88.02. DSM - repurchase of shares (18-24 May 2018) DSM repurchased 176,500 shares from 18 to 24 May 2018 at an average price of €88.02. 30 May 2018 DSM links Greenhouse Gas emission reduction to interest rate in new €1 billion Revolving Credit Facility DSM has linked the interest rate of new €1 billion Revolving Credit Facility to its performance on the reduction of GHG emissions. DSM links Greenhouse Gas emission reduction to interest rate in new €1 billion Revolving Credit Facility DSM has linked the interest rate of new €1 billion Revolving Credit Facility to its performance on the reduction of GHG emissions. 1 June 2018 DSM - repurchase of shares (25-31 May 2018) DSM repurchased 233,975 shares from 25 to 31 May 2018 at an average price of €86.30. DSM - repurchase of shares (25-31 May 2018) DSM repurchased 233,975 shares from 25 to 31 May 2018 at an average price of €86.30. 12 June 2018 DSM - repurchase of shares (1-7 June 2018) DSM repurchased 141,033 shares from 1 to 7 June 2018 at an average price of €88.22. DSM - repurchase of shares (1-7 June 2018) DSM repurchased 141,033 shares from 1 to 7 June 2018 at an average price of €88.22. 15 June 2018 DSM - repurchase of shares (8-14 June 2018) DSM repurchased 132,098 shares from 8 to 14 June 2018 at an average price of €89.07. DSM - repurchase of shares (8-14 June 2018) DSM repurchased 132,098 shares from 8 to 14 June 2018 at an average price of €89.07. 20 June 2018 DSM strategy update With its unique science-based competences, DSM is ideally positioned to capture the growth opportunities offered by the global megatrends and Sustainable Development Goals (SDGs), with a particular focus on Nutrition & Health, Climate & Energy and Resources & Circularity. DSM strategy update With its unique science-based competences, DSM is ideally positioned to capture the growth opportunities offered by the global megatrends and Sustainable Development Goals (SDGs), with a particular focus on Nutrition & Health, Climate & Energy and Resources & Circularity. 22 June 2018 DSM finalizes repurchase of shares to cover existing option plans and stock dividends DSM repurchased 324,894 shares from 15 to 20 June 2018 at an average price of €88.18, concluding program to repurchase 1,600,000 shares for a total of €136.7 million. DSM finalizes repurchase of shares to cover existing option plans and stock dividends DSM repurchased 324,894 shares from 15 to 20 June 2018 at an average price of €88.18, concluding program to repurchase 1,600,000 shares for a total of €136.7 million. 20 March 2018 AkzoNobel Specialty Chemicals, DSM, Google and Philips receive first power from new Dutch windfarm Bouwdokken Companies signed two long-term power purchase agreements (PPAs) that enabled construction of two windfarm projects. AkzoNobel Specialty Chemicals, DSM, Google and Philips receive first power from new Dutch windfarm Bouwdokken Companies signed two long-term power purchase agreements (PPAs) that enabled construction of two windfarm projects. 19 April 2018 Redirect to Honorary Chairman PR Redirect to Honorary Chairman PR 20 April 2018 Redirect to Honorary Chairman PR Redirect to Honorary Chairman PR 31 May 2018 Africa Improved Foods celebrates one year AIF’s plant in Kigali has an annual production capacity of 45,000 tons making it one of the largest nutrition factory sites on the continent and it works with over 9,000 farmers across Rwanda and produces meals for 1.5 million people every day. Africa Improved Foods celebrates one year AIF’s plant in Kigali has an annual production capacity of 45,000 tons making it one of the largest nutrition factory sites on the continent and it works with over 9,000 farmers across Rwanda and produces meals for 1.5 million people every day. 7 June 2018 DSM operates on 100% renewable purchased electricity in the Netherlands From 2018 all DSM's purchased electricity in the Netherlands will come from renewable sources, thanks to an agreement with Dutch energy supplier Eneco. DSM operates on 100% renewable purchased electricity in the Netherlands From 2018 all DSM's purchased electricity in the Netherlands will come from renewable sources, thanks to an agreement with Dutch energy supplier Eneco. 9 October 2018 DSM and WFP extend their partnership to tackle malnutrition DSM has extended its partnership with the World Food Programme by 3 years to continue fighting hidden hunger and enabling better nutrition for vulnerable people. DSM and WFP extend their partnership to tackle malnutrition DSM has extended its partnership with the World Food Programme by 3 years to continue fighting hidden hunger and enabling better nutrition for vulnerable people. 25 October 2018 Supporting climate adaptation Improving society’s ability to adapt to a changing climate. 25 October 2018 Supporting climate adaptation Improving society’s ability to adapt to a changing climate. 29 June 2018 DSM informs market on the announced sale of DSM Sinochem Pharmaceuticals to Bain Capital Bain Capital intends to acquire DSM Sinochem Pharmaceuticals, a DSM and Sinochem Group 50/50 joint venture, with the transaction expected to be completed in the fourth quarter of 2018 subject to customary regulatory approvals and consultations. DSM informs market on the announced sale of DSM Sinochem Pharmaceuticals to Bain Capital Bain Capital intends to acquire DSM Sinochem Pharmaceuticals, a DSM and Sinochem Group 50/50 joint venture, with the transaction expected to be completed in the fourth quarter of 2018 subject to customary regulatory approvals and consultations. 2 July 2018 DSM becomes largest shareholder in Mixfit Inc. to enter B2C personalized nutrition Acquisition builds on partnership combining DSM’s unparalleled expertise in micronutrients with Mixfit technology. DSM becomes largest shareholder in Mixfit Inc. to enter B2C personalized nutrition Acquisition builds on partnership combining DSM’s unparalleled expertise in micronutrients with Mixfit technology. 1 August 2018 DSM reports H1 2018 results DSM reports a very good H1 with strong performance across all businesses. DSM reports H1 2018 results DSM reports a very good H1 with strong performance across all businesses. 13 August 2018 DSM announces repurchase of shares to cover share-based compensation plans and stock dividend DSM intends to repurchase 1,100,000 ordinary shares: 500,000 to cover commitments under share-based compensation plans and 600,000 to cover part of the interim dividend 2018. DSM announces repurchase of shares to cover share-based compensation plans and stock dividend DSM intends to repurchase 1,100,000 ordinary shares: 500,000 to cover commitments under share-based compensation plans and 600,000 to cover part of the interim dividend 2018. 21 August 2018 DSM - repurchase of shares (13-17 August 2018) DSM repurchased 215,656 shares from 13 to 17 August 2018 at an average price of €89.80. DSM - repurchase of shares (13-17 August 2018) DSM repurchased 215,656 shares from 13 to 17 August 2018 at an average price of €89.80. 23 August 2018 DSM ranked by Fortune Magazine’s ‘Change the World’ list and Sustainalytics DSM named on Fortune Magazine’s ‘Change the World’ List for third consecutive year and again ranked number 1 globally in sustainability by Sustainalytics DSM ranked by Fortune Magazine’s ‘Change the World’ list and Sustainalytics DSM named on Fortune Magazine’s ‘Change the World’ List for third consecutive year and again ranked number 1 globally in sustainability by Sustainalytics 28 August 2018 DSM - repurchase of shares (20-24 August 2018) DSM repurchased 82,975 shares from 20 to 24 August 2018 at an average price of €89.58. DSM - repurchase of shares (20-24 August 2018) DSM repurchased 82,975 shares from 20 to 24 August 2018 at an average price of €89.58. 4 September 2018 DSM - repurchase of shares (27-31 August 2018) DSM repurchased 117,471 shares from 27 to 31 August 2018 at an average price of €91.17. 4 September 2018 DSM - repurchase of shares (27-31 August 2018) DSM repurchased 117,471 shares from 27 to 31 August 2018 at an average price of €91.17. 11 September 2018 DSM - repurchase of shares (3-7 September 2018) DSM repurchased 189,309 shares from 3 to 7 September 2018 at an average price of €88.16. 11 September 2018 DSM - repurchase of shares (3-7 September 2018) DSM repurchased 189,309 shares from 3 to 7 September 2018 at an average price of €88.16. 13 September 2018 DSM tops Dow Jones Sustainability World Index DSM recognized among the DJSI leaders for 15 years running and held the number one position in the sector eight times. 13 September 2018 DSM tops Dow Jones Sustainability World Index DSM recognized among the DJSI leaders for 15 years running and held the number one position in the sector eight times. 18 September 2018 DSM - repurchase of shares (10-14 September 2018) DSM repurchased 94,032 shares from 10 to 14 September 2018 at an average price of €88.38. 18 September 2018 DSM - repurchase of shares (10-14 September 2018) DSM repurchased 94,032 shares from 10 to 14 September 2018 at an average price of €88.38. 25 September 2018 DSM - repurchase of shares (17-21 September 2018) DSM repurchased 69,638 shares from 17 to 21 September 2018 at an average price of €91.24. 25 September 2018 DSM - repurchase of shares (17-21 September 2018) DSM repurchased 69,638 shares from 17 to 21 September 2018 at an average price of €91.24. 2 October 2018 DSM - repurchase of shares (24-28 September 2018) DSM repurchased 121,592 shares from 24 to 28 September 2018 at an average price of €91.88. DSM - repurchase of shares (24-28 September 2018) DSM repurchased 121,592 shares from 24 to 28 September 2018 at an average price of €91.88. 9 October 2018 DSM finalizes repurchase of shares to cover existing option plans and stock dividends DSM repurchased 209,327 shares from 1 to 5 October 2018 at an average price of €90.13, finalizing program to repurchase 1,100,000 shares for a total of €98.9 million. DSM finalizes repurchase of shares to cover existing option plans and stock dividends DSM repurchased 209,327 shares from 1 to 5 October 2018 at an average price of €90.13, finalizing program to repurchase 1,100,000 shares for a total of €98.9 million. 12 October 2018 DSM welcomes new Sustainability Advisory Board member Ertharin Cousin Ertharin Cousin, former Executive Director of the United Nations World Food Programme, has joined DSM's Sustainability Advisory Board. 12 October 2018 DSM welcomes new Sustainability Advisory Board member Ertharin Cousin Ertharin Cousin, former Executive Director of the United Nations World Food Programme, has joined DSM's Sustainability Advisory Board. 30 October 2018 DSM informs market on the completion of the sale of Fibrant’s caprolactam business to Highsun DSM anticipates receiving about €200 million in cash in various steps in 2018 and 2019. 30 October 2018 DSM informs market on the completion of the sale of Fibrant’s caprolactam business to Highsun DSM anticipates receiving about €200 million in cash in various steps in 2018 and 2019. 31 October 2018 DSM reports results first nine months 2018 DSM reports another very good quarter and is confident in achieving full year outlook. 31 October 2018 DSM reports results first nine months 2018 DSM reports another very good quarter and is confident in achieving full year outlook. 31 October 2018 DSM informs market on the completion of the sale of DSM Sinochem Pharmaceuticals to Bain Capital Bain Capital completes acquisition of DSM Sinochem Pharmaceuticals from DSM and Sinochem, both of whom held an equity stake of 50%. 31 October 2018 DSM informs market on the completion of the sale of DSM Sinochem Pharmaceuticals to Bain Capital Bain Capital completes acquisition of DSM Sinochem Pharmaceuticals from DSM and Sinochem, both of whom held an equity stake of 50%. 8 November 2018 Cargill and Royal DSM to establish joint venture to bring zero-calorie, cost-effective sweeteners to market faster Companies to produce highly sought-after molecules such as steviol glycosides Reb M and Reb D through fermentation. 8 November 2018 Cargill and Royal DSM to establish joint venture to bring zero-calorie, cost-effective sweeteners to market faster Companies to produce highly sought-after molecules such as steviol glycosides Reb M and Reb D through fermentation. 9 May 2018 Annual General Meeting of Shareholders 2018 Summary of the resolutions and voting at DSM's Annual General Meeting of Shareholders 2018. Annual General Meeting of Shareholders 2018 Summary of the resolutions and voting at DSM's Annual General Meeting of Shareholders 2018. 29 December 2017 DSM and Amyris close transactions for Brazilian production facility Sale of Amyris Brasil Ltda to DSM and the establishment of a long-term manufacturing partnership for Amyris’s high-volume products finalized. 29 December 2017 DSM and Amyris close transactions for Brazilian production facility Sale of Amyris Brasil Ltda to DSM and the establishment of a long-term manufacturing partnership for Amyris’s high-volume products finalized. 22 December 2017 DSM acquires BioCare Copenhagen to expand gut health ingredients portfolio with probiotics DSM expands its offering in gut health ingredients with probiotics, an attractive market segment in nutritional ingredients, growing an estimated 7% per year. 22 December 2017 DSM acquires BioCare Copenhagen to expand gut health ingredients portfolio with probiotics DSM expands its offering in gut health ingredients with probiotics, an attractive market segment in nutritional ingredients, growing an estimated 7% per year. 11 December 2017 DSM calls for accelerated climate action as part of a broad coalition of major global companies Call for framework conditions laying foundation for a pathway to limiting global temperature rise to well below 2° Celsius and allow them to actively contribute to the implementation of the Paris Agreement. 11 December 2017 DSM calls for accelerated climate action as part of a broad coalition of major global companies Call for framework conditions laying foundation for a pathway to limiting global temperature rise to well below 2° Celsius and allow them to actively contribute to the implementation of the Paris Agreement. 7 December 2017 RMI case study showcases successful aggregation of corporate renewable energy demand Report details how four major corporate renewable energy buyers came together to successfully aggregate demand and jointly sign multiple wind power PPAs in Europe. 7 December 2017 RMI case study showcases successful aggregation of corporate renewable energy demand Report details how four major corporate renewable energy buyers came together to successfully aggregate demand and jointly sign multiple wind power PPAs in Europe. 17 November 2017 DSM expands strategic alliance with Amyris and acquires Brazilian production facility from Amyris DSM and Amyris enhance their strategic alliance through the sale of Amyris Brasil Ltda to DSM and the establishment of a long-term manufacturing partnership for Amyris’ high-volume products. 17 November 2017 DSM expands strategic alliance with Amyris and acquires Brazilian production facility from Amyris DSM and Amyris enhance their strategic alliance through the sale of Amyris Brasil Ltda to DSM and the establishment of a long-term manufacturing partnership for Amyris’ high-volume products. 17 November 2017 DSM finalizes repurchase of shares to cover existing option plans and stock dividends DSM repurchased 151,900 shares from 10 to 14 November 2017 at an average price of €75.63, concluding program to repurchase 1,600,000 shares for a total of €109.3 million. 17 November 2017 DSM finalizes repurchase of shares to cover existing option plans and stock dividends DSM repurchased 151,900 shares from 10 to 14 November 2017 at an average price of €75.63, concluding program to repurchase 1,600,000 shares for a total of €109.3 million. 13 November 2017 DSM to operate on 40% renewable electricity in the U.S. thanks to new wind power agreement with NextEra DSM positioned to outpace its global target of 50% purchased electricity from renewable sources by 2025. 13 November 2017 DSM to operate on 40% renewable electricity in the U.S. thanks to new wind power agreement with NextEra DSM positioned to outpace its global target of 50% purchased electricity from renewable sources by 2025. 10 November 2017 DSM and Haixing strengthen hydrocolloids business with acquisition of Inner Mongolia Rainbow Biotechnology Co., Ltd. (China) DSM and Haixing will be able to expand their global business of sustainable and innovative hydrocolloid solutions applied in food, beverage and personal care products to provide texture and stability. 10 November 2017 DSM and Haixing strengthen hydrocolloids business with acquisition of Inner Mongolia Rainbow Biotechnology Co., Ltd. (China) DSM and Haixing will be able to expand their global business of sustainable and innovative hydrocolloid solutions applied in food, beverage and personal care products to provide texture and stability. 10 November 2017 DSM - repurchase of shares (3-9 November 2017) DSM repurchased 243,624 shares from 3 to 9 November 2017 at an average price of €76.15. 10 November 2017 DSM - repurchase of shares (3-9 November 2017) DSM repurchased 243,624 shares from 3 to 9 November 2017 at an average price of €76.15. 2 November 2017 DSM reports results first nine months 2017 Strong performance in Q3 2017, contributing to very good first nine months. 2 November 2017 DSM reports results first nine months 2017 Strong performance in Q3 2017, contributing to very good first nine months. 30 October 2017 DSM, UNICEF, and Sight and Life partner to deliver better nutrition in Nigeria Partnership to focus on reaching mothers and children with nutrition interventions during the crucial first 1,000 days of children’s lives, from conception to age 2. 30 October 2017 DSM, UNICEF, and Sight and Life partner to deliver better nutrition in Nigeria Partnership to focus on reaching mothers and children with nutrition interventions during the crucial first 1,000 days of children’s lives, from conception to age 2. 13 October 2017 Redirect to Honorary Chairman PR 13 October 2017 Redirect to Honorary Chairman PR 9 October 2017 DSM - repurchase of shares (6-12 October 2017) DSM repurchased 37,600 shares from 6 to 12 October 2017 at an average price of €69.54. DSM - repurchase of shares (6-12 October 2017) DSM repurchased 37,600 shares from 6 to 12 October 2017 at an average price of €69.54. 6 October 2017 DSM - repurchase of shares (29 September - 5 October 2017) DSM repurchased 140,692 shares from 29 September to 5 October 2017 at an average price of €69.52. DSM - repurchase of shares (29 September - 5 October 2017) DSM repurchased 140,692 shares from 29 September to 5 October 2017 at an average price of €69.52. 29 September 2017 DSM reports fatal accident at Augusta site On 27 September 2017 a fatal accident took place at DSM's site in Augusta (GA, US), in which a contractor sadly lost his life and two others injured, and expected to recover. 29 September 2017 DSM reports fatal accident at Augusta site On 27 September 2017 a fatal accident took place at DSM's site in Augusta (GA, US), in which a contractor sadly lost his life and two others injured, and expected to recover. 29 September 2017 DSM - repurchase of shares (22-28 September 2017) DSM repurchased 163,310 shares from 22 to 28 September 2017 at an average price of €67.75. 29 September 2017 DSM - repurchase of shares (22-28 September 2017) DSM repurchased 163,310 shares from 22 to 28 September 2017 at an average price of €67.75. 25 September 2017 DSM updates market on Strategy 2018 EBITDA and ROCE outlook for 2017 confirmed. DSM aims to continue to deliver against its strategic targets in 2018. DSM brings forward its regular strategic review process for the period beyond 2018 and expects to share the conclusions before the summer of 2018. 25 September 2017 DSM updates market on Strategy 2018 EBITDA and ROCE outlook for 2017 confirmed. DSM aims to continue to deliver against its strategic targets in 2018. DSM brings forward its regular strategic review process for the period beyond 2018 and expects to share the conclusions before the summer of 2018. 22 September 2017 DSM - repurchase of shares (15-21 September 2017) DSM repurchased 117,424 shares from 15 to 21 September 2017 at an average price of €66.56. 22 September 2017 DSM - repurchase of shares (15-21 September 2017)

DSM repurchased 117,424 shares from 15 to 21 September 2017 at an average price of €66.56. 22 September 2017 DSM to acquire Twilmij B.V. to strengthen position in Animal Nutrition & Health Twilmij’s core values, customer portfolio and solutions are a perfect fit with DSM’s ambitions in the animal nutrition & health market. 22 September 2017 DSM to acquire Twilmij B.V. to strengthen position in Animal Nutrition & Health Twilmij’s core values, customer portfolio and solutions are a perfect fit with DSM’s ambitions in the animal nutrition & health market. 15 September 2017 DSM - repurchase of shares (8-14 September 2017) DSM repurchased 128,851 shares from 8 to 14 September 2017 at an average price of €66.04. 15 September 2017 DSM - repurchase of shares (8-14 September 2017) DSM repurchased 128,851 shares from 8 to 14 September 2017 at an average price of €66.04. 11 September 2017 DSM 2nd on Fortune’s “Change the World” list DSM in 2nd place in Fortune Magazine’s 3rd annual Change the World list, which recognizes 56 companies that have had a positive social impact through activities that are part of their core business strategy. 11 September 2017 DSM 2nd on Fortune’s “Change the World” list DSM in 2nd place in Fortune Magazine’s 3rd annual Change the World list, which recognizes 56 companies that have had a positive social impact through activities that are part of their core business strategy. 8 September 2017 DSM - repurchase of shares (1-7 September 2017) DSM repurchased 142,315 shares from 1 to 7 September 2017 at an average price of €65.01. 8 September 2017 DSM - repurchase of shares (1-7 September 2017) DSM repurchased 142,315 shares from 1 to 7 September 2017 at an average price of €65.01. 7 September 2017 DSM among leaders in Dow Jones Sustainability World Index DSM again named among worldwide leaders in the Materials industry group in the Dow Jones Sustainability World Index having been named among the global leaders for the past 14 years and holding the number one position in the sector seven times, including last year. 7 September 2017 DSM among leaders in Dow Jones Sustainability World Index DSM again named among worldwide leaders in the Materials industry group in the Dow Jones Sustainability World Index having been named among the global leaders for the past 14 years and holding the number one position in the sector seven times, including last year. 1 September 2017 DSM - repurchase of shares (25-31 August 2017) DSM repurchased 188,430 shares from 25 to 31 August 2017 at an average price of €64.01. 1 September 2017 DSM - repurchase of shares (25-31 August 2017) DSM repurchased 188,430 shares from 25 to 31 August 2017 at an average price of €64.01. 1 September 2017 In Memoriam Peter Elverding It is with great sadness that we share the news that our friend and former colleague, Peter Elverding has passed away. 1 September 2017 In Memoriam Peter Elverding It is with great sadness that we share the news that our friend and former colleague, Peter Elverding has passed away. 29 August 2017 DSM informs market on Patheon N.V. Thermo Fisher Scientific Inc. has completed the acquisition of Patheon N.V. (NYSE:PTHN), a company in which DSM held approximately 48.7 million ordinary shares. DSM informs market on Patheon N.V. Thermo Fisher Scientific Inc. has completed the acquisition of Patheon N.V. (NYSE:PTHN), a company in which DSM held approximately 48.7 million ordinary shares. 25 August 2017 DSM - repurchase of shares (18-24 August 2017) DSM repurchased 185,837 shares from 18 to 24 August 2017 at an average price of €63.98. DSM - repurchase of shares (18-24 August 2017) DSM repurchased 185,837 shares from 18 to 24 August 2017 at an average price of €63.98. 18 August 2017 DSM - repurchase of shares (14-17 August 2017) DSM repurchased 100,017 shares from 14 to 17 August 2017 at an average price of €63.21. DSM - repurchase of shares (14-17 August 2017) DSM repurchased 100,017 shares from 14 to 17 August 2017 at an average price of €63.21. 14 August 2017 DSM announces repurchase of shares to cover existing option plans and stock dividend DSM intends to repurchase 1,600,000 ordinary shares to cover commitments under management and personnel option plans and for part of the interim dividend 2017. DSM announces repurchase of shares to cover existing option plans and stock dividend DSM intends to repurchase 1,600,000 ordinary shares to cover commitments under management and personnel option plans and for part of the interim dividend 2017. 1 August 2017 DSM reports H1 2017 results DSM maintained its positive momentum with a very strong first half-year performance with Q2 another very good quarter. DSM reports H1 2017 results DSM maintained its positive momentum with a very strong first half-year performance with Q2 another very good quarter. 21 July 2017 DSM appoints new EVP People & Organization and member of the Executive Committee Judith Wiese will join DSM as Executive Vice President Group People & Organization on 1 October 2017. DSM appoints new EVP People & Organization and member of the Executive Committee Judith Wiese will join DSM as Executive Vice President Group People & Organization on 1 October 2017. 14 July 2017 DSM finalizes repurchase of shares to cover existing option plans and stock dividends DSM repurchased 261,898 shares from 7 to 13 July 2017 at an average price of €63.24, concluding program to repurchase 2,900,000 shares for a total of €187.2 million. DSM finalizes repurchase of shares to cover existing option plans and stock dividends DSM repurchased 261,898 shares from 7 to 13 July 2017 at an average price of €63.24, concluding program to repurchase 2,900,000 shares for a total of €187.2 million. 7 July 2017 DSM - repurchase of shares (30 June - 6 July 2017) DSM repurchased 218,403 shares from 30 June to 6 July 2017 at an average price of €63.72. DSM - repurchase of shares (30 June - 6 July 2017) DSM repurchased 218,403 shares from 30 June to 6 July 2017 at an average price of €63.72. 30 June 2017 DSM - repurchase of shares (23-29 June 2017) DSM repurchased 182,175 shares from 23 to 29 June 2017 at an average price of €65.07. DSM - repurchase of shares (23-29 June 2017) DSM repurchased 182,175 shares from 23 to 29 June 2017 at an average price of €65.07. 23 June 2017 DSM - repurchase of shares (16-22 June 2017) DSM repurchased 122,307 shares from 16 to 22 June 2017 at an average price of €67.16. DSM - repurchase of shares (16-22 June 2017) DSM repurchased 122,307 shares from 16 to 22 June 2017 at an average price of €67.16. 16 June 2017 DSM - repurchase of shares (9-15 June 2017) DSM repurchased 123,435 shares from 9 to 15 June 2017 at an average price of €66.00. DSM - repurchase of shares (9-15 June 2017) DSM repurchased 123,435 shares from 9 to 15 June 2017 at an average price of €66.00. 13 June 2017 Bright Minds Challenge award for Ernesto Julio Calvo with Inquimae Support from DSM and global partners to scale-up 100% renewable energy solution. Bright Minds Challenge award for Ernesto Julio Calvo with Inquimae Support from DSM and global partners to scale-up 100% renewable energy solution. 9 June 2017 DSM - repurchase of shares (2-8 June 2017) DSM repurchased 132,717 shares from 2 to 8 June 2017 at an average price of €65.73. DSM - repurchase of shares (2-8 June 2017) DSM repurchased 132,717 shares from 2 to 8 June 2017 at an average price of €65.73. 2 June 2017 DSM - repurchase of shares (26 May - 1 June 2017) DSM repurchased 123,673 shares from 26 May to 1 June 2017 at an average price of €66.16. DSM - repurchase of shares (26 May - 1 June 2017) DSM repurchased 123,673 shares from 26 May to 1 June 2017 at an average price of €66.16. 29 May 2017 Key international partners to attend official Africa Improved Foods plant unveiling AIF Rwanda now producing highly nutritious porridge flours (with added milk, vitamins and minerals) targeting vulnerable population segments such as pregnant and breast-feeding mothers, older infants and young children in the first 1,000 days of their lives. Key international partners to attend official Africa Improved Foods plant unveiling AIF Rwanda now producing highly nutritious porridge flours (with added milk, vitamins and minerals) targeting vulnerable population segments such as pregnant and breast-feeding mothers, older infants and young children in the first 1,000 days of their lives. 26 May 2017 DSM - repurchase of shares (19-25 May 2017) DSM repurchased 123,847 shares from 19 to 25 May 2017 at an average price of €66.10. DSM - repurchase of shares (19-25 May 2017) DSM repurchased 123,847 shares from 19 to 25 May 2017 at an average price of €66.10. 19 May 2017 DSM - repurchase of shares (12-18 May 2017) DSM repurchased 139,447 shares from 12 to 18 May 2017 at an average price of €66.66. DSM - repurchase of shares (12-18 May 2017) DSM repurchased 139,447 shares from 12 to 18 May 2017 at an average price of €66.66. 15 May 2017 DSM informs market on Patheon N.V. Thermo Fisher will commence a tender offer to acquire all of the issued and outstanding shares of Patheon for $35.00 per ordinary share in cash. DSM informs market on Patheon N.V. Thermo Fisher will commence a tender offer to acquire all of the issued and outstanding shares of Patheon for $35.00 per ordinary share in cash. 12 May 2017 DSM - repurchase of shares (5-11 May 2017) DSM repurchased 128,958 shares from 5 to 11 May 2017 at an average price of €65.76. DSM - repurchase of shares (5-11 May 2017) DSM repurchased 128,958 shares from 5 to 11 May 2017 at an average price of €65.76. 8 May 2017 Royal DSM to make equity investment in Amyris with the purpose of establishing a long-term relationship DSM to make equity investment in Amyris and the companies to enter development cooperation focused on products for the health and nutrition markets. Royal DSM to make equity investment in Amyris with the purpose of establishing a long-term relationship DSM to make equity investment in Amyris and the companies to enter development cooperation focused on products for the health and nutrition markets. 5 May 2017 DSM - repurchase of shares (28 April - 4 May 2017) DSM repurchased 114,048 shares from 28 April to 4 May 2017 at an average price of €66.44. DSM - repurchase of shares (28 April - 4 May 2017) DSM repurchased 114,048 shares from 28 April to 4 May 2017 at an average price of €66.44. 3 May 2017 Final dividend 2016 Royal DSM DSM declares a dividend for the financial year 2016 of €1.75 per ordinary share. Final dividend 2016 Royal DSM DSM declares a dividend for the financial year 2016 of €1.75 per ordinary share. 3 May 2017 DSM announces results of 2017 Annual General Meeting of Shareholders DSM held its Annual General Meeting of Shareholders on 3 May 2017. Shareholders approved all resolutions on the agenda. DSM announces results of 2017 Annual General Meeting of Shareholders DSM held its Annual General Meeting of Shareholders on 3 May 2017. Shareholders approved all resolutions on the agenda. 3 May 2017 Annual General Meeting of Shareholders 2017 Summary of the resolutions at DSM'S Annual General Meeting of Shareholders 2017. Annual General Meeting of Shareholders 2017 Summary of the resolutions at DSM'S Annual General Meeting of Shareholders 2017. 2 May 2017 DSM reports Q1 2017 results DSM reports a very strong first quarter in 2017. DSM reports Q1 2017 results DSM reports a very strong first quarter in 2017. 28 April 2017 DSM - repurchase of shares (21-27 April 2017) DSM repurchased 126,540 shares from 21 to 27 April 2017 at an average price of €65.81. DSM - repurchase of shares (21-27 April 2017) DSM repurchased 126,540 shares from 21 to 27 April 2017 at an average price of €65.81. 21 April 2017 Redirect to Honorary Chairman PR Redirect to Honorary Chairman PR 21 April 2017 DSM - repurchase of shares (18-20 April 2017) DSM repurchased 75,948 shares from 18 to 20 April 2017 at an average price of €65.02. DSM - repurchase of shares (18-20 April 2017) DSM repurchased 75,948 shares from 18 to 20 April 2017 at an average price of €65.02. 14 April 2017 DSM - repurchase of shares (7-13 April 2017) DSM repurchased 126,073 shares from 7 to 13 April 2017 at an average price of €65.16. DSM - repurchase of shares (7-13 April 2017) DSM repurchased 126,073 shares from 7 to 13 April 2017 at an average price of €65.16. 12 April 2017 Bright Minds Challenge names three finalists in global solar energy and storage competition Finalists selected from ten best science and entrepreneurial team submissions. Bright Minds Challenge names three finalists in global solar energy and storage competition Finalists selected from ten best science and entrepreneurial team submissions. 7 April 2017 DSM - repurchase of shares (31 March - 6 April 2017) DSM repurchased 134,338 shares from 31 March to 6 April 2017 at an average price of €64.04. DSM - repurchase of shares (31 March - 6 April 2017) DSM repurchased 134,338 shares from 31 March to 6 April 2017 at an average price of €64.04. 3 April 2017 DSM opens new biotechnology center in Delft, the Netherlands New state-of-the-art biotechnology facility will accelerate DSM’s biotechnology research and development capabilities for applications in food and nutrition, feed, fuel, pharma and bio-based materials. DSM opens new biotechnology center in Delft, the Netherlands New state-of-the-art biotechnology facility will accelerate DSM’s biotechnology research and development capabilities for applications in food and nutrition, feed, fuel, pharma and bio-based materials. 31 March 2017 DSM - repurchase of shares (24-30 March 2017) DSM repurchased 235,605 shares from 24 to 30 March 2017 at an average price of €62.81. DSM - repurchase of shares (24-30 March 2017) DSM repurchased 235,605 shares from 24 to 30 March 2017 at an average price of €62.81. 24 March 2017 DSM - repurchase of shares (17-23 March 2017) DSM repurchased 308,025 shares from 17 to 23 March 2017 at an average price of €62.12. DSM - repurchase of shares (17-23 March 2017) DSM repurchased 308,025 shares from 17 to 23 March 2017 at an average price of €62.12. 21 March 2017 DSM proposes Managing Board re-appointment and two new Supervisory Board members DSM proposes re-appointment of Dimitri de Vreeze the Managing Board and appointment of John Ramsay and Frits van Paasschen to the Supervisory Board. DSM proposes Managing Board re-appointment and two new Supervisory Board members DSM proposes re-appointment of Dimitri de Vreeze the Managing Board and appointment of John Ramsay and Frits van Paasschen to the Supervisory Board. 17 March 2017 DSM - repurchase of shares (13-16 March 2017) DSM repurchased 222,563 shares from 13 to 16 March 2017 at an average price of €62.92 for a total of €14.0 million. DSM - repurchase of shares (13-16 March 2017) DSM repurchased 222,563 shares from 13 to 16 March 2017 at an average price of €62.92 for a total of €14.0 million. 13 March 2017 DSM announces repurchase of shares to cover existing option plans and stock dividend DSM to repurchase 2,900,000 ordinary shares to cover commitments under management and personnel option plans and for part of final dividend 2016. DSM announces repurchase of shares to cover existing option plans and stock dividend DSM to repurchase 2,900,000 ordinary shares to cover commitments under management and personnel option plans and for part of final dividend 2016. 3 March 2017 DSM publishes 2016 Integrated Annual Report 2016 Integrated Annual Report, in which DSM reports on its progress and performance over the year in terms of People, Planet and Profit, published on 3 March 2017. DSM publishes 2016 Integrated Annual Report 2016 Integrated Annual Report, in which DSM reports on its progress and performance over the year in terms of People, Planet and Profit, published on 3 March 2017. 16 February 2017 POET-DSM plans on-site enzyme manufacturing facility at Project Liberty Plant has achieved 70 gallon per ton conversion rate and POET-DSM Advanced Biofuels will now build an on-site enzyme manufacturing facility in Emmetsburg, Iowa, pending state and local approvals. 16 February 2017 POET-DSM plans on-site enzyme manufacturing facility at Project Liberty Plant has achieved 70 gallon per ton conversion rate and POET-DSM Advanced Biofuels will now build an on-site enzyme manufacturing facility in Emmetsburg, Iowa, pending state and local approvals. 15 February 2017 DSM reports 2016 results DSM reports a very good 2016 in which it achieved strong EBITDA and ROCE growth, well ahead of the mid-term targets set out in its Strategy 2018: Driving Profitable Growth. 15 February 2017 DSM reports 2016 results DSM reports a very good 2016 in which it achieved strong EBITDA and ROCE growth, well ahead of the mid-term targets set out in its Strategy 2018: Driving Profitable Growth. 14 February 2017 DSM new presentation of accounts as from Q4 2016 DSM updates way its financial results are presented starting with Q4/full-year results for 2016, following recent changes to accounting and reporting guidelines in Europe. 14 February 2017 DSM new presentation of accounts as from Q4 2016 DSM updates way its financial results are presented starting with Q4/full-year results for 2016, following recent changes to accounting and reporting guidelines in Europe. 23 January 2017 DSM welcomes new Sustainability Advisory Board member Robin Chase Robin Chase, cofounder and former CEO of Zipcar, member of Boards of Veniam, World Resources Institute and Tucows and advisor to French National Digital Agency and USDOT’s Advisory Committee on Automated Transportation, joins DSM's Sustainability Advisory Board. 23 January 2017 DSM welcomes new Sustainability Advisory Board member Robin Chase Robin Chase, cofounder and former CEO of Zipcar, member of Boards of Veniam, World Resources Institute and Tucows and advisor to French National Digital Agency and USDOT’s Advisory Committee on Automated Transportation, joins DSM's Sustainability Advisory Board. 9 December 2016 DSM finalizes repurchase of shares to cover existing option plans DSM repurchased 361,907 shares from 2 to 8 December 2016 at an average price of €56.21 and concluded the program to repurchase 1,700,000 shares. 9 December 2016 DSM finalizes repurchase of shares to cover existing option plans DSM repurchased 361,907 shares from 2 to 8 December 2016 at an average price of €56.21 and concluded the program to repurchase 1,700,000 shares. 2 December 2016 DSM - repurchase of shares (25 November 2016 - 1 December 2016) DSM repurchased 215,424 of its own shares from 25 November to 1 December 2016 at an average price of €57.32. 2 December 2016 DSM - repurchase of shares (25 November 2016 - 1 December 2016) DSM repurchased 215,424 of its own shares from 25 November to 1 December 2016 at an average price of €57.32. 25 November 2016 DSM - repurchase of shares (18-24 November 2016) DSM repurchased 248,036 shares from 18 to 24 November 2016 at an average price of €57.14. 25 November 2016 DSM - repurchase of shares (18-24 November 2016) DSM repurchased 248,036 shares from 18 to 24 November 2016 at an average price of €57.14. 22 November 2016 DSM Managing Board change DSM announces the departure of Managing Board and Executive Committee member Stephan B. Tanda as of 1 February 2017. 22 November 2016 DSM Managing Board change DSM announces the departure of Managing Board and Executive Committee member Stephan B. Tanda as of 1 February 2017. 18 November 2016 DSM - repurchase of shares (11-17 November 2016) DSM repurchased 360,149 shares from 11 to 17 November 2016 at an average price of €56.21. 18 November 2016 DSM - repurchase of shares (11-17 November 2016) DSM repurchased 360,149 shares from 11 to 17 November 2016 at an average price of €56.21. 12 November 2016 DSM reports Q3 2016 results DSM reports another strong quarter in Q3 2016. 12 November 2016 DSM reports Q3 2016 results DSM reports another strong quarter in Q3 2016. 11 November 2016 DSM - repurchase of shares (4-10 November 2016) DSM repurchased 514,484 shares from 4 to 10 November 2016 at an average price of €56.17. 11 November 2016 DSM - repurchase of shares (4-10 November 2016) DSM repurchased 514,484 shares from 4 to 10 November 2016 at an average price of €56.17. 4 November 2016 DSM announces repurchase of shares to cover existing option plans DSM intends to repurchase up to 1,700,000 ordinary shares in order to cover its commitments under management and personnel option plans. 4 November 2016 DSM announces repurchase of shares to cover existing option plans DSM intends to repurchase up to 1,700,000 ordinary shares in order to cover its commitments under management and personnel option plans. 19 September 2016 DSM issues long-term €750 million bond DSM announces the successful launch of a €750 million bond, with a ten-year maturity due in 2026, at a coupon of 0.75%. 19 September 2016 DSM issues long-term €750 million bond DSM announces the successful launch of a €750 million bond, with a ten-year maturity due in 2026, at a coupon of 0.75%. 8 September 2016 DSM named leader in Dow Jones Sustainability World Index DSM has been named the worldwide leader in the Materials industry group in the Dow Jones Sustainability World Index 2016. 8 September 2016 DSM named leader in Dow Jones Sustainability World Index DSM has been named the worldwide leader in the Materials industry group in the Dow Jones Sustainability World Index 2016. 2 August 2016 DSM reports Q2 2016 results DSM reports a second consecutive strong quarter in 2016. DSM reports Q2 2016 results DSM reports a second consecutive strong quarter in 2016. 27 July 2016 DSM successfully completes secondary offering of shares in Patheon N.V. DSM announces the successful completion of its secondary offering of 4,761,905 ordinary shares in Patheon N.V. in connection with Patheon N.V.’s Initial Public Offering of ordinary shares. DSM successfully completes secondary offering of shares in Patheon N.V. DSM announces the successful completion of its secondary offering of 4,761,905 ordinary shares in Patheon N.V. in connection with Patheon N.V.’s Initial Public Offering of ordinary shares. 22 July 2016 DSM finalizes repurchase of shares to cover existing option plans and stock dividend DSM repurchased 83,073 shares from 15 to 21 July 2016 at an average price of €56.75 and concluded the program to repurchase 3,500,000 shares. DSM finalizes repurchase of shares to cover existing option plans and stock dividend DSM repurchased 83,073 shares from 15 to 21 July 2016 at an average price of €56.75 and concluded the program to repurchase 3,500,000 shares. 21 July 2016 DSM informs market of final pricing of Patheon N.V. IPO Patheon N.V., a company in which DSM holds approximately 53.5 million ordinary shares, has priced its Initial Public Offering at USD 21.00 per ordinary share. DSM informs market of final pricing of Patheon N.V. IPO Patheon N.V., a company in which DSM holds approximately 53.5 million ordinary shares, has priced its Initial Public Offering at USD 21.00 per ordinary share. 15 July 2016 DSM - repurchase of shares (8-14 July 2016) DSM repurchased 107,432 shares from 8 to 14 July 2016 at an average price of €54.67. DSM - repurchase of shares (8-14 July 2016) DSM repurchased 107,432 shares from 8 to 14 July 2016 at an average price of €54.67. 11 July 2016 DSM informs market of amended S-1 filing by Patheon N.V. Patheon N.V., a company in which DSM holds approximately 53.5 million ordinary shares, has today commenced an Initial Public Offering. DSM informs market of amended S-1 filing by Patheon N.V. Patheon N.V., a company in which DSM holds approximately 53.5 million ordinary shares, has today commenced an Initial Public Offering. 8 July 2016 DSM - repurchase of shares (1-7 July 2016) DSM repurchased 95,055 shares from 1 to 7 July 2016 at an average price of €52.09. DSM - repurchase of shares (1-7 July 2016) DSM repurchased 95,055 shares from 1 to 7 July 2016 at an average price of €52.09. 1 July 2016 DSM - repurchase of shares (24-30 June 2016) DSM repurchased 248,553 shares from 24 to 30 June 2016 at an average price of €50.64. DSM - repurchase of shares (24-30 June 2016) DSM repurchased 248,553 shares from 24 to 30 June 2016 at an average price of €50.64. 30 June 2016 Increased crash protection with Dyneema® Protective properties of the bib-shorts are further enhanced by a new and optimized design of the Dyneema fabric. Increased crash protection with Dyneema® Protective properties of the bib-shorts are further enhanced by a new and optimized design of the Dyneema fabric. 24 June 2016 DSM - repurchase of shares (17-23 June 2016) DSM repurchased 115,202 shares from 17 to 23 June 2016 at an average price of €53.57. DSM - repurchase of shares (17-23 June 2016) DSM repurchased 115,202 shares from 17 to 23 June 2016 at an average price of €53.57. 17 June 2016 DSM - repurchase of shares (10-16 June 2016) DSM repurchased 125,684 shares from 10 to 16 June 2016 at an average price of €53.20. DSM - repurchase of shares (10-16 June 2016) DSM repurchased 125,684 shares from 10 to 16 June 2016 at an average price of €53.20. 10 June 2016 DSM announces amendment to share repurchase program and reports repurchase of shares (3-9 June 2016) DSM intends to increase the running share repurchase program by an additional 300,000 shares to a total of 3,500,000 to cover the interim stock dividend 2016. DSM announces amendment to share repurchase program and reports repurchase of shares (3-9 June 2016) DSM intends to increase the running share repurchase program by an additional 300,000 shares to a total of 3,500,000 to cover the interim stock dividend 2016. 3 June 2016 DSM - repurchase of shares (27 May 2016 - 2 June 2016) DSM repurchased 151,361 shares from 27 May to 2 June 2016 at an average price of €54.46. DSM - repurchase of shares (27 May 2016 - 2 June 2016) DSM repurchased 151,361 shares from 27 May to 2 June 2016 at an average price of €54.46. 27 May 2016 DSM - repurchase of shares (20-26 May 2016) DSM repurchased 152,420 shares from 20 to 26 May 2016 at an average price of €53.26 DSM - repurchase of shares (20-26 May 2016) DSM repurchased 152,420 shares from 20 to 26 May 2016 at an average price of €53.26 20 May 2016 DSM - repurchase of shares (13-19 May 2016) DSM repurchased 152,511 shares from 13 to 19 May 2016 at an average price of €52.54. DSM - repurchase of shares (13-19 May 2016) DSM repurchased 152,511 shares from 13 to 19 May 2016 at an average price of €52.54. 13 May 2016 DSM - repurchase of shares (6-12 May 2016) DSM repurchased 153,360 shares from 6 to 12 May 2016 at an average price of €52.27. DSM - repurchase of shares (6-12 May 2016) DSM repurchased 153,360 shares from 6 to 12 May 2016 at an average price of €52.27. 6 May 2016 DSM - repurchase of shares (29 April - 5 May 2016) DSM repurchased 153,694 shares from 29 April to 5 May 2016 at an average price of €52.34. DSM - repurchase of shares (29 April - 5 May 2016) DSM repurchased 153,694 shares from 29 April to 5 May 2016 at an average price of €52.34. 3 May 2016 DSM provides update on Nutrition organization to support growth DSM provides an update on the development of its Nutrition organization and several key positions to further support its growth plans. DSM provides update on Nutrition organization to support growth DSM provides an update on the development of its Nutrition organization and several key positions to further support its growth plans. 29 April 2016 DSM announces results of 2016 Annual General Meeting of Shareholders DSM held its Annual General Meeting of Shareholders on 29 April 2016. Shareholders approved all resolutions on the agenda. DSM announces results of 2016 Annual General Meeting of Shareholders DSM held its Annual General Meeting of Shareholders on 29 April 2016. Shareholders approved all resolutions on the agenda. 29 April 2016 Annual General Meeting of Shareholders 2016 Summary of the resolutions at DSM'S Annual General Meeting of Shareholders 2016. Annual General Meeting of Shareholders 2016 Summary of the resolutions at DSM'S Annual General Meeting of Shareholders 2016. 29 April 2016 DSM - repurchase of shares (22-28 April 2016) DSM repurchased 163,523 shares from 22 to 28 April 2016 at an average price of €53.25. DSM - repurchase of shares (22-28 April 2016) DSM repurchased 163,523 shares from 22 to 28 April 2016 at an average price of €53.25. 29 April 2016 Final dividend 2015 Royal DSM DSM declares a dividend for the financial year 2015 of €1.65 per ordinary share of €1.50 nominal value. Final dividend 2015 Royal DSM DSM declares a dividend for the financial year 2015 of €1.65 per ordinary share of €1.50 nominal value. 26 April 2016 DSM reports Q1 2016 results DSM reports a strong first quarter in 2016. DSM reports Q1 2016 results DSM reports a strong first quarter in 2016. 22 April 2016 DSM - repurchase of shares (15-21 April 2016) DSM repurchased 153,579 shares from 15 to 21 April 2016 at an average price of €52.05. DSM - repurchase of shares (15-21 April 2016) DSM repurchased 153,579 shares from 15 to 21 April 2016 at an average price of €52.05. 15 April 2016 DSM - repurchase of shares (8-14 April 2016) DSM repurchased 153,992 shares from 8 to 14 April 2016 at an average price of €50.01. DSM - repurchase of shares (8-14 April 2016) DSM repurchased 153,992 shares from 8 to 14 April 2016 at an average price of €50.01. 8 April 2016 DSM - repurchase of shares (1-7 April 2016) DSM repurchased 167,229 shares from 1 to 7 April 2016 at an average price of €47.8951. DSM - repurchase of shares (1-7 April 2016) DSM repurchased 167,229 shares from 1 to 7 April 2016 at an average price of €47.8951. 1 April 2016 DSM - repurchase of shares (29-31 March 2016) DSM repurchased 93,033 shares from 29 to 31 March 2016 at an average price of €48.5712. DSM - repurchase of shares (29-31 March 2016) DSM repurchased 93,033 shares from 29 to 31 March 2016 at an average price of €48.5712. 31 March 2016 DSM Executive Committee members purchase DSM shares All members of the Executive Committee purchase ordinary shares in Royal DSM, expressing their confidence in the growth prospects of the company. DSM Executive Committee members purchase DSM shares All members of the Executive Committee purchase ordinary shares in Royal DSM, expressing their confidence in the growth prospects of the company. 25 March 2016 DSM - repurchase of shares (18-24 March 2016) DSM repurchased 159,637 shares from 18 to 24 March 2016 at an average price of €48.28. DSM - repurchase of shares (18-24 March 2016) DSM repurchased 159,637 shares from 18 to 24 March 2016 at an average price of €48.28. 18 March 2016 DSM - repurchase of shares (11-17 March 2016) DSM repurchased 161,667 shares from 11 to 17 March 2016 at an average price of €48.06. DSM - repurchase of shares (11-17 March 2016) DSM repurchased 161,667 shares from 11 to 17 March 2016 at an average price of €48.06. 11 March 2016 DSM - repurchase of shares (4-10 March 2016) DSM repurchased 232,331 shares from 4 to 10 March 2016 at an average price of €47.13. DSM - repurchase of shares (4-10 March 2016) DSM repurchased 232,331 shares from 4 to 10 March 2016 at an average price of €47.13. 4 March 2016 DSM - repurchase of shares (26 February 2016 - 3 March 2016) DSM repurchased 269,930 shares from 26 February to 3 March 2016 at an average price of €45.84. DSM - repurchase of shares (26 February 2016 - 3 March 2016) DSM repurchased 269,930 shares from 26 February to 3 March 2016 at an average price of €45.84. 1 March 2016 DSM publishes 2015 Integrated Annual Report DSM announces the publication of its 2015 Integrated Annual Report. DSM publishes 2015 Integrated Annual Report DSM announces the publication of its 2015 Integrated Annual Report. 26 February 2016 DSM - repurchase of shares (22-25 February 2016) DSM repurchased 267,680 shares from 22 to 25 February 2016 at an average price of €43.94. 26 February 2016 DSM - repurchase of shares (22-25 February 2016) DSM repurchased 267,680 shares from 22 to 25 February 2016 at an average price of €43.94. 25 February 2016 DSM welcomes new Sustainability Advisory Board member Ndidi Okonkwo Nwuneli Ndidi Okonkwo Nwuneli, founder of LEAP Africa and co-founder of AACE Food Processing & Distribution Ltd and partner at Sahel Capital, an advisory and private equity firm, has joined DSM's Sustainability Advisory Board. 25 February 2016 DSM welcomes new Sustainability Advisory Board member Ndidi Okonkwo Nwuneli Ndidi Okonkwo Nwuneli, founder of LEAP Africa and co-founder of AACE Food Processing & Distribution Ltd and partner at Sahel Capital, an advisory and private equity firm, has joined DSM's Sustainability Advisory Board. 22 February 2016 DSM announces repurchase of shares to cover existing option plans and stock dividend DSM to repurchase 3,200,000 ordinary shares to cover commitments under management and personnel option plans and as part of the final dividend 2015. 22 February 2016 DSM announces repurchase of shares to cover existing option plans and stock dividend DSM to repurchase 3,200,000 ordinary shares to cover commitments under management and personnel option plans and as part of the final dividend 2015. 17 February 2016 DSM reports Q4 2015 results Q4 Group net sales up 6% to €1,926m and EBITDA up 3% to €261m. 17 February 2016 DSM reports Q4 2015 results Q4 Group net sales up 6% to €1,926m and EBITDA up 3% to €261m. 7 January 2016 DSM proposes Pradeep Pant as new Supervisory Board member At the Annual General Meeting of Shareholders the Supervisory Board will nominate Mr. Pradeep Pant for appointment as a member of DSM's Supervisory Board. DSM proposes Pradeep Pant as new Supervisory Board member At the Annual General Meeting of Shareholders the Supervisory Board will nominate Mr. Pradeep Pant for appointment as a member of DSM's Supervisory Board. 17 December 2015 DSM and WFP reconfirm partnership to combat global malnutrition DSM and the United Nations World Food Programme sign agreement extending their existing partnership to combat hidden hunger and malnutrition in the developing world to 2018. 17 December 2015 DSM and WFP reconfirm partnership to combat global malnutrition DSM and the United Nations World Food Programme sign agreement extending their existing partnership to combat hidden hunger and malnutrition in the developing world to 2018. 6 November 2015 DSM and Syngenta to develop and commercialize biological solutions for agriculture DSM and Syngenta R&D partnership to develop microbial-based agricultural solutions, including bio-controls, bio-pesticides and bio-stimulants. 6 November 2015 DSM and Syngenta to develop and commercialize biological solutions for agriculture DSM and Syngenta R&D partnership to develop microbial-based agricultural solutions, including bio-controls, bio-pesticides and bio-stimulants. 4 November 2015 DSM sets Strategy 2018 After a period of transformation, DSM will focus on improving its financial results through organic growth, reducing costs and strict capital allocation. 4 November 2015 DSM sets Strategy 2018 After a period of transformation, DSM will focus on improving its financial results through organic growth, reducing costs and strict capital allocation. 3 November 2015 DSM reports Q3 2015 results Sales up 8%, driven by 7% organic growth in Nutrition and foreign exchange. 3 November 2015 DSM reports Q3 2015 results Sales up 8%, driven by 7% organic growth in Nutrition and foreign exchange. 30 October 2015 DSM wins FD-Sijthoff prize for best annual report by a Dutch listed company DSM awarded FD-Henri Sijthoff prize for the best annual report by a company listed on the AEX stock exchange in the Netherlands for its 2014 Integrated Annual Report. 30 October 2015 DSM wins FD-Sijthoff prize for best annual report by a Dutch listed company DSM awarded FD-Henri Sijthoff prize for the best annual report by a company listed on the AEX stock exchange in the Netherlands for its 2014 Integrated Annual Report. 15 September 2015 DSM issues long-term €500 million bond DSM successfully issued a €500 million 1.375% bond due 2022. 15 September 2015 DSM issues long-term €500 million bond DSM successfully issued a €500 million 1.375% bond due 2022. 10 September 2015 DSM among leaders in Dow Jones Sustainability World Index DSM named among the worldwide leaders in the Materials industry group in the Dow Jones Sustainability World Index 2015. 10 September 2015 DSM among leaders in Dow Jones Sustainability World Index DSM named among the worldwide leaders in the Materials industry group in the Dow Jones Sustainability World Index 2015. 27 August 2015 Dyneema® reinforced shorts win award Eurobike Award is a fantastic recognition of a breakthrough development that greatly benefits professional and amateur riders alike. Dyneema® reinforced shorts win award Eurobike Award is a fantastic recognition of a breakthrough development that greatly benefits professional and amateur riders alike. 25 August 2015 DSM adjusts organizational model Adjustments to organizational and operating model aim to create more agile, focused and cost efficient organization, with a stronger business and market focus and globally leveraged support functions. DSM adjusts organizational model Adjustments to organizational and operating model aim to create more agile, focused and cost efficient organization, with a stronger business and market focus and globally leveraged support functions. 4 August 2015 DSM reports Q2 2015 results Solid sales performance with a 12% increase to €1,965 million, supported by foreign exchange rates and 3% volume growth. DSM reports Q2 2015 results Solid sales performance with a 12% increase to €1,965 million, supported by foreign exchange rates and 3% volume growth. 31 July 2015 DSM and CVC finalize partnership for Polymer Intermediates and Composite Resins Partnership finalized for DSM’s activities in Polymer Intermediates (Caprolactam & Acrylonitrile) and Composite Resins with formation of ChemicaInvest B.V.. DSM and CVC finalize partnership for Polymer Intermediates and Composite Resins Partnership finalized for DSM’s activities in Polymer Intermediates (Caprolactam & Acrylonitrile) and Composite Resins with formation of ChemicaInvest B.V.. 29 July 2015 DSM finalizes repurchase of shares to cover existing option plans DSM repurchased 204,254 shares from 24 to 28 July 2015 at an average price of €52.44 and concluded the program to repurchase 2,300,000 shares. DSM finalizes repurchase of shares to cover existing option plans DSM repurchased 204,254 shares from 24 to 28 July 2015 at an average price of €52.44 and concluded the program to repurchase 2,300,000 shares. 24 July 2015 DSM - repurchase of shares (17-23 July 2015) DSM repurchased 184,648 shares from 17 to 23 July 2015 at an average price of €54.52. DSM - repurchase of shares (17-23 July 2015) DSM repurchased 184,648 shares from 17 to 23 July 2015 at an average price of €54.52. 17 July 2015 DSM - repurchase of shares (10-16 July 2015) DSM repurchased 74,088 shares from 10 to 16 July 2015 at an average price of €53.54. DSM - repurchase of shares (10-16 July 2015) DSM repurchased 74,088 shares from 10 to 16 July 2015 at an average price of €53.54. 10 July 2015 DSM - repurchase of shares (3-9 July 2015) DSM repurchased 190,870 shares from 3 to 9 July 2015 at an average price of €51.34. DSM - repurchase of shares (3-9 July 2015) DSM repurchased 190,870 shares from 3 to 9 July 2015 at an average price of €51.34. 3 July 2015 DSM - repurchase of shares (26 June - 2 July 2015) DSM repurchased 362,143 shares from 26 June to 2 July 2015 at an average price of €53.03. DSM - repurchase of shares (26 June - 2 July 2015) DSM repurchased 362,143 shares from 26 June to 2 July 2015 at an average price of €53.03. 1 July 2015 Dyneema® powers riders’ shorts in Tour de France 2015 Shorts feature new fabric with Dyneema® fiber to provide increased protection to the thigh in the event of a crash. Dyneema® powers riders’ shorts in Tour de France 2015 Shorts feature new fabric with Dyneema® fiber to provide increased protection to the thigh in the event of a crash. 26 June 2015 DSM - repurchase of shares (19-25 June 2015) DSM repurchased 245,123 shares from 19 to 25 June 2015 at an average price of €53.87. DSM - repurchase of shares (19-25 June 2015) DSM repurchased 245,123 shares from 19 to 25 June 2015 at an average price of €53.87. 24 June 2015 DSM launches campaign to pay tribute to “caring” scientists DSM begins debate on the contribution of science to society: www.sciencecanchangetheworld.org. DSM launches campaign to pay tribute to “caring” scientists DSM begins debate on the contribution of science to society: www.sciencecanchangetheworld.org. 19 June 2015 DSM - repurchase of shares (12-18 June 2015) DSM repurchased 223,561 shares from 12 to 18 June 2015 at an average price of €52.87. DSM - repurchase of shares (12-18 June 2015) DSM repurchased 223,561 shares from 12 to 18 June 2015 at an average price of €52.87. 12 June 2015 DSM - repurchase of shares (5-11 June 2015) DSM repurchased 185,315 shares from 5 to 11 June 2015 at an average price of €53.36. DSM - repurchase of shares (5-11 June 2015) DSM repurchased 185,315 shares from 5 to 11 June 2015 at an average price of €53.36. 5 June 2015 DSM - repurchase of shares (29 May - 4 June 2015) DSM repurchased 277,686 shares from 29 May to 4 June 2015 at an average price of €53.95. DSM - repurchase of shares (29 May - 4 June 2015) DSM repurchased 277,686 shares from 29 May to 4 June 2015 at an average price of €53.95. 29 May 2015 DSM - repurchase of shares (22-28 May 2015) DSM repurchased 128,219 shares from 22 to 28 May 2015 at an average price of €53.8102. DSM - repurchase of shares (22-28 May 2015) DSM repurchased 128,219 shares from 22 to 28 May 2015 at an average price of €53.8102. 22 May 2015 DSM - repurchase of shares (18-21 May 2015) DSM repurchased 224,093 shares from 18 to 21 May 2015 at an average price of €53.18. DSM - repurchase of shares (18-21 May 2015) DSM repurchased 224,093 shares from 18 to 21 May 2015 at an average price of €53.18. 14 May 2015 DSM announces repurchase of shares to cover existing option plans DSM intends repurchasing 2,300,000 ordinary shares in order to cover its commitments under management and personnel option plans. DSM announces repurchase of shares to cover existing option plans DSM intends repurchasing 2,300,000 ordinary shares in order to cover its commitments under management and personnel option plans. 30 April 2015 Final dividend 2014 Royal DSM DSM declares dividend for the financial year 2014 of €1.65 per ordinary share. Final dividend 2014 Royal DSM DSM declares dividend for the financial year 2014 of €1.65 per ordinary share. 30 April 2015 DSM announces results of 2015 Annual General Meeting of Shareholders DSM held its Annual General Meeting of Shareholders on 30 April 2015. Shareholders approved all resolutions on the agenda. DSM announces results of 2015 Annual General Meeting of Shareholders DSM held its Annual General Meeting of Shareholders on 30 April 2015. Shareholders approved all resolutions on the agenda. 30 April 2015 Annual General Meeting of Shareholders 2015 Summary of the resolutions at DSM'S Annual General Meeting of Shareholders 2015. Annual General Meeting of Shareholders 2015 Summary of the resolutions at DSM'S Annual General Meeting of Shareholders 2015. 29 April 2015 DSM reports Q1 2015 results Sales of €1,886 million, up 11%, including 2% organic sales growth. DSM reports Q1 2015 results Sales of €1,886 million, up 11%, including 2% organic sales growth. 2 April 2015 DSM finalizes sale of DSM Synres to Standard Investment DSM Synres produced solvent-borne alkyd and acrylic coating resins for the global coatings, adhesives and graphic arts markets. DSM finalizes sale of DSM Synres to Standard Investment DSM Synres produced solvent-borne alkyd and acrylic coating resins for the global coatings, adhesives and graphic arts markets. 2 April 2015 DSM provides 2014 comparative figures Figures reflect reclassification of Polymer Intermediates cluster and DSM Composite Resins to discontinued operations. Corporate Activities are restated and also reflect the sale of DSM Synres. DSM provides 2014 comparative figures Figures reflect reclassification of Polymer Intermediates cluster and DSM Composite Resins to discontinued operations. Corporate Activities are restated and also reflect the sale of DSM Synres. 1 April 2015 DSM issues long-term €500 million bond DSM has successfully issued a €500 million 1.0% bond due 2025. DSM issues long-term €500 million bond DSM has successfully issued a €500 million 1.0% bond due 2025. 31 March 2015 DSM finalizes acquisition of Aland (China) DSM finalizes acquisition of Aland, a Hong Kong-based company producing vitamin C in mainland China. DSM finalizes acquisition of Aland (China) DSM finalizes acquisition of Aland, a Hong Kong-based company producing vitamin C in mainland China. 18 March 2015 DSM Managing Board re-appointments DSM proposes re-appointment of Stephan B. Tanda and announces departure of Stefan Doboczky as of 1 June 2015. DSM Managing Board re-appointments DSM proposes re-appointment of Stephan B. Tanda and announces departure of Stefan Doboczky as of 1 June 2015. 16 March 2015 DSM and CVC announce partnership for Polymer Intermediates and Composite Resins Partnership for DSM’s activities in Polymer Intermediates (Caprolactam and Acrylonitrile) and Composite Resins with formation of new company 65% owned by CVC and 35% by DSM. DSM and CVC announce partnership for Polymer Intermediates and Composite Resins Partnership for DSM’s activities in Polymer Intermediates (Caprolactam and Acrylonitrile) and Composite Resins with formation of new company 65% owned by CVC and 35% by DSM. 3 March 2015 DSM finalizes sale of Euroresins to Cathay Investments Euroresins, a distributor of products to the composite resins industry, sold to Cathay Investments. DSM finalizes sale of Euroresins to Cathay Investments Euroresins, a distributor of products to the composite resins industry, sold to Cathay Investments. 3 March 2015 DSM publishes 2014 Integrated Annual Report DSM announces publication of 2014 Integrated Annual Report. DSM publishes 2014 Integrated Annual Report DSM announces publication of 2014 Integrated Annual Report. 11 February 2015 DSM reports 2014 results Sales of €9,181 million, a 4% increase versus 2013. In line with market expectations, DSM reported EBITDA of €1,168 million compared to €1,261 million in 2013. 11 February 2015 DSM reports 2014 results Sales of €9,181 million, a 4% increase versus 2013. In line with market expectations, DSM reported EBITDA of €1,168 million compared to €1,261 million in 2013. 5 January 2015 New innovation partnership in pro-cycling Partnership aimed at enabling Team Giant-Alpecin to benefit from DSM's innovative power. New innovation partnership in pro-cycling Partnership aimed at enabling Team Giant-Alpecin to benefit from DSM's innovative power. 23 December 2014 DSM to sell Euroresins to Cathay Investments DSM has reached agreement with Cathay Investments for the sale of Euroresins and the transaction is expected to close in Q1 2015. 23 December 2014 DSM to sell Euroresins to Cathay Investments DSM has reached agreement with Cathay Investments for the sale of Euroresins and the transaction is expected to close in Q1 2015. 17 December 2014 DSM to sell DSM Synres to Standard Investment DSM has reached agreement with Standard Investment for the sale of DSM Synres and the transaction is expected to close in Q1 2015. 17 December 2014 DSM to sell DSM Synres to Standard Investment DSM has reached agreement with Standard Investment for the sale of DSM Synres and the transaction is expected to close in Q1 2015. 5 November 2014 DSM updates financial markets at its Capital Markets Day DSM provides investors with update on its strategic progress and current priorities at annual Capital Markets Day. 5 November 2014 DSM updates financial markets at its Capital Markets Day DSM provides investors with update on its strategic progress and current priorities at annual Capital Markets Day. 4 November 2014 DSM reports Q3 2014 results Third quarter 2014 EBITDA from continuing operations of €315 million compared to €293 million in Q2 2014 and €331 million in Q3 2013. 4 November 2014 DSM reports Q3 2014 results Third quarter 2014 EBITDA from continuing operations of €315 million compared to €293 million in Q2 2014 and €331 million in Q3 2013. 11 September 2014 DSM once again among leaders in DJ Sustainability World Index DSM named among the worldwide leaders in the Materials industry group in the Dow Jones Sustainability World Index 2014. 11 September 2014 DSM once again among leaders in DJ Sustainability World Index DSM named among the worldwide leaders in the Materials industry group in the Dow Jones Sustainability World Index 2014. 3 September 2014 First commercial-scale cellulosic ethanol plant in the U.S. opens for business POET-DSM Advanced Biofuels proves its revolutionary technology that converts agricultural residue into renewable fuel at opening of its first commercial cellulosic ethanol plant. 3 September 2014 First commercial-scale cellulosic ethanol plant in the U.S. opens for business POET-DSM Advanced Biofuels proves its revolutionary technology that converts agricultural residue into renewable fuel at opening of its first commercial cellulosic ethanol plant. 5 August 2014 DSM reports Q2 2014 results DSM's second quarter 2014 EBITDA from continuing operations of €293 million compared to €332 million in Q2 2013, and €272 million in Q1 2014. DSM reports Q2 2014 results DSM's second quarter 2014 EBITDA from continuing operations of €293 million compared to €332 million in Q2 2013, and €272 million in Q1 2014. 11 July 2014 DSM to acquire Aland (China) to strengthen vitamin C position DSM reaches agreement to acquire Aland, a Hong Kong-based company producing vitamin C in mainland China. DSM to acquire Aland (China) to strengthen vitamin C position DSM reaches agreement to acquire Aland, a Hong Kong-based company producing vitamin C in mainland China. 2 July 2014 DSM reports fire in utilities building in Sisseln (CH) Production of a few intermediates, mainly for Animal Nutrition & Health interrupted. Impact on customers expected to be minimal. DSM reports fire in utilities building in Sisseln (CH) Production of a few intermediates, mainly for Animal Nutrition & Health interrupted. Impact on customers expected to be minimal. 20 May 2014 DSM finalizes repurchase of shares to cover existing option plans DSM repurchased 69,522 shares from 16 to 19 May 2014 at an average price of €51.67 and concluded the program to repurchase 5,000,000 shares. DSM finalizes repurchase of shares to cover existing option plans DSM repurchased 69,522 shares from 16 to 19 May 2014 at an average price of €51.67 and concluded the program to repurchase 5,000,000 shares. 16 May 2014 DSM - repurchase of shares (9-15 May 2014) DSM repurchased 176,832 shares from 9 to 15 May 2014 at an average price of €51.97. DSM - repurchase of shares (9-15 May 2014) DSM repurchased 176,832 shares from 9 to 15 May 2014 at an average price of €51.97. 9 May 2014 DSM - repurchase of shares (2-8 May 2014) DSM repurchased 294,921 shares from 2 to 8 May 2014 at an average price of €52.03. DSM - repurchase of shares (2-8 May 2014) DSM repurchased 294,921 shares from 2 to 8 May 2014 at an average price of €52.03. 7 May 2014 Final dividend 2013 Royal DSM DSM declares dividend for the financial year 2013 of €1.65 per ordinary share. Final dividend 2013 Royal DSM DSM declares dividend for the financial year 2013 of €1.65 per ordinary share. 7 May 2014 DSM announces results of 2014 Annual General Meeting of Shareholders DSM held its Annual General Meeting of Shareholders on 7 May 2014. Shareholders approved all resolutions on the agenda. DSM announces results of 2014 Annual General Meeting of Shareholders DSM held its Annual General Meeting of Shareholders on 7 May 2014. Shareholders approved all resolutions on the agenda. 7 May 2014 Annual General Meeting of Shareholders 2014 Summary of the resolutions at DSM'S Annual General Meeting of Shareholders 2014. Annual General Meeting of Shareholders 2014 Summary of the resolutions at DSM'S Annual General Meeting of Shareholders 2014. 6 May 2014 DSM reports Q1 2014 results DSM reports first quarter EBITDA from continuing operations of €272 million compared to €301 million in Q1 2013. DSM reports Q1 2014 results DSM reports first quarter EBITDA from continuing operations of €272 million compared to €301 million in Q1 2013. 2 May 2014 DSM - repurchase of shares (25-30 April 2014) DSM repurchased 201,426 shares from 25 to 30 April 2014 at an average price of €51.49. DSM - repurchase of shares (25-30 April 2014) DSM repurchased 201,426 shares from 25 to 30 April 2014 at an average price of €51.49. 25 April 2014 DSM - repurchase of shares (22-24 April 2014) DSM repurchased 170,120 shares from 22 to 24 April 2014 at an average price of €50.42. DSM - repurchase of shares (22-24 April 2014) DSM repurchased 170,120 shares from 22 to 24 April 2014 at an average price of €50.42. 18 April 2014 DSM - repurchase of shares (11-17 April 2014) DSM repurchased 231,586 shares from 11 to 17 April 2014 at an average price of €49.15. DSM - repurchase of shares (11-17 April 2014) DSM repurchased 231,586 shares from 11 to 17 April 2014 at an average price of €49.15. 11 April 2014 DSM - repurchase of shares (4-10 April 2014) DSM repurchased 256,801 shares from 4 to 10 April 2014 at an average price of €50.17. DSM - repurchase of shares (4-10 April 2014) DSM repurchased 256,801 shares from 4 to 10 April 2014 at an average price of €50.17. 9 April 2014 DSM in exclusive discussions to acquire Aland (China) DSM in exclusive discussions with Aland that may or may not result in the acquisition of this China-based global producer of vitamin C. DSM in exclusive discussions to acquire Aland (China) DSM in exclusive discussions with Aland that may or may not result in the acquisition of this China-based global producer of vitamin C. 4 April 2014 DSM - repurchase of shares (28 March - 3 April 2014) DSM repurchased 149,321 shares from 28 March to 3 April 2014 at an average price of €50.05. DSM - repurchase of shares (28 March - 3 April 2014) DSM repurchased 149,321 shares from 28 March to 3 April 2014 at an average price of €50.05. 28 March 2014 DSM - repurchase of shares (21-27 March 2014) DSM repurchased 157,579 shares from 21 to 27 March 2014 at an average price of €48.46. DSM - repurchase of shares (21-27 March 2014) DSM repurchased 157,579 shares from 21 to 27 March 2014 at an average price of €48.46. 21 March 2014 DSM - repurchase of shares (14-20 March 2014) DSM repurchased 108,500 shares from 14 to 20 March 2014 at an average price of €46.51. DSM - repurchase of shares (14-20 March 2014) DSM repurchased 108,500 shares from 14 to 20 March 2014 at an average price of €46.51. 14 March 2014 DSM - repurchase of shares (7-13 March 2014) DSM repurchased 254,756 shares from 7 to 13 March 2014 at an average price of €47.40. DSM - repurchase of shares (7-13 March 2014) DSM repurchased 254,756 shares from 7 to 13 March 2014 at an average price of €47.40. 11 March 2014 Royal DSM and JLL Partners Create DPx USD 2.65 billion transaction to create global CDMO leader successfully completed. Royal DSM and JLL Partners Create DPx USD 2.65 billion transaction to create global CDMO leader successfully completed. 10 March 2014 DSM proposes appointment of new Chief Financial Officer DSM to appoint Geraldine Matchett as Member of the Managing Board of Directors as of 1 August 2014 and as of 1 December 2014, she will become Chief Financial Officer. DSM proposes appointment of new Chief Financial Officer DSM to appoint Geraldine Matchett as Member of the Managing Board of Directors as of 1 August 2014 and as of 1 December 2014, she will become Chief Financial Officer. 7 March 2014 DSM - repurchase of shares (27 February - 6 March 2014) DSM repurchased 428,636 shares from 27 February to 6 March 2014 at an average price of €46.54. DSM - repurchase of shares (27 February - 6 March 2014) DSM repurchased 428,636 shares from 27 February to 6 March 2014 at an average price of €46.54. 28 February 2014 DSM issues long-term €500 million bond DSM issues €500 million 2.375% bond due 2024. 28 February 2014 DSM issues long-term €500 million bond DSM issues €500 million 2.375% bond due 2024. 27 February 2014 DSM resumes repurchase of shares to cover existing option plans DSM intends to repurchase of 2,500,000 ordinary shares to cover commitments under management and personnel option plans. 27 February 2014 DSM resumes repurchase of shares to cover existing option plans DSM intends to repurchase of 2,500,000 ordinary shares to cover commitments under management and personnel option plans. 26 February 2014 DSM reports final 2013 results, increases dividend For full year 2013 DSM delivered 18% higher EBITDA while facing challenging economic environment. In Q4 the company realized 30% higher EBITDA. 26 February 2014 DSM reports final 2013 results, increases dividend For full year 2013 DSM delivered 18% higher EBITDA while facing challenging economic environment. In Q4 the company realized 30% higher EBITDA. 23 January 2014 DSM finalizes repurchase of shares to cover existing option plans DSM repurchased 874,725 shares from 17 January 2014 up to and including 21 January 2014 at an average price of €51.85 and concludes first part of program to repurchase 4-5 million shares in total. 23 January 2014 DSM finalizes repurchase of shares to cover existing option plans DSM repurchased 874,725 shares from 17 January 2014 up to and including 21 January 2014 at an average price of €51.85 and concludes first part of program to repurchase 4-5 million shares in total. 21 January 2014 DSM reports preliminary 2013 results, provides 2014 outlook DSM delivered roughly 20% higher EBITDA for the full year 2013, in spite of the challenging economic environment and in Q4 realized an approximately 30% higher EBITDA. 21 January 2014 DSM reports preliminary 2013 results, provides 2014 outlook DSM delivered roughly 20% higher EBITDA for the full year 2013, in spite of the challenging economic environment and in Q4 realized an approximately 30% higher EBITDA. 17 January 2014 DSM - repurchase of shares (10-16 January 2014) DSM repurchased 245,742 shares from 10 to 16 January 2014 at an average price of €56.90. 17 January 2014 DSM - repurchase of shares (10-16 January 2014) DSM repurchased 245,742 shares from 10 to 16 January 2014 at an average price of €56.90. 10 January 2014 DSM - repurchase of shares (6-9 January 2014) DSM repurchased 112,588 shares from 6 to 9 January 2014 at an average price of €57.88. 10 January 2014 DSM - repurchase of shares (6-9 January 2014) DSM repurchased 112,588 shares from 6 to 9 January 2014 at an average price of €57.88. 20 December 2013 DSM - repurchase of shares (13-19 December 2013) DSM repurchased 154,586 shares from 13 to 19 December 2013 at an average price of €55.35. 20 December 2013 DSM - repurchase of shares (13-19 December 2013) DSM repurchased 154,586 shares from 13 to 19 December 2013 at an average price of €55.35. 18 December 2013 DSM announces final terms of €300 million bond Final Terms of the €300,000,000 1.75% Notes due 13 November 2019 adjusted to reflect investors have a put option in the event of a change of control. 18 December 2013 DSM announces final terms of €300 million bond Final Terms of the €300,000,000 1.75% Notes due 13 November 2019 adjusted to reflect investors have a put option in the event of a change of control. 13 December 2013 DSM - repurchase of shares (6-12 December 2013) DSM repurchased 185,761 shares from 6 to 12 December 2013 at an average price of €56.08. 13 December 2013 DSM - repurchase of shares (6-12 December 2013) DSM repurchased 185,761 shares from 6 to 12 December 2013 at an average price of €56.08. 6 December 2013 DSM - repurchase of shares (29 November - 5 December 2013) DSM repurchased 164,545 shares from 29 November to 5 December 2013 at an average price of €57.17. 6 December 2013 DSM - repurchase of shares (29 November - 5 December 2013) DSM repurchased 164,545 shares from 29 November to 5 December 2013 at an average price of €57.17. 4 December 2013 Johns Hopkins Bloomberg School of Public Health awards Dean’s Medal to Royal DSM N.V. Award recognizes DSM's global corporate leadership in efforts to mitigate food insecurity, prevent hidden hunger and promote sustainable development in low-income countries. 4 December 2013 Johns Hopkins Bloomberg School of Public Health awards Dean’s Medal to Royal DSM N.V. Award recognizes DSM's global corporate leadership in efforts to mitigate food insecurity, prevent hidden hunger and promote sustainable development in low-income countries. 21 November 2013 DSM - repurchase of shares (15-21 November 2013) DSM repurchased 346.038 shares from 15 to 21 November 2013 at an average price of €59.06. 21 November 2013 DSM - repurchase of shares (15-21 November 2013) DSM repurchased 346.038 shares from 15 to 21 November 2013 at an average price of €59.06. 21 November 2013 DSM - repurchase of shares (22-28 November 2013) DSM repurchased 198,288 shares from 22 to 28 November 2013 at an average price of €58.39. 21 November 2013 DSM - repurchase of shares (22-28 November 2013) DSM repurchased 198,288 shares from 22 to 28 November 2013 at an average price of €58.39. 19 November 2013 Royal DSM and JLL create leading pharma services company in USD 2.6 bn transaction Global CDMO company combines DSM Pharmaceutical Products and Patheon. 19 November 2013 Royal DSM and JLL create leading pharma services company in USD 2.6 bn transaction Global CDMO company combines DSM Pharmaceutical Products and Patheon. 15 November 2013 DSM - repurchase of shares (6-14 November 2013) DSM repurchased 217,727 shares from 6 to 14 November 2013 at an average price of €58.05. 15 November 2013 DSM - repurchase of shares (6-14 November 2013) DSM repurchased 217,727 shares from 6 to 14 November 2013 at an average price of €58.05. 6 November 2013 DSM issues long-term €300 mln bond DSM successfully issues €300 million 1.75% bond due 2019. 6 November 2013 DSM issues long-term €300 mln bond DSM successfully issues €300 million 1.75% bond due 2019. 6 November 2013 DSM announces repurchase of shares to cover existing option plans DSM intends to repurchase 2,500,000 ordinary shares to cover commitments under management and personnel option plans. 6 November 2013 DSM announces repurchase of shares to cover existing option plans DSM intends to repurchase 2,500,000 ordinary shares to cover commitments under management and personnel option plans. 5 November 2013 DSM maintains positive momentum in challenging markets Q3 EBITDA of €342 million compared to €270 million in Q3 2012. 27% improvement realized despite ongoing challenging macro-economic environment. 5 November 2013 DSM maintains positive momentum in challenging markets Q3 EBITDA of €342 million compared to €270 million in Q3 2012. 27% improvement realized despite ongoing challenging macro-economic environment. 9 October 2013 DSM completes acquisition of stake in Andre Pectin (China) DSM acquires 19% equity interest in Yantai Andre Pectin Co. Ltd., a China based producer of texturing ingredients. DSM completes acquisition of stake in Andre Pectin (China) DSM acquires 19% equity interest in Yantai Andre Pectin Co. Ltd., a China based producer of texturing ingredients. 26 September 2013 DSM updates financial markets at its Capital Markets Day DSM providing review of strategic progress and update on its 2015 targets at its annual Capital Markets Day. 26 September 2013 DSM updates financial markets at its Capital Markets Day DSM providing review of strategic progress and update on its 2015 targets at its annual Capital Markets Day. 12 September 2013 DSM once again among leaders in DJ Sustainability World Index DSM once again amongst leaders in chemical industry sector in Dow Jones Sustainability World Index 2013. 12 September 2013 DSM once again among leaders in DJ Sustainability World Index DSM once again amongst leaders in chemical industry sector in Dow Jones Sustainability World Index 2013. 6 August 2013 DSM delivers higher profits; full year outlook unchanged DSM reports second quarter EBITDA of €345 million compared to €290 million in Q2 2012 and €311 million in Q1 2013. DSM delivers higher profits; full year outlook unchanged DSM reports second quarter EBITDA of €345 million compared to €290 million in Q2 2012 and €311 million in Q1 2013. 1 July 2013 DSM to better serve Nutrition customers in Asia with acquisition of Unitech (NZ) DSM acquires Unitech Industries Limited, a New Zealand based producer of nutritional products for both human and animal markets. DSM to better serve Nutrition customers in Asia with acquisition of Unitech (NZ) DSM acquires Unitech Industries Limited, a New Zealand based producer of nutritional products for both human and animal markets. 11 June 2013 DSM CEO joins Global CEO Council to support Chinese leadership on innovation, urbanization and sustainability Feike Sijbesma joins Global CEO Council (GCC) of the Chinese People’s Association for Friendship with Foreign Countries (CPAFFC). DSM CEO joins Global CEO Council to support Chinese leadership on innovation, urbanization and sustainability Feike Sijbesma joins Global CEO Council (GCC) of the Chinese People’s Association for Friendship with Foreign Countries (CPAFFC). 8 June 2013 DSM to contribute to new 2020 global nutrition target DSM to help provide effective nutrition interventions to 50 million pregnant and lactating woman and children under two per year by 2020 as part of DSM’s endorsement of Global Nutrition for Growth Compact. DSM to contribute to new 2020 global nutrition target DSM to help provide effective nutrition interventions to 50 million pregnant and lactating woman and children under two per year by 2020 as part of DSM’s endorsement of Global Nutrition for Growth Compact. 22 May 2013 Royal DSM, World Vision announce partnership to nourish millions of the world's most vulnerable children Working together to achieve lasting progress in global health and development by improving the nutritional status of mothers and children. Royal DSM, World Vision announce partnership to nourish millions of the world's most vulnerable children Working together to achieve lasting progress in global health and development by improving the nutritional status of mothers and children. 7 May 2013 DSM to acquire 19% interest in Andre Pectin (China) Agreement to acquire 19% equity interest in Yantai Andre Pectin Co. Ltd. (Andre Pectin), a China based producer of texturing ingredients. DSM to acquire 19% interest in Andre Pectin (China) Agreement to acquire 19% equity interest in Yantai Andre Pectin Co. Ltd. (Andre Pectin), a China based producer of texturing ingredients. 3 May 2013 Final dividend 2012 Royal DSM DSM declares a dividend for the financial year 2012 of €1.50 per ordinary share of €1.50 nominal value. Final dividend 2012 Royal DSM DSM declares a dividend for the financial year 2012 of €1.50 per ordinary share of €1.50 nominal value. 3 May 2013 DSM announces results of 2013 Annual General Meeting of Shareholders DSM held its Annual General Meeting of Shareholders on 3 May 2013. Shareholders approved all resolutions on the agenda. DSM announces results of 2013 Annual General Meeting of Shareholders DSM held its Annual General Meeting of Shareholders on 3 May 2013. Shareholders approved all resolutions on the agenda. 3 May 2013 Annual General Meeting of Shareholders 2013 Summary of the resolutions at DSM's Annual General Meeting of Shareholders 2013. Annual General Meeting of Shareholders 2013 Summary of the resolutions at DSM's Annual General Meeting of Shareholders 2013. 2 May 2013 DSM reports good start to the year in challenging environment DSM reports first quarter EBITDA of €311 million compared to €306 million in Q1 2012 and €243 million in Q4 2012. DSM reports good start to the year in challenging environment DSM reports first quarter EBITDA of €311 million compared to €306 million in Q1 2012 and €243 million in Q4 2012. 8 April 2013 DSM and Rostekhnologii to cooperate on biotechnology and functional materials Strategic partnership with Rostekhnologii (Rostec) in fields of biotechnology and functional materials. DSM and Rostekhnologii to cooperate on biotechnology and functional materials Strategic partnership with Rostekhnologii (Rostec) in fields of biotechnology and functional materials. 8 April 2013 DSM and Republic of Tatarstan sign MOU for fortified nutrition Partnership with Ministry of Health Care of the Republic of Tatarstan aims to modernize the Republic’s public health sector through fortified nutrition. DSM and Republic of Tatarstan sign MOU for fortified nutrition Partnership with Ministry of Health Care of the Republic of Tatarstan aims to modernize the Republic’s public health sector through fortified nutrition. 8 April 2013 DSM completes acquisition of Tortuga DSM acquires Tortuga, a nutritional supplements company with a focus on pasture raised beef and dairy cattle for a total enterprise value of about €440 million. DSM completes acquisition of Tortuga DSM acquires Tortuga, a nutritional supplements company with a focus on pasture raised beef and dairy cattle for a total enterprise value of about €440 million. 14 March 2013 DSM - proposed appointment to the Managing Board of Directors DSM proposes appointing Mr. Dimitri de Vreeze to the Managing Board effective 1 September 2013. DSM - proposed appointment to the Managing Board of Directors DSM proposes appointing Mr. Dimitri de Vreeze to the Managing Board effective 1 September 2013. 4 March 2013 DSM completes sale of participation in DEXPlastomers JV to Borealis DSM sells its participation in DEXPlastomers, a 50/50 Joint Venture of DSM with affiliate of ExxonMobil Chemical, to Borealis. DSM completes sale of participation in DEXPlastomers JV to Borealis DSM sells its participation in DEXPlastomers, a 50/50 Joint Venture of DSM with affiliate of ExxonMobil Chemical, to Borealis. 20 February 2013 DSM is positioned for strong EBITDA growth and increases dividend DSM delivered growth across all clusters in 2012 excluding caprolactam. Nutrition represents more than 70% of total EBITDA and become high value, global business with attractive growth prospects across the full value chain. 20 February 2013 DSM is positioned for strong EBITDA growth and increases dividend DSM delivered growth across all clusters in 2012 excluding caprolactam. Nutrition represents more than 70% of total EBITDA and become high value, global business with attractive growth prospects across the full value chain. 24 January 2013 DSM and UN WFP strengthen partnership to combat global malnutrition Agreement extends existing partnership to 2015 to combat hidden hunger and malnutrition in the developing world. 24 January 2013 DSM and UN WFP strengthen partnership to combat global malnutrition Agreement extends existing partnership to 2015 to combat hidden hunger and malnutrition in the developing world. 12 December 2012 DSM wins Corporate Steward Award 2012 Award recognizes DSM's integrated Triple P approach to creating a sustainable business and shared value with all stakeholders. 12 December 2012 DSM wins Corporate Steward Award 2012 Award recognizes DSM's integrated Triple P approach to creating a sustainable business and shared value with all stakeholders. 7 December 2012 DSM CEO to receive honorary doctorate University of Maastricht confers honor on Feike Sijbesma because of way he embodies DSM’s core value, sustainability. 7 December 2012 DSM CEO to receive honorary doctorate University of Maastricht confers honor on Feike Sijbesma because of way he embodies DSM’s core value, sustainability. 6 December 2012 DSM completes acquisition of Cargill’s cultures and enzymes business Acquisition enables DSM to become a global tier one dairy ingredients supplier. 6 December 2012 DSM completes acquisition of Cargill’s cultures and enzymes business Acquisition enables DSM to become a global tier one dairy ingredients supplier. 28 November 2012 DSM’s sustainable supply chain management recognized DSM awarded Sustainable Supply Chain Award 2012 for its responsible way of managing its supply chain. 28 November 2012 DSM’s sustainable supply chain management recognized DSM awarded Sustainable Supply Chain Award 2012 for its responsible way of managing its supply chain. 23 November 2012 DSM awarded for its integrated reporting DSM receives three prestigious awards in the Netherlands for its 2011 Integrated Annual Report. 23 November 2012 DSM awarded for its integrated reporting DSM receives three prestigious awards in the Netherlands for its 2011 Integrated Annual Report. 12 November 2012 DSM to sell participation in DEXPlastomers JV to Borealis Agreement with Borealis AG reached for sale of DEXPlastomers V.o.F and DSM's LldPE Compact Solution Technology. 12 November 2012 DSM to sell participation in DEXPlastomers JV to Borealis Agreement with Borealis AG reached for sale of DEXPlastomers V.o.F and DSM's LldPE Compact Solution Technology. 6 November 2012 DSM reports solid Q3 results despite weak economic conditions DSM continues to generate good results mainly driven by Nutrition cluster and make good progress towards strategic goals with purchase of Tortuga and Cargill’s cultures and enzymes business. 6 November 2012 DSM reports solid Q3 results despite weak economic conditions DSM continues to generate good results mainly driven by Nutrition cluster and make good progress towards strategic goals with purchase of Tortuga and Cargill’s cultures and enzymes business. 26 October 2012 DSM to acquire Cargill’s cultures and enzymes business DSM to acquire Cargill’s cultures and enzymes business in an all cash transaction for a total enterprise value of €85 million. 26 October 2012 DSM to acquire Cargill’s cultures and enzymes business DSM to acquire Cargill’s cultures and enzymes business in an all cash transaction for a total enterprise value of €85 million. 27 September 2012 DSM updates market on strategy progress at Capital Markets Days DSM updates financial community at its annual Capital Markets Days on progress made with its DSM in Motion: driving focused growth strategy. 27 September 2012 DSM updates market on strategy progress at Capital Markets Days DSM updates financial community at its annual Capital Markets Days on progress made with its DSM in Motion: driving focused growth strategy. 20 September 2012 DSM appoints new President DSM Nutritional Products Chris Goppelsroeder appointed President and CEO DSM Nutritional Products effective 1 January 2013. 20 September 2012 DSM appoints new President DSM Nutritional Products Chris Goppelsroeder appointed President and CEO DSM Nutritional Products effective 1 January 2013. 20 September 2012 DSM in exclusive discussions to acquire Cargill’s cultures and enzymes business DSM in exclusive discussions with Cargill which may, or may not result in DSM's acquisition of Cargill’s cultures and enzymes business. 20 September 2012 DSM in exclusive discussions to acquire Cargill’s cultures and enzymes business DSM in exclusive discussions with Cargill which may, or may not result in DSM's acquisition of Cargill’s cultures and enzymes business. 13 September 2012 DSM amongst leaders in Dow Jones Sustainability World Index DSM again among leaders in chemical industry sector in the Dow Jones Sustainability World Index 2012. 13 September 2012 DSM amongst leaders in Dow Jones Sustainability World Index DSM again among leaders in chemical industry sector in the Dow Jones Sustainability World Index 2012. 8 August 2012 DSM to acquire Tortuga to strengthen animal nutrition business Definitive agreement to acquire Tortuga Companhia Zootécnica Agrária (Tortuga) in all cash transaction for total enterprise value of about €465 million. DSM to acquire Tortuga to strengthen animal nutrition business Definitive agreement to acquire Tortuga Companhia Zootécnica Agrária (Tortuga) in all cash transaction for total enterprise value of about €465 million. 7 August 2012 DSM reports robust Q2 in challenging environment Life Sciences cluster accounts for around 70% of Q2 EBITDA offsetting weakness caused by caprolactam in Materials Sciences. Other Materials Sciences businesses improve. DSM reports robust Q2 in challenging environment Life Sciences cluster accounts for around 70% of Q2 EBITDA offsetting weakness caused by caprolactam in Materials Sciences. Other Materials Sciences businesses improve. 19 July 2012 DSM completes acquisition of Ocean Nutrition Canada and expands its Nutritional Lipids growth platform DSM acquires Ocean Nutrition Canada, leading global provider of fish-oil derived nutritional products to dietary supplement and food and beverage markets for a total enterprise value of C$540 million. DSM completes acquisition of Ocean Nutrition Canada and expands its Nutritional Lipids growth platform DSM acquires Ocean Nutrition Canada, leading global provider of fish-oil derived nutritional products to dietary supplement and food and beverage markets for a total enterprise value of C$540 million. 25 June 2012 DSM completes acquisition of Kensey Nash and strengthens its biomedical business DSM completes acquisition of Kensey Nash for a total enterprise value of approximately $360 million. DSM completes acquisition of Kensey Nash and strengthens its biomedical business DSM completes acquisition of Kensey Nash for a total enterprise value of approximately $360 million. 19 June 2012 DSM tender offer for Kensey Nash is successful; acquisition expected to close within next few days Tender offer to purchase all outstanding shares of common stock of Kensey Nash Corporation at a price of $38.50 per share successful. DSM tender offer for Kensey Nash is successful; acquisition expected to close within next few days Tender offer to purchase all outstanding shares of common stock of Kensey Nash Corporation at a price of $38.50 per share successful. 6 June 2012 DSM announces expiration of waiting period under Hart-Scott-Rodino Act Expiration of mandatory waiting period under Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, for previously announced tender offer for all outstanding shares of common stock of Kensey Nash Corporation. DSM announces expiration of waiting period under Hart-Scott-Rodino Act Expiration of mandatory waiting period under Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, for previously announced tender offer for all outstanding shares of common stock of Kensey Nash Corporation. 5 June 2012 DSM enzymes for cellulosic ethanol qualified by DONG Energy DSM qualified as supplier of enzymes for DONG Energy - Inbicon’s wheat straw to cellulosic ethanol process. DSM enzymes for cellulosic ethanol qualified by DONG Energy DSM qualified as supplier of enzymes for DONG Energy - Inbicon’s wheat straw to cellulosic ethanol process. 21 May 2012 DSM commences tender offer for Kensey Nash DSM commences previously announced tender offer for all outstanding shares of common stock of Kensey Nash at a price of $38.50 per share. DSM commences tender offer for Kensey Nash DSM commences previously announced tender offer for all outstanding shares of common stock of Kensey Nash at a price of $38.50 per share. 18 May 2012 DSM to acquire Ocean Nutrition Canada to expand its Nutritional Lipids growth platform Definitive agreement with Clearwater Fine Foods and funds managed by Richardson Capital to acquire Ocean Nutrition Canada for a total enterprise value of C$540 million. DSM to acquire Ocean Nutrition Canada to expand its Nutritional Lipids growth platform Definitive agreement with Clearwater Fine Foods and funds managed by Richardson Capital to acquire Ocean Nutrition Canada for a total enterprise value of C$540 million. 11 May 2012 DSM appoints two new Supervisory Board members Annual General Meeting of Shareholders approves appointing Mrs. Victoria Haynes and Mrs. Eileen Kennedy as Supervisory Board members. DSM appoints two new Supervisory Board members Annual General Meeting of Shareholders approves appointing Mrs. Victoria Haynes and Mrs. Eileen Kennedy as Supervisory Board members. 11 May 2012 Final dividend 2011 Royal DSM DSM declares a dividend for 2011 of €1.45 per ordinary share of €1.50 par value. Final dividend 2011 Royal DSM DSM declares a dividend for 2011 of €1.45 per ordinary share of €1.50 par value. 11 May 2012 DSM announces results of 2012 Annual General Meeting of Shareholders DSM held its Annual General Meeting of Shareholders on 11 May 2012. Shareholders approved all resolutions on the agenda. DSM announces results of 2012 Annual General Meeting of Shareholders DSM held its Annual General Meeting of Shareholders on 11 May 2012. Shareholders approved all resolutions on the agenda. 11 May 2012 Annual General Meeting of Shareholders 2012 Summary of the resolutions at DSM's Annual General Meeting of Shareholders 2012. Annual General Meeting of Shareholders 2012 Summary of the resolutions at DSM's Annual General Meeting of Shareholders 2012. 8 May 2012 DSM reports positive start to the year with robust Q1 results In a challenging business environment, DSM continued to make good progress in Q1 and the robust results represent a positive start to 2012. DSM reports positive start to the year with robust Q1 results In a challenging business environment, DSM continued to make good progress in Q1 and the robust results represent a positive start to 2012. 3 May 2012 DSM agrees to acquire Kensey Nash to strengthen its biomedical business DSM will acquire all outstanding shares of common stock of Kensey Nash through a cash tender offer, followed by a merger with a subsidiary of DSM, for $38.50 in cash per share for total enterprise value of approximately $360 million. DSM agrees to acquire Kensey Nash to strengthen its biomedical business DSM will acquire all outstanding shares of common stock of Kensey Nash through a cash tender offer, followed by a merger with a subsidiary of DSM, for $38.50 in cash per share for total enterprise value of approximately $360 million. 1 May 2012 DSM announces management changes Jos Op Heij new Senior Vice President Corporate Control and Accounting, Hans Vossen new VP Corporate Treasury & Dave Huizing new VP Investor Relations. DSM announces management changes Jos Op Heij new Senior Vice President Corporate Control and Accounting, Hans Vossen new VP Corporate Treasury & Dave Huizing new VP Investor Relations. 26 March 2012 DSM acquires food enzymes business and key technology from Verenium DSM acquires certain assets, licenses and other agreements in the area of food enzymes and oilseed processing from Verenium for a total consideration including transaction and related expenses of $37 million. DSM acquires food enzymes business and key technology from Verenium DSM acquires certain assets, licenses and other agreements in the area of food enzymes and oilseed processing from Verenium for a total consideration including transaction and related expenses of $37 million. 29 February 2012 DSM reports another strong year and increases dividend 2011 was another strong year for DSM despite challenges of global economy, adverse currency movements and high raw material costs and increases dividend for second consecutive year. 29 February 2012 DSM reports another strong year and increases dividend 2011 was another strong year for DSM despite challenges of global economy, adverse currency movements and high raw material costs and increases dividend for second consecutive year. 14 February 2012 DSM appoints new General Counsel Cees Los joins DSM as General Counsel and Director Legal Affairs as of 15 April 2012. 14 February 2012 DSM appoints new General Counsel Cees Los joins DSM as General Counsel and Director Legal Affairs as of 15 April 2012. 23 January 2012 DSM and POET to make advanced biofuels a reality by 2013 Joint Venture to commercially demonstrate and license cellulosic bio-ethanol, the next step in the development of biofuels, based on their proprietary and complementary technologies. 23 January 2012 DSM and POET to make advanced biofuels a reality by 2013 Joint Venture to commercially demonstrate and license cellulosic bio-ethanol, the next step in the development of biofuels, based on their proprietary and complementary technologies. 26 November 2011 DSM reports strong Q3 results Q3 2011 EBITDA from continuing operations €339 million, 26% ahead of Q3 2010, outlook remains unchanged: 2011 is expected to be a strong year with further progress towards achieving 2013 targets. 26 November 2011 DSM reports strong Q3 results Q3 2011 EBITDA from continuing operations €339 million, 26% ahead of Q3 2010, outlook remains unchanged: 2011 is expected to be a strong year with further progress towards achieving 2013 targets. 3 November 2011 DSM finalizes repurchase of shares to cover existing option plans DSM repurchased 502,990 shares from 27 October to 2 November 2011 at an average price of €37.33 and concluded the program to repurchase 4,000,000 shares. 3 November 2011 DSM finalizes repurchase of shares to cover existing option plans DSM repurchased 502,990 shares from 27 October to 2 November 2011 at an average price of €37.33 and concluded the program to repurchase 4,000,000 shares. 27 October 2011 DSM – repurchase of shares (20–26 October 2011) DSM repurchased 471,588 shares from 20 to 26 October 2011 at an average price of €36.81. 27 October 2011 DSM – repurchase of shares (20–26 October 2011) DSM repurchased 471,588 shares from 20 to 26 October 2011 at an average price of €36.81. 27 October 2011 DSM sells majority stake in TCG to MocoLabs TCG developed OtCM™ system to monitor compliance with drug therapy. 27 October 2011 DSM sells majority stake in TCG to MocoLabs TCG developed OtCM™ system to monitor compliance with drug therapy. 20 October 2011 DSM – repurchase of shares (13–19 October 2011) DSM repurchased 545,760 shares from 13 to 19 October 2011 at an average price of €37.15. 20 October 2011 DSM – repurchase of shares (13–19 October 2011) DSM repurchased 545,760 shares from 13 to 19 October 2011 at an average price of €37.15. 13 October 2011 DSM - repurchase of shares (6-12 October 2011) DSM repurchased 391,817 shares from 6 to 12 October 2011 at an average price of €35.51. 13 October 2011 DSM - repurchase of shares (6-12 October 2011) DSM repurchased 391,817 shares from 6 to 12 October 2011 at an average price of €35.51. 11 October 2011 DSM proposes two new members of Supervisory Board DSM Supervisory Board proposes appointing Mrs. Victoria Haynes and Mrs. Eileen Kennedy as Supervisory Board members. 11 October 2011 DSM proposes two new members of Supervisory Board DSM Supervisory Board proposes appointing Mrs. Victoria Haynes and Mrs. Eileen Kennedy as Supervisory Board members. 6 October 2011 DSM – repurchase of shares (29 September – 5 October 2011) DSM repurchased 519,526 shares from 29 September to 5 October 2011 at an average price of €32.42. DSM – repurchase of shares (29 September – 5 October 2011) DSM repurchased 519,526 shares from 29 September to 5 October 2011 at an average price of €32.42. 30 September 2011 DSM completes acquisition of majority share in China-based UHMWPE fiber manufacturer DSM acquires Shandong ICD High Performance Fiber Co. Ltd. (ICD), based in Laiwu, Shandong province, China. 30 September 2011 DSM completes acquisition of majority share in China-based UHMWPE fiber manufacturer DSM acquires Shandong ICD High Performance Fiber Co. Ltd. (ICD), based in Laiwu, Shandong province, China. 29 September 2011 DSM updates market on strategy progress at Capital Markets Days DSM updates investment community on progress made with strategy marking the shift from an era of intensive portfolio transformation to a strategy for the coming years of maximizing sustainable and profitable growth of ‘the new DSM’. 29 September 2011 DSM updates market on strategy progress at Capital Markets Days DSM updates investment community on progress made with strategy marking the shift from an era of intensive portfolio transformation to a strategy for the coming years of maximizing sustainable and profitable growth of ‘the new DSM’. 29 September 2011 DSM – repurchase of shares (22-28 September 2011) DSM repurchased 523,199 shares from 22 to 28 September 2011 at an average price of €31.49. 29 September 2011 DSM – repurchase of shares (22-28 September 2011) DSM repurchased 523,199 shares from 22 to 28 September 2011 at an average price of €31.49. 29 September 2011 DSM renews €500 million credit facility Unsecured credit facility of €500 million is for a minumum term of 5 years and a maximum term of 7 years. 29 September 2011 DSM renews €500 million credit facility Unsecured credit facility of €500 million is for a minumum term of 5 years and a maximum term of 7 years. 22 September 2011 DSM – repurchase of shares (15-21 September 2011) DSM repurchased 404,055 shares from 15 to 21 September 2011 at an average price of €32.52. 22 September 2011 DSM – repurchase of shares (15-21 September 2011) DSM repurchased 404,055 shares from 15 to 21 September 2011 at an average price of €32.52. 16 September 2011 DSM reports fatal accident at Augusta (Georgia, USA) On 13 September 2011 a fatal accident took place on DSM property in Augusta (Georgia, USA), in which one contractor lost his life. DSM deeply regrets this tragic accident and expresses its sympathy to the victim’s family. 16 September 2011 DSM reports fatal accident at Augusta (Georgia, USA) On 13 September 2011 a fatal accident took place on DSM property in Augusta (Georgia, USA), in which one contractor lost his life. DSM deeply regrets this tragic accident and expresses its sympathy to the victim’s family. 15 September 2011 DSM – repurchase of shares (7-14 September 2011) DSM repurchased 641,065 shares from 7 to 14 September 2011 at an average price of €31.84. 15 September 2011 DSM – repurchase of shares (7-14 September 2011) DSM repurchased 641,065 shares from 7 to 14 September 2011 at an average price of €31.84. 13 September 2011 DSM to sell Personalized Nutrition to Viocare DSM Personalized Nutrition’s corporate wellness business will become part of Viocare’s operations. 13 September 2011 DSM to sell Personalized Nutrition to Viocare DSM Personalized Nutrition’s corporate wellness business will become part of Viocare’s operations. 8 September 2011 DSM continues leadership in Dow Jones Sustainability World Index DSM once again retained its number one position in the chemical industry sector in the Dow Jones Sustainability World Index. 8 September 2011 DSM continues leadership in Dow Jones Sustainability World Index DSM once again retained its number one position in the chemical industry sector in the Dow Jones Sustainability World Index. 7 September 2011 DSM announces repurchase of shares to cover existing option plans DSM intends to repurchase 4,000,000 ordinary shares to cover commitments under management and personnel option plans. 7 September 2011 DSM announces repurchase of shares to cover existing option plans DSM intends to repurchase 4,000,000 ordinary shares to cover commitments under management and personnel option plans. 31 August 2011 DSM and Sinochem Group establish global anti-infectives joint venture Sinochem Group has taken a 50% equity interest in DSM Anti-Infectives for total cash consideration of €210 million on a cash and debt-free basis with 1 January 2011 as effective date. DSM and Sinochem Group establish global anti-infectives joint venture Sinochem Group has taken a 50% equity interest in DSM Anti-Infectives for total cash consideration of €210 million on a cash and debt-free basis with 1 January 2011 as effective date. 24 August 2011 DSM announces exchange ratio interim stock dividend 2011 Exchange ratio for the dividend in shares has been determined at 1 new ordinary share for every 72.338 existing ordinary shares. DSM announces exchange ratio interim stock dividend 2011 Exchange ratio for the dividend in shares has been determined at 1 new ordinary share for every 72.338 existing ordinary shares. 23 August 2011 DSM appoints new Executive Vice President Corporate Strategy & Acquisitions Philip Eykerman will join DSM as Executive Vice President Corporate Strategy & Acquisitions. DSM appoints new Executive Vice President Corporate Strategy & Acquisitions Philip Eykerman will join DSM as Executive Vice President Corporate Strategy & Acquisitions. 2 August 2011 DSM reports strong Q2 results with solid growth Q2 EBITDA from continuing operations €339 million, above both Q2 2010 and Q1 2011. DSM reports strong Q2 results with solid growth Q2 EBITDA from continuing operations €339 million, above both Q2 2010 and Q1 2011. 27 July 2011 Joint statement by DSM and Nutreco regarding Provimi DSM and Nutreco confirm they have decided to jointly explore the possibility to acquire Provimi. Joint statement by DSM and Nutreco regarding Provimi DSM and Nutreco confirm they have decided to jointly explore the possibility to acquire Provimi. 12 July 2011 DSM successfully acquires 51% stake in AGI Corporation (Taiwan) DSM acquires interest in manufacturer of environmentally friendly UV-curable resins. DSM successfully acquires 51% stake in AGI Corporation (Taiwan) DSM acquires interest in manufacturer of environmentally friendly UV-curable resins. 4 July 2011 DSM and KuibyshevAzot commence strategic cooperation in Russia Ventures cover marketing and production of engineering plastics compounds in Russia. DSM and KuibyshevAzot commence strategic cooperation in Russia Ventures cover marketing and production of engineering plastics compounds in Russia. 4 July 2011 DSM completes acquisition of Vitatene S.A.U. Acquisition of Vitatene allows DSM to strengthen the natural carotenoids offerings of its nutrition business as consumer demand for natural products continues to grow. DSM completes acquisition of Vitatene S.A.U. Acquisition of Vitatene allows DSM to strengthen the natural carotenoids offerings of its nutrition business as consumer demand for natural products continues to grow. 28 June 2011 DSM strengthens yeast technology leadership for 2G biofuels Acquisition adds new yeast and enzyme technologies for second generation biofuels. DSM strengthens yeast technology leadership for 2G biofuels Acquisition adds new yeast and enzyme technologies for second generation biofuels. 24 May 2011 DSM provides information on optional stock dividend Exchange ratio for the dividend in shares has been determined at 1 new ordinary share for every 48.077 existing ordinary shares. DSM provides information on optional stock dividend Exchange ratio for the dividend in shares has been determined at 1 new ordinary share for every 48.077 existing ordinary shares. 17 May 2011 DSM finalizes repurchase of shares to cover existing option plans DSM repurchased 264,319 shares from 13 to 16 May 2011 at an average price of €46.56 and concluded the program to repurchase 5,000,000 shares. DSM finalizes repurchase of shares to cover existing option plans DSM repurchased 264,319 shares from 13 to 16 May 2011 at an average price of €46.56 and concluded the program to repurchase 5,000,000 shares. 13 May 2011 DSM – repurchase of shares (6-12 May 2011) DSM repurchased 502,059 shares from 6 to 12 May 2011 at an average price of €46.05. DSM – repurchase of shares (6-12 May 2011) DSM repurchased 502,059 shares from 6 to 12 May 2011 at an average price of €46.05. 10 May 2011 DSM to acquire Vitatene S.A.U. to expand position in natural carotenoids Acquisition allows DSM to strengthen the natural carotenoids offerings of its nutrition business as consumer demand for natural products continues to grow. DSM to acquire Vitatene S.A.U. to expand position in natural carotenoids Acquisition allows DSM to strengthen the natural carotenoids offerings of its nutrition business as consumer demand for natural products continues to grow. 9 May 2011 Feike Sijbesma recognized with George Washington Carver Award Feike Sijbesma received award in recognition of his outstanding contribution to development and innovation in industrial biotechnology. Feike Sijbesma recognized with George Washington Carver Award Feike Sijbesma received award in recognition of his outstanding contribution to development and innovation in industrial biotechnology. 9 May 2011 DSM and Roquette to open commercial scale bio-based succinic acid plant in 2012 New chemical building block offers bio-based alternative. DSM and Roquette to open commercial scale bio-based succinic acid plant in 2012 New chemical building block offers bio-based alternative. 6 May 2011 DSM – repurchase of shares (29 April - 5 May 2011) DSM repurchased 601,953 shares from 29 April to 5 May 2011 at an average price of €45.78. DSM – repurchase of shares (29 April - 5 May 2011) DSM repurchased 601,953 shares from 29 April to 5 May 2011 at an average price of €45.78. 3 May 2011 DSM completes sale of DSM Elastomers to LANXESS DSM completes sale of DSM Elastomers to LANXESS for €310 million on a cash and debt-free basis. DSM completes sale of DSM Elastomers to LANXESS DSM completes sale of DSM Elastomers to LANXESS for €310 million on a cash and debt-free basis. 2 May 2011 DSM tenders Danisco shareholding DSM has tendered its 4.95% stake in Danisco to DuPont. DSM tenders Danisco shareholding DSM has tendered its 4.95% stake in Danisco to DuPont. 29 April 2011 DSM – repurchase of shares (26-28 April 2011) DSM repurchased 435,987 shares from 26 to 28 April 2011 at an average price of €45.33. DSM – repurchase of shares (26-28 April 2011) DSM repurchased 435,987 shares from 26 to 28 April 2011 at an average price of €45.33. 28 April 2011 Final dividend 2010 Royal DSM DSM declares dividend for 2010 of €1.35 per ordinary share of €1.50 par value. Final dividend 2010 Royal DSM DSM declares dividend for 2010 of €1.35 per ordinary share of €1.50 par value. 28 April 2011 DSM announces results of 2011 Annual General Meeting of Shareholders DSM held its Annual General Meeting of Shareholders on 28 April 2011. Shareholders approved all resolutions on the agenda. DSM announces results of 2011 Annual General Meeting of Shareholders DSM held its Annual General Meeting of Shareholders on 28 April 2011. Shareholders approved all resolutions on the agenda. 28 April 2011 Annual General Meeting of Shareholders 2011 Summary of the resolutions at DSM's Annual General Meeting of Shareholders 2011. Annual General Meeting of Shareholders 2011 Summary of the resolutions at DSM's Annual General Meeting of Shareholders 2011. 27 April 2011 DSM reports very strong Q1 2011 continuing its positive momentum Q1 EBITDA from continuing operations up 14% to €325 million. DSM reports very strong Q1 2011 continuing its positive momentum Q1 EBITDA from continuing operations up 14% to €325 million. 26 April 2011 DSM announces new President of DSM Netherlands DSM intends to appoint Mr. Atzo Nicolaï (1960), currently Member of the Dutch House of Representatives (“Tweede Kamer der Staten-Generaal”) with effect from 1 June 2011. DSM announces new President of DSM Netherlands DSM intends to appoint Mr. Atzo Nicolaï (1960), currently Member of the Dutch House of Representatives (“Tweede Kamer der Staten-Generaal”) with effect from 1 June 2011. 26 April 2011 DSM – repurchase of shares (15-21 April 2011) DSM repurchased 368,294 shares from 15 to 21 April 2011 at an average price of €42.70. DSM – repurchase of shares (15-21 April 2011) DSM repurchased 368,294 shares from 15 to 21 April 2011 at an average price of €42.70. 15 April 2011 DSM – repurchase of shares (8-14 April 2011) DSM repurchased 326,090 shares from 8 to 14 April 2011 at an average price of €43.53. DSM – repurchase of shares (8-14 April 2011) DSM repurchased 326,090 shares from 8 to 14 April 2011 at an average price of €43.53. 8 April 2011 DSM – repurchase of shares (1-7 April 2011) DSM repurchased 376,582 shares from 1 to 7 April 2011 at an average price of €43.97. DSM – repurchase of shares (1-7 April 2011) DSM repurchased 376,582 shares from 1 to 7 April 2011 at an average price of €43.97. 8 April 2011 DSM provides comparative 2010 figures in line with new reporting structure DSM will implement changes in the presentation of its financial results as from Q1 2011. DSM provides comparative 2010 figures in line with new reporting structure DSM will implement changes in the presentation of its financial results as from Q1 2011. 1 April 2011 DSM – repurchase of shares (25-31 March 2011) DSM repurchased 349,822 of its own shares from 25 to 31 March 2011 at an average price of €43.34. DSM – repurchase of shares (25-31 March 2011) DSM repurchased 349,822 of its own shares from 25 to 31 March 2011 at an average price of €43.34. 25 March 2011 DSM – repurchase of shares (18-24 March 2011) DSM repurchased 331,532 shares from 18 to 24 March 2011 at an average price of €42.33. DSM – repurchase of shares (18-24 March 2011) DSM repurchased 331,532 shares from 18 to 24 March 2011 at an average price of €42.33. 18 March 2011 DSM – repurchase of shares (11-17 March 2011) DSM repurchased 479,895 shares from 11 to 17 March 2011 at an average price of €41.13. DSM – repurchase of shares (11-17 March 2011) DSM repurchased 479,895 shares from 11 to 17 March 2011 at an average price of €41.13. 11 March 2011 DSM – repurchase of shares (4-10 March 2011) DSM repurchased 499,687 shares from 4 to 10 March at an average price of € 43.49. DSM – repurchase of shares (4-10 March 2011) DSM repurchased 499,687 shares from 4 to 10 March at an average price of € 43.49. 4 March 2011 DSM – repurchase of shares (24 February - 3 March 2011) DSM repurchased 463,780 shares from 24 February to 3 March 2011 at an average price of €42.74. DSM – repurchase of shares (24 February - 3 March 2011) DSM repurchased 463,780 shares from 24 February to 3 March 2011 at an average price of €42.74. 1 March 2011 DSM announces partnership for specialty resins with Kemrock Industries in India Partnership with Kemrock Industries in India for the production of specialty composite resins in India. DSM announces partnership for specialty resins with Kemrock Industries in India Partnership with Kemrock Industries in India for the production of specialty composite resins in India. 28 February 2011 DSM completes acquisition of Martek; adding new Nutrition growth platform Acquisition adds new growth platform for healthy and natural food ingredients, focused on Omega-3 DHA and Omega-6 ARA. 28 February 2011 DSM completes acquisition of Martek; adding new Nutrition growth platform Acquisition adds new growth platform for healthy and natural food ingredients, focused on Omega-3 DHA and Omega-6 ARA. 25 February 2011 DSM successfully completes tender offer for Martek and expects to complete acquisition today DSM successfully completes subsequent offering period to its all-cash tender offer. 25 February 2011 DSM successfully completes tender offer for Martek and expects to complete acquisition today DSM successfully completes subsequent offering period to its all-cash tender offer. 25 February 2011 DSM joint venture to build world class composite resins facility in China Jinling DSM Resins Co., Ltd. (JDR) will invest approximately €50 million in a new production facility for composite resins in Nanjing, China. 25 February 2011 DSM joint venture to build world class composite resins facility in China Jinling DSM Resins Co., Ltd. (JDR) will invest approximately €50 million in a new production facility for composite resins in Nanjing, China. 25 February 2011 DSM – proposed appointment to the Managing Board of Directors Supervisory Board proposes appointing Mr. Stefan Doboczky to DSM's Managing Board with effect from 1 May 2011. 25 February 2011 DSM – proposed appointment to the Managing Board of Directors Supervisory Board proposes appointing Mr. Stefan Doboczky to DSM's Managing Board with effect from 1 May 2011. 23 February 2011 DSM reports strong 2010 results and proposes dividend increase to €1.35 Full-year operating profit continuing operations up 74% to €752 million, dividend increase of 12.5% per ordinary share proposed. 23 February 2011 DSM reports strong 2010 results and proposes dividend increase to €1.35 Full-year operating profit continuing operations up 74% to €752 million, dividend increase of 12.5% per ordinary share proposed. 23 February 2011 DSM marks its transformation with new brand Royal DSM N.V today introduces a new company brand: Bright Science. Brighter Living™. The new brand is symbolic of the transition to the ‘new’ DSM. 23 February 2011 DSM marks its transformation with new brand Royal DSM N.V today introduces a new company brand: Bright Science. Brighter Living™. The new brand is symbolic of the transition to the ‘new’ DSM. 23 February 2011 DSM announces repurchase of shares to cover existing option plans DSM intends to repurchase 5,000,000 ordinary shares to cover commitments under management and personnel option plans. 23 February 2011 DSM announces repurchase of shares to cover existing option plans DSM intends to repurchase 5,000,000 ordinary shares to cover commitments under management and personnel option plans. 22 February 2011 DSM announces new Supervisory Board chairman DSM Supervisory Board has appointed Rob Routs as its new Chairman. 22 February 2011 DSM announces new Supervisory Board chairman DSM Supervisory Board has appointed Rob Routs as its new Chairman. 21 February 2011 DSM tender offer for Martek Biosciences Corporation is successful Tender offer to purchase all outstanding shares of common stock of Martek Biosciences Corporation successful. 21 February 2011 DSM tender offer for Martek Biosciences Corporation is successful Tender offer to purchase all outstanding shares of common stock of Martek Biosciences Corporation successful. 17 February 2011 DSM announces receipt of final competition clearance for acquisition of Martek Counsel of the National Competition Commission approves acquisition. 17 February 2011 DSM announces receipt of final competition clearance for acquisition of Martek Counsel of the National Competition Commission approves acquisition. 17 February 2011 DSM acquires majority share in UHMWPE fiber manufacturer in China DSM to acquire the majority shareholding in Shandong ICD High Performance Fibre Co Ltd. based in Laiwu, China. 17 February 2011 DSM acquires majority share in UHMWPE fiber manufacturer in China DSM to acquire the majority shareholding in Shandong ICD High Performance Fibre Co Ltd. based in Laiwu, China. 16 February 2011 DSM provides 2009 comparative figures DSM will use new P&L from the publication of the full year 2010 results onwards. 16 February 2011 DSM provides 2009 comparative figures DSM will use new P&L from the publication of the full year 2010 results onwards. 1 February 2011 DSM announces expiration of waiting period under Hart-Scott-Rodino Act Waiting period for DSM's offer for all outstanding shares of Martek Biosciences Corporation at a price of $31.50 per share closes. 1 February 2011 DSM announces expiration of waiting period under Hart-Scott-Rodino Act Waiting period for DSM's offer for all outstanding shares of Martek Biosciences Corporation at a price of $31.50 per share closes. 28 January 2011 DSM and USAID partnership to meet nutritional challenges of developing world DSM and United States Agency for International Development (USAID) to collaborate and collectively work to meet the nutritional challenges presented in the developing world. 28 January 2011 DSM and USAID partnership to meet nutritional challenges of developing world DSM and United States Agency for International Development (USAID) to collaborate and collectively work to meet the nutritional challenges presented in the developing world. 20 January 2011 DSM and KuibyshevAzot announce strategic cooperation in Russia DSM Engineering Plastics to enter two joint ventures with KA. 20 January 2011 DSM and KuibyshevAzot announce strategic cooperation in Russia DSM Engineering Plastics to enter two joint ventures with KA. 13 January 2011 DSM commences tender offer for Martek Biosciences Corporation DSM commences tender offer for all outstanding shares of common stock of Martek Biosciences Corporation at a price of $31.50 per share. 13 January 2011 DSM commences tender offer for Martek Biosciences Corporation DSM commences tender offer for all outstanding shares of common stock of Martek Biosciences Corporation at a price of $31.50 per share. 12 January 2011 DSM discloses shareholding in Danisco DSM holds a 4.95% stake in Danisco which has been acquired some years ago. 12 January 2011 DSM discloses shareholding in Danisco DSM holds a 4.95% stake in Danisco which has been acquired some years ago. Firmenich Archive Read press releases from last 3 years of Firmenich. 19 June 2026 Firmenich International SA financial statements for 2025 Read more Firmenich International SA financial statements for 2025 8 April 2025 Firmenich International SA financial statements for 2024 Read more Firmenich International SA financial statements for 2024 9 May 2023 Firmenich completes merger of equals with DSM Read more Firmenich completes merger of equals with DSM 2 May 2023 Firmenich deliveres strong results in the third quarter of financial year 2023 Read more Firmenich deliveres strong results in the third quarter of financial year 2023 20 March 2023 Firmenich recognized as one of the 2023 World’s Most Ethical Companies® Read more Firmenich recognized as one of the 2023 World’s Most Ethical Companies® 6 February 2023 Firmenich Receives Top-Recognition by EDGE for Accelerated Efforts on Diversity, Equity and Inclusion Read more 6 February 2023 Firmenich Receives Top-Recognition by EDGE for Accelerated Efforts on Diversity, Equity and Inclusion 31 January 2023 Firmenich recognized as one of the world’s most dynamic innovators by LexisNexis Read more 31 January 2023 Firmenich recognized as one of the world’s most dynamic innovators by LexisNexis 13 December 2022 Firmenich recognized for global environmental leadership with fifth CDP triple “A” Read more 13 December 2022 Firmenich recognized for global environmental leadership with fifth CDP triple “A” 11 October 2022 Firmenich Inaugurates New Campus in Geneva Read more 11 October 2022 Firmenich Inaugurates New Campus in Geneva 5 August 2022 Firmenich delivers record results despite challenging macro-economic environment Read more Firmenich delivers record results despite challenging macro-economic environment 12 July 2022 Firmenich appoints Dr Eric Frérot as Distinguished Scientist Read more Firmenich appoints Dr Eric Frérot as Distinguished Scientist 30 May 2022 Firmenich Signs Strategic Partnership with ScentRealm in China Read more Firmenich Signs Strategic Partnership with ScentRealm in China 23 March 2022 Firmenich and Leading Dignitaries from Switzerland and Dubai Inaugurate State-Of-The-Art Creation & Development Center At Dubai Science Park Read more Firmenich and Leading Dignitaries from Switzerland and Dubai Inaugurate State-Of-The-Art Creation & Development Center At Dubai Science Park 10 February 2022 Firmenich delivers strong results in the first half of fiscal year 2022, despite challenging raw material and supply chain environment Read more 10 February 2022 Firmenich delivers strong results in the first half of fiscal year 2022, despite challenging raw material and supply chain environment 7 December 2021 Firmenich Demonstrates Consistent Global Environmental Leadership with fourth CDP Triple “A” Read more 7 December 2021 Firmenich Demonstrates Consistent Global Environmental Leadership with fourth CDP Triple “A” 1 December 2021 Celebrating 20 Years of Inspiring TRENZ: Firmenich’s Pioneering Foresight Engine Read more 1 December 2021 Celebrating 20 Years of Inspiring TRENZ: Firmenich’s Pioneering Foresight Engine 15 November 2021 Firmenich’s Leading AI Expertise Wins Digital Innovation of the Year Read more 15 November 2021 Firmenich’s Leading AI Expertise Wins Digital Innovation of the Year 5 November 2021 Firmenich and MG International Fragrance Company Launch Construction of Regional Perfumery Production Hub in Turkey Read more 5 November 2021 Firmenich and MG International Fragrance Company Launch Construction of Regional Perfumery Production Hub in Turkey 7 October 2021 Firmenich Brings the Scent of Switzerland to Expo 2020 Dubai Read more Firmenich Brings the Scent of Switzerland to Expo 2020 Dubai 6 October 2021 Firmenich Reports Robust FY 2021 Sustainability Performance Read more Firmenich Reports Robust FY 2021 Sustainability Performance 27 September 2021 Firmenich Opens Studio Guangzhou, A Unique Customer Experience Center Tailored to China’s Fast-Growing Market Read more 27 September 2021 Firmenich Opens Studio Guangzhou, A Unique Customer Experience Center Tailored to China’s Fast-Growing Market 6 August 2021 Firmenich Reports Solid Full Year Results With Accelerating Momentum In The Second Half Read more Firmenich Reports Solid Full Year Results With Accelerating Momentum In The Second Half 30 June 2021 Firmenich Marks 3 Years of its Flagship ALIBABA E-shop with Broadest Ingredients Portfolio & Enhanced Digital Experience Read more Firmenich Marks 3 Years of its Flagship ALIBABA E-shop with Broadest Ingredients Portfolio & Enhanced Digital Experience 17 June 2021 Firmenich launches Scentmate™, The New Way to Scent Read more Firmenich launches Scentmate™, The New Way to Scent 8 March 2021 Firmenich Leads on Equality in the Workplace, Reaching Next Level of Global EDGE Certification Read more Firmenich Leads on Equality in the Workplace, Reaching Next Level of Global EDGE Certification 11 February 2021 Firmenich Reports Solid Half Year Results despite Pandemic Read more 11 February 2021 Firmenich Reports Solid Half Year Results despite Pandemic 9 February 2021 Firmenich Achieves Fourth CDP Top Score This Year, Setting the Pace in Environmental Leadership Read more 9 February 2021 Firmenich Achieves Fourth CDP Top Score This Year, Setting the Pace in Environmental Leadership 4 February 2021 Firmenich Commits to be Carbon Neutral by 2025 Read more 4 February 2021 Firmenich Commits to be Carbon Neutral by 2025 8 December 2020 Firmenich Recognized as Global Environmental Leader with CDP Triple “A” Listing for Third Year Running Read more 8 December 2020 Firmenich Recognized as Global Environmental Leader with CDP Triple “A” Listing for Third Year Running Firmenich | World's largest privately-owned Fragrance and Taste company Read more Firmenich | World's largest privately-owned Fragrance and Taste company Firmenich successfully completes aquisition of DRT Read more Firmenich successfully completes aquisition of DRT Firmenich Strengthens Sustainability Performance in FY2022 Read more Firmenich Strengthens Sustainability Performance in FY2022 Firmenich recognized by Better Society Network for ethical business Read more Firmenich recognized by Better Society Network for ethical business Firmenich Receives SBTi Approval For Net-Zero Emissions Target Read more Firmenich Receives SBTi Approval For Net-Zero Emissions Target Firmenich Studio, a new One-Stop Online Customer Experience Read more Firmenich Studio, a new One-Stop Online Customer Experience Firmenich receives industry-leading Sustainalytics ESG score of 7.5, ranking 37th of approximately 15,000 companies rated worldwide Read more Firmenich receives industry-leading Sustainalytics ESG score of 7.5, ranking 37th of approximately 15,000 companies rated worldwide Firmenich marks its 125th anniversary with new customer-focused website Read more Firmenich marks its 125th anniversary with new customer-focused website Firmenich launches “FOR GOOD NATURALLY”, marking new chapter in 124-year legacy of responsible business Read more Firmenich launches “FOR GOOD NATURALLY”, marking new chapter in 124-year legacy of responsible business Firmenich launches first holistic fragrance sustainability measurement: ECOSCENT COMPASS™ Read more Firmenich launches first holistic fragrance sustainability measurement: ECOSCENT COMPASS™ Firmenich delivers strong results in half of fiscal year 2023 Read more Firmenich delivers strong results in half of fiscal year 2023 Firmenich confirms anti-trust probes into fragrances sector Read more Firmenich confirms anti-trust probes into fragrances sector Firmenich Appoints Dr. Sarah Reisinger as Chief Research Officer Read more Firmenich Appoints Dr. Sarah Reisinger as Chief Research Officer Firmenich achieves highest EcoVadis Platinum sustainability rating and improves its score to 88/100 Read more Firmenich achieves highest EcoVadis Platinum sustainability rating and improves its score to 88/100 dsm-firmenich launches as innovators in nutrition, health, and beauty Read more dsm-firmenich launches as innovators in nutrition, health, and beauty News Read more about news from dsm-firmenich and its businesses Read more Read more about news from dsm-firmenich and its businesses Sustainability Sustainability is fundamental to how dsm-firmenich brings progress to life – for people and planet. Read more Sustainability is fundamental to how dsm-firmenich brings progress to life – for people and planet. Investors Through science and innovation, we are creating a world of potential for investors. Read more Through science and innovation, we are creating a world of potential for investors.